{
    "docs": [
        {
            "location": "/", 
            "text": "Welcome to ICGC Docs\n\n\nThis is the official project documentation site of the ICGC.\n\n\nContents\n\n\nThe ICGC documentation is divided into the following top-level sections:\n\n\n\n\nPortal\n\n\nCloud\n\n\nSubmission\n\n\n\n\nContributing\n\n\nTo help contribute to the documentation, open a pull request at \n https://github.com/icgc/icgc-docs\n.\n\n\nContact\n\n\nFor support, please contact us at \ndcc-support@icgc.org\n.", 
            "title": "Home"
        }, 
        {
            "location": "/#welcome-to-icgc-docs", 
            "text": "This is the official project documentation site of the ICGC.", 
            "title": "Welcome to ICGC Docs"
        }, 
        {
            "location": "/#contents", 
            "text": "The ICGC documentation is divided into the following top-level sections:   Portal  Cloud  Submission", 
            "title": "Contents"
        }, 
        {
            "location": "/#contributing", 
            "text": "To help contribute to the documentation, open a pull request at   https://github.com/icgc/icgc-docs .", 
            "title": "Contributing"
        }, 
        {
            "location": "/#contact", 
            "text": "For support, please contact us at  dcc-support@icgc.org .", 
            "title": "Contact"
        }, 
        {
            "location": "/portal/about/", 
            "text": "About\n\n\nOverview\n\n\nThis is the Portal documentation section which describes the various features of the ICGC Data Portal hosted at \nhttps://dcc.icgc.org\n.\n\n\nOne of most popular features of the portal is \nAdvanced Search\n which maybe found at \nhttps://dcc.icgc.org/search\n. This is a great place to begin exploring the ICGC data set.\n\n\nFor offline analysis, it is often convenient to work with archive files. These are made available in the \nReleases\n feature and is served at \nhttps://dcc.icgc.org/releases", 
            "title": "About"
        }, 
        {
            "location": "/portal/about/#about", 
            "text": "", 
            "title": "About"
        }, 
        {
            "location": "/portal/about/#overview", 
            "text": "This is the Portal documentation section which describes the various features of the ICGC Data Portal hosted at  https://dcc.icgc.org .  One of most popular features of the portal is  Advanced Search  which maybe found at  https://dcc.icgc.org/search . This is a great place to begin exploring the ICGC data set.  For offline analysis, it is often convenient to work with archive files. These are made available in the  Releases  feature and is served at  https://dcc.icgc.org/releases", 
            "title": "Overview"
        }, 
        {
            "location": "/portal/access/", 
            "text": "Access Controlled Data\n\n\nICGC controlled-access data\n\n\nTwo major types of ICGC data are protected: raw sequencing reads and analyzed germline data. Application for access to these data can be submitted to \nICGC's Data Access and Compliance Office (DACO)\n.\n\n\nRaw sequencing and other primary data\n\n\nICGC member projects are required by ICGC policies to submit their raw sequencing reads and other primary data, to controlled access public repositories. The official ICGC DCC-supported repository for \nICGC sequencing reads\n is the European Bioinformatics Institute's (EBI) \nEuropean Genome-phenome Archive (EGA)\n. For the ICGC member projects which are part of the U.S. \nTCGA\n project, raw data will be hosted either at the \nTCGA DCC\n or the \nCancer Genomics Hub (CGHub)\n.\n\n\nAnalyzed germline data\n\n\nAnalyzed germline data are hosted at the ICGC DCC and accessible through the \nICGC Data Portal\n. Analyzed germline data include variants in cancer donors' normal genomes, such as simple germline variations (SGV), and a very small portion of the simple somatic mutations (SSM) that could leak germline information, ie, alleles that are not in concordance with human reference genome. These SSMs are censored through the \ngermline data masking\n process. Censored SSMs will then be made publicly accessible while original unmasked SSMs are only accessible to DACO approved users.\n\n\nPCAWG Data (Pan-Cancer Analysis of Whole Genome) \n\n\nThe PCAWG data set consists of uniformly aligned (by BWA-MEM) sample-level BAM files, plus sets of germline variant and somatic mutation data (in VCF format) produced by PCAWG core pipelines. Some uniformly aligned RNA-Seq data for matched genomic data are also available.\n\n\nPCAWG data are stored in individual GNOS repositories hosted at different academic centres globally. To improve accessibility some data entries have been synchronized among GNOS repositories.\n\n\n\n\nYou can browse and search for PCAWG data files on ICGC Data Portal - Repository Browser \nhttps://dcc.icgc.org/repositories\n.\n\n\nFor actual data download, you will need to apply for data access via ICGC DACO for non-TCGA portion of the ICGC data, and via dbGAP for TCGA portion.\n\n\n\n\nFor more information on ICGC/TCGA PCWAG Status, please go to .\n\nPlease note: PCAWG data set is currently restricted to the researchers who are part of the PCAWG study and will be open to the broader community at the end of the study.", 
            "title": "Access"
        }, 
        {
            "location": "/portal/access/#access-controlled-data", 
            "text": "", 
            "title": "Access Controlled Data"
        }, 
        {
            "location": "/portal/access/#icgc-controlled-access-data", 
            "text": "Two major types of ICGC data are protected: raw sequencing reads and analyzed germline data. Application for access to these data can be submitted to  ICGC's Data Access and Compliance Office (DACO) .", 
            "title": "ICGC controlled-access data"
        }, 
        {
            "location": "/portal/access/#raw-sequencing-and-other-primary-data", 
            "text": "ICGC member projects are required by ICGC policies to submit their raw sequencing reads and other primary data, to controlled access public repositories. The official ICGC DCC-supported repository for  ICGC sequencing reads  is the European Bioinformatics Institute's (EBI)  European Genome-phenome Archive (EGA) . For the ICGC member projects which are part of the U.S.  TCGA  project, raw data will be hosted either at the  TCGA DCC  or the  Cancer Genomics Hub (CGHub) .", 
            "title": "Raw sequencing and other primary data"
        }, 
        {
            "location": "/portal/access/#analyzed-germline-data", 
            "text": "Analyzed germline data are hosted at the ICGC DCC and accessible through the  ICGC Data Portal . Analyzed germline data include variants in cancer donors' normal genomes, such as simple germline variations (SGV), and a very small portion of the simple somatic mutations (SSM) that could leak germline information, ie, alleles that are not in concordance with human reference genome. These SSMs are censored through the  germline data masking  process. Censored SSMs will then be made publicly accessible while original unmasked SSMs are only accessible to DACO approved users.", 
            "title": "Analyzed germline data"
        }, 
        {
            "location": "/portal/access/#pcawg-data-pan-cancer-analysis-of-whole-genome", 
            "text": "The PCAWG data set consists of uniformly aligned (by BWA-MEM) sample-level BAM files, plus sets of germline variant and somatic mutation data (in VCF format) produced by PCAWG core pipelines. Some uniformly aligned RNA-Seq data for matched genomic data are also available.  PCAWG data are stored in individual GNOS repositories hosted at different academic centres globally. To improve accessibility some data entries have been synchronized among GNOS repositories.   You can browse and search for PCAWG data files on ICGC Data Portal - Repository Browser  https://dcc.icgc.org/repositories .  For actual data download, you will need to apply for data access via ICGC DACO for non-TCGA portion of the ICGC data, and via dbGAP for TCGA portion.   For more information on ICGC/TCGA PCWAG Status, please go to . \nPlease note: PCAWG data set is currently restricted to the researchers who are part of the PCAWG study and will be open to the broader community at the end of the study.", 
            "title": "PCAWG Data (Pan-Cancer Analysis of Whole Genome)"
        }, 
        {
            "location": "/portal/analysis/", 
            "text": "Analysis\n\n\nOverview\n\n\nThis is the Analysis documentation page", 
            "title": "Analysis"
        }, 
        {
            "location": "/portal/analysis/#analysis", 
            "text": "", 
            "title": "Analysis"
        }, 
        {
            "location": "/portal/analysis/#overview", 
            "text": "This is the Analysis documentation page", 
            "title": "Overview"
        }, 
        {
            "location": "/portal/api/", 
            "text": "Data Portal API\n\n\nThe ICGC Portal API can be accessed from the command line using \ncURL\n but we suggest using \nhttpie\n, a cURL replacement that is particularly well-suited to JSON-based REST APIs. The following examples will contain instuctions for using both cURL and httpie.\n\n\nICGC API is a set of RESTful endpoints -- programmable interfaces over the Web -- that allows third-party developers to build automation scripts and apps.\n\n\nPlease see \nhttps://dcc.icgc.org/docs/\n for detailed information on the API endpoints, representations and how the API responds to different requests.\n\n\nControlled Access\n\n\nLogging in from the Command Line\n\n\nLogging in to the \nICGC Portal API\n from the command line requires an ICGC.org account.\n\n\nRequest\n\n\n$ curl -XPOST -i -H 'Content-Type: application/json' 'https://dcc.icgc.org/api/v1/auth/login' -d {\nusername\n:\n...\n,\npassword\n:\n...\n}\n\n$ http POST username=\n...\n password=\n...\n 'https://dcc.icgc.org/api/v1/auth/login'\n\n\n\n\nResponse\n\n\n{token: YOUR_DCC_PORTAL_TOKEN_HERE}\n\n\n\n\nDownloading Static Files\n\n\nRequest\n\n\n$ curl -o simple_somatic_mutation.open.COAD-US.tsv.gz https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.open.COAD-US.tsv.gz\n\n$ http -o simple_somatic_mutation.open.COAD-US.tsv.gz https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.open.COAD-US.tsv.gz\n\n\n\n\nResponse\n\n\n% Total    % Received % Xferd  Average Speed   Time    Time     Time     Current\n                               Dload  Upload   Total   Spent    Left     Speed\n100 21.8M  100 21.8M    0     0  27.6M      0 --:--:-- --:--:-- --:--:-- 27.5M\n\n\n\n\nControlled Access\n\n\nRequest\n\n\n$ curl -o simple_somatic_mutation.controlled.COAD-US.tsv.gz 'https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.controlled.COAD-US.tsv.gz' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n$ http -o simple_somatic_mutation.controlled.COAD-US.tsv.gz 'https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.controlled.COAD-US.tsv.gz' 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n\n\n\nResponse\n\n\n% Total    % Received % Xferd  Average Speed   Time    Time     Time     Current\n                               Dload  Upload   Total   Spent    Left     Speed\n100 21.8M  100 21.8M    0     0  27.6M      0 --:--:-- --:--:-- --:--:-- 27.5M\n\n\n\n\nDynamic Filtered Download\n\n\nStart a job\n\n\nRequest\n\n\n$ curl 'https://dcc.icgc.org/api/v1/download/submit?filters={\ndonor\n:{\nprimarySite\n:{\nis\n:[\nBrain\n]}}}\ninfo=[{\nkey\n:\nssm\n,\nvalue\n:\nTSV\n}]\nemail=YOUR@EMAIL.COM'\n\n$ http 'https://dcc.icgc.org/api/v1/download/submit' 'filters=={\ndonor\n:{\nprimarySite\n:{\nis\n:[\nBrain\n]}}}' 'info==[{\nkey\n:\nssm\n,\nvalue\n:\nTSV\n}]' 'email==YOUR@EMAIL.COM'\n\n\n\n\nResponse\n\n\n{\ndownloadId\n:\nYOUR_DOWNLOAD_ID\n}\n\n\n\n\nOptional\n\n\nYou can include your email address in the request to recieve email updates on the status of your download but it is not required. You can also view the status of your download by going to \nhttps://dcc.icgc.orb/downloads/YOUR_DOWNLOAD_ID\n\n\nView status\n\n\nRequest\n\n\n$ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status'\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status'\n\n\n\n\nResponse\n\n\n[{\n    \ndownloadId\n: \nYOUR_DOWNLOAD_ID\n,\n    \nprogress\n: [\n        {\n            \ncompleted\n: \ntrue\n,\n            \ndataType\n: \nssm\n,\n            \ndenominator\n: \n328238\n,\n            \nnumerator\n: \n629347\n,\n            \npercentage\n: \n0.5\n\n        }\n    ],\n    \nstatus\n: \nRUNNING\n\n}]\n\n\n\n\nDownloading\n\n\nWhen you see \n\"status\": \"SUCCEEDED\"\n you can download the file.\n\n\nRequest\n\n\n$ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' -o my_dl.tar\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' -o my_dl.tar\n\n\n\n\nResponse\n\n\n% Total    % Received % Xferd  Average Speed   Time    Time     Time     Current\n                               Dload  Upload   Total   Spent    Left     Speed\n100 12.3M    0 12.3M    0     0   471k      0 --:--:--  0:00:26 --:--:-- 3411k\n\n\n\n\nControlled Access\n\n\nIf the Dynamic Download Job contains controlled access data you must include your \ndcc_portal_token\n with every request.\n\n\nRequest\n\n\n$ curl 'https://dcc.icgc.org/api/v1/download/submit?filters={\ndonor\n:{\nprimarySite\n:{\nis\n:[\nBrain\n]}}}\ninfo=[{\nkey\n:\nsgv\n,\nvalue\n:\nTSV\n}]\nemail=YOUR@EMAIL.COM' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n$ http 'https://dcc.icgc.org/api/v1/download/submit' 'filters=={\ndonor\n:{\nprimarySite\n:{\nis\n:[\nBrain\n]}}}' 'info==[{\nkey\n:\nsgv\n,\nvalue\n:\nTSV\n}]' 'email==YOUR@EMAIL.COM' 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n\n\n\nRequest\n\n\n$ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status' 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n\n\n\nRequest\n\n\n$ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE' -o my_dl.tar\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' -o my_dl.tar 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n\n\n\nCommon Errors\n\n\nFile downloaded successfully but only 133B\n\n\nLook into the file, you should see a message along the lines of:\n\n\nError(code=404, message=Download with id '/release_16/Projects/COAD-US/simple_somatic_mutation.controlled.COAD-US.tsv.gz' not found.)\n\n\n\n\nSolution\n\n\nMake sure the path to the file is correct and if you are trying to download a controlled access file make sure your \ndcc_access_token\n is valid.", 
            "title": "API"
        }, 
        {
            "location": "/portal/api/#data-portal-api", 
            "text": "The ICGC Portal API can be accessed from the command line using  cURL  but we suggest using  httpie , a cURL replacement that is particularly well-suited to JSON-based REST APIs. The following examples will contain instuctions for using both cURL and httpie.  ICGC API is a set of RESTful endpoints -- programmable interfaces over the Web -- that allows third-party developers to build automation scripts and apps.  Please see  https://dcc.icgc.org/docs/  for detailed information on the API endpoints, representations and how the API responds to different requests.", 
            "title": "Data Portal API"
        }, 
        {
            "location": "/portal/api/#controlled-access", 
            "text": "", 
            "title": "Controlled Access"
        }, 
        {
            "location": "/portal/api/#logging-in-from-the-command-line", 
            "text": "Logging in to the  ICGC Portal API  from the command line requires an ICGC.org account.  Request  $ curl -XPOST -i -H 'Content-Type: application/json' 'https://dcc.icgc.org/api/v1/auth/login' -d { username : ... , password : ... }\n\n$ http POST username= ...  password= ...  'https://dcc.icgc.org/api/v1/auth/login'  Response  {token: YOUR_DCC_PORTAL_TOKEN_HERE}", 
            "title": "Logging in from the Command Line"
        }, 
        {
            "location": "/portal/api/#downloading-static-files", 
            "text": "Request  $ curl -o simple_somatic_mutation.open.COAD-US.tsv.gz https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.open.COAD-US.tsv.gz\n\n$ http -o simple_somatic_mutation.open.COAD-US.tsv.gz https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.open.COAD-US.tsv.gz  Response  % Total    % Received % Xferd  Average Speed   Time    Time     Time     Current\n                               Dload  Upload   Total   Spent    Left     Speed\n100 21.8M  100 21.8M    0     0  27.6M      0 --:--:-- --:--:-- --:--:-- 27.5M", 
            "title": "Downloading Static Files"
        }, 
        {
            "location": "/portal/api/#controlled-access_1", 
            "text": "Request  $ curl -o simple_somatic_mutation.controlled.COAD-US.tsv.gz 'https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.controlled.COAD-US.tsv.gz' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n$ http -o simple_somatic_mutation.controlled.COAD-US.tsv.gz 'https://dcc.icgc.org/api/v1/download?fn=/release_16/Projects/COAD-US/simple_somatic_mutation.controlled.COAD-US.tsv.gz' 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'  Response  % Total    % Received % Xferd  Average Speed   Time    Time     Time     Current\n                               Dload  Upload   Total   Spent    Left     Speed\n100 21.8M  100 21.8M    0     0  27.6M      0 --:--:-- --:--:-- --:--:-- 27.5M", 
            "title": "Controlled Access"
        }, 
        {
            "location": "/portal/api/#dynamic-filtered-download", 
            "text": "", 
            "title": "Dynamic Filtered Download"
        }, 
        {
            "location": "/portal/api/#start-a-job", 
            "text": "Request  $ curl 'https://dcc.icgc.org/api/v1/download/submit?filters={ donor :{ primarySite :{ is :[ Brain ]}}} info=[{ key : ssm , value : TSV }] email=YOUR@EMAIL.COM'\n\n$ http 'https://dcc.icgc.org/api/v1/download/submit' 'filters=={ donor :{ primarySite :{ is :[ Brain ]}}}' 'info==[{ key : ssm , value : TSV }]' 'email==YOUR@EMAIL.COM'  Response  { downloadId : YOUR_DOWNLOAD_ID }  Optional  You can include your email address in the request to recieve email updates on the status of your download but it is not required. You can also view the status of your download by going to  https://dcc.icgc.orb/downloads/YOUR_DOWNLOAD_ID", 
            "title": "Start a job"
        }, 
        {
            "location": "/portal/api/#view-status", 
            "text": "Request  $ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status'\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status'  Response  [{\n     downloadId :  YOUR_DOWNLOAD_ID ,\n     progress : [\n        {\n             completed :  true ,\n             dataType :  ssm ,\n             denominator :  328238 ,\n             numerator :  629347 ,\n             percentage :  0.5 \n        }\n    ],\n     status :  RUNNING \n}]", 
            "title": "View status"
        }, 
        {
            "location": "/portal/api/#downloading", 
            "text": "When you see  \"status\": \"SUCCEEDED\"  you can download the file.  Request  $ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' -o my_dl.tar\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' -o my_dl.tar  Response  % Total    % Received % Xferd  Average Speed   Time    Time     Time     Current\n                               Dload  Upload   Total   Spent    Left     Speed\n100 12.3M    0 12.3M    0     0   471k      0 --:--:--  0:00:26 --:--:-- 3411k", 
            "title": "Downloading"
        }, 
        {
            "location": "/portal/api/#controlled-access_2", 
            "text": "If the Dynamic Download Job contains controlled access data you must include your  dcc_portal_token  with every request.  Request  $ curl 'https://dcc.icgc.org/api/v1/download/submit?filters={ donor :{ primarySite :{ is :[ Brain ]}}} info=[{ key : sgv , value : TSV }] email=YOUR@EMAIL.COM' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n$ http 'https://dcc.icgc.org/api/v1/download/submit' 'filters=={ donor :{ primarySite :{ is :[ Brain ]}}}' 'info==[{ key : sgv , value : TSV }]' 'email==YOUR@EMAIL.COM' 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'  Request  $ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID/status' 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'  Request  $ curl 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' --cookie 'dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE' -o my_dl.tar\n\n$ http 'https://dcc.icgc.org/api/v1/download/YOUR_DOWNLOAD_ID' -o my_dl.tar 'Cookie:dcc_portal_token=YOUR_DCC_PORTAL_TOKEN_HERE'", 
            "title": "Controlled Access"
        }, 
        {
            "location": "/portal/api/#common-errors", 
            "text": "", 
            "title": "Common Errors"
        }, 
        {
            "location": "/portal/api/#file-downloaded-successfully-but-only-133b", 
            "text": "Look into the file, you should see a message along the lines of:  Error(code=404, message=Download with id '/release_16/Projects/COAD-US/simple_somatic_mutation.controlled.COAD-US.tsv.gz' not found.)  Solution  Make sure the path to the file is correct and if you are trying to download a controlled access file make sure your  dcc_access_token  is valid.", 
            "title": "File downloaded successfully but only 133B"
        }, 
        {
            "location": "/portal/methods/", 
            "text": "Methods\n\n\nThe ICGC Data Portal uses gene models produced by Ensembl \nhttp://www.ensembl.org\n.\n\n\nThe canonical gene data (release 75) is available from Ensembl FTP site at \n ftp://ftp.ensembl.org/pub/release-75/mysql/homo_sapiens_core_75_37\n. We downloaded files with gene, transcript, translation, exon, xref, and domain etc data, built a document-oriented data store with essential gene information. We then further integrated gene summary information downloaded from NCBI Entrez Gene. This gene document is then integrated with somatic mutation datasets based on mutation consequence annotation (described in the next section) results.\n\n\nAs part of the effort to enable cross cancer projects functional analysis, we perform standardized gene consequences annotation, using Sequence Ontology's controlled vocabulary regarding mutation-induced changes (\nwww.sequenceontology.org\n). This type of annotation provides a list of predicted gene effects, such as a non-conservative amino acid substitution, but does not attempt to prioritize the changes by their functional impact. Simple somatic mutation data submitted by member projects are annotated using the variant annotation tool SnpEff (v3.3c, ) recommended by the ICGC Mutation Consequences and Pathways (MUCOPA) Working Subgroup (Nature Methods, 2013, PMID:\n23900255\n).\n\n\nIn order to assess functional impact of non-synonymous (SO term: \nmissense_variant\n) somatic mutations on protein coding genes, we used well-known prediction tools (currently \nFatHMM\n, with more to be added such as \nMutation Assessor\n and \nSIFT\n) to compute functional impact scores and assign impact categories. ICGC DCC defines the following four categories: \nHigh\n, \nMedium\n, \nLow\n and \nUnknown\n.\n\n\nWe first compute original impact prediction with these different tools for all simple somatic mutations (\nSSM\n) that cause \nmissense\n consequence, each mutation is expressed at amino acid level, e.g., \nENSP00000358548 Q61R\n to feed into individual functional impact prediction tools. When a mutation affects multiple splice forms of the same gene, prediction will be performed on all of them whenever possible. For a particular mutation, using a simple rule-based approach, predictions for each transcript isoform reported by different tools will then be summarized to a single impact category. The rule is straightforward: the highest impact category will be picked up from results of all tools. When no prediction is reported, \nUnknown\n is assigned.\n\n\nFor all other SSMs that cause consequence other than \nmissense\n, impact category will be assigned based on consequence type a mutation causes. \nHigh\n impact will be assigned for \nframeshift_variant, non_conservative_missense_variant, initiator_codon_variant, stop_gained\n and \nstop_lost\n, \nUnknown\n will be assigned for all other mutations.\n\n\nIn order to assess how often a particular simple somatic mutation (SSM) occurs in cancer patients, we establishes specific criteria to determine whether SSMs reported from different donors are considered to be the same. When all of these fields from two reported SSMs: chromosome, chromosome start, chromosome end, mutation type, DNA change, genome assembly version are identical, they are merged into one mutation entity. With this, we build a non-redundant collection of all simple somatic mutations. Each mutation entry in the collection is assigned a stable identifier for persisted referencing portal wide and across releases. Information for linking these non-redundant SSMs to the reported ones is also kept, enabling mutation counts across donors.\n\n\nWhen a somatic mutation falls on the same position as a germline SNP, there is potential to leak a small amount of germline data. To prevent this, as of Release 15, ICGC DCC will be censoring the patient's germline genotype in the case where it does not match the reference genome allele:\n\n\n\n\nthe mutated allele from control genotype will be replaced with the reference gernome allele when we publish to the open-access tier.\n\n\nthe germline genotype that was censored will be flagged internally and the patient's true genotype will only be available to researchers' with access to controlled tier.\n\n\n\n\nUpon a valid submission, a report will be generated indicating the total number of submitted simple somatic mutation observations, and the total number of controlled access simple somatic mutation observations:\n\n\n\n\nTotal number of the submitted SSM observations\n\n\nNumber of SSMs marked as controlled (containing germline data)\n\n\nPercentage of observations marked as controlled\n\n\n\n\nExample of open access simple somatic mutation:\n\n\n\n\nThe alleles in the control_genotype match the reference_genome_allele. This mutation will be accessible for both open-access and controlled-access tiers.\n\n\n\n\n\n\n\n\n\n\nreference_genome_allele\n\n\ncontrol_genotype\n\n\ntumour_genotype\n\n\nmutated_from_allele\n\n\nmutated_to_allele\n\n\nmasked_flag\n\n\n\n\n\n\n\n\n\n\nA\n\n\nA/A\n\n\nA/G\n\n\nA\n\n\nG\n\n\nOpen\n\n\n\n\n\n\n\n\nExample of controlled access simple somatic mutation:\n\n\n\n\nThe control_genotype contains an allele (T) which is different from the reference_genome_allele (G).\n\n\nThis mutation will only be accessible at the controlled-access tier\n\n\n\n\n\n\n\n\n\n\nreference_genome_allele\n\n\ncontrol_genotype\n\n\ntumour_genotype\n\n\nmutated_from_allele\n\n\nmutated_to_allele\n\n\nmasked_flag\n\n\n\n\n\n\n\n\n\n\nG\n\n\nG/T\n\n\nG/C\n\n\nT\n\n\nC\n\n\nControlled\n\n\n\n\n\n\n\n\n\n\nHow this mutation will be censored in \nopen-access tier\n:\n\n\nThe mutated_from_allele (T) will be masked using the reference_genome_allele (G) so the true germline allele (T) will not be leaked. This masked mutation will be accessible in open-access tier.\n\n\nPlease be advised that the open-access tier contains a small fraction of mutations that are masked (ie. they are different from the original true mutations). To access the original true mutations, one must apply for access to controlled-access to \nDACO\n (Data Access Compliance Office) \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nreference_genome_allele\n\n\ncontrol_genotype\n\n\ntumour_genotype\n\n\nmutated_from_allele\n\n\nmutated_to_allele\n\n\nmasked_flag\n\n\n\n\n\n\n\n\n\n\nG\n\n\n\n\n\n\nG\n\n\nC\n\n\nMasked\n\n\n\n\n\n\n\n\nGene sets source\n\n\nReactome Pathways\n\n\n\n\nPathway entries: \nhttp://www.reactome.org/ReactomeRESTfulAPI/RESTfulWS/pathwayHierarchy/ho...\n\n\nPathway to gene mapping file: \nhttp://www.reactome.org/download/current/UniProt2Reactome.txt\n\n\nPathway summation file: \nhttp://www.reactome.org/download/current/pathway2summation.txt\n\n\n\n\nGene Ontology\n\n\nNote that ICGC does not display complete list of GO terms available on GO website (exclusion of obsolete GO and GO that are not annotated to human genes).\n\n\n\n\nInferred Trees: \nhttp://geneontology.org/ontology/go.owl\n\n\nGO Terms: \nhttp://purl.obolibrary.org/obo/go.obo\n\n\nGO Associations: \nhttp://geneontology.org/gene-associations/gene_association.goa_human.gz\n\n\n\n\nCurated Gene Sets\n\n\n\n\nCancer Gene Census: \nhttp://cancer.sanger.ac.uk/cancergenome/projects/census/\n\n\n\n\nGene Set Enrichment Analysis\n\n\nGene Set Enrichment Analysis is a method to identify statistically significantly over-represented groups of gene sets (eg, pathways or GO terms) when comparing user input genes and genes from a chosen background (such as all genes annotated with GO biological process terms). You can launch Enrichment Analysis from the Gene tab in Advanced Search or from Set Analysis.\n\n\nStatistical methods used in Gene Set Enrichment Analysis:\n\n\n\n\nHypergeometric test to calculate significance of over-representation.\n\n\nBenjamini-Hochberg procedure is used for multiple test correction by controlling user selected FDR threshold.", 
            "title": "Methods"
        }, 
        {
            "location": "/portal/methods/#methods", 
            "text": "The ICGC Data Portal uses gene models produced by Ensembl  http://www.ensembl.org .  The canonical gene data (release 75) is available from Ensembl FTP site at   ftp://ftp.ensembl.org/pub/release-75/mysql/homo_sapiens_core_75_37 . We downloaded files with gene, transcript, translation, exon, xref, and domain etc data, built a document-oriented data store with essential gene information. We then further integrated gene summary information downloaded from NCBI Entrez Gene. This gene document is then integrated with somatic mutation datasets based on mutation consequence annotation (described in the next section) results.  As part of the effort to enable cross cancer projects functional analysis, we perform standardized gene consequences annotation, using Sequence Ontology's controlled vocabulary regarding mutation-induced changes ( www.sequenceontology.org ). This type of annotation provides a list of predicted gene effects, such as a non-conservative amino acid substitution, but does not attempt to prioritize the changes by their functional impact. Simple somatic mutation data submitted by member projects are annotated using the variant annotation tool SnpEff (v3.3c, ) recommended by the ICGC Mutation Consequences and Pathways (MUCOPA) Working Subgroup (Nature Methods, 2013, PMID: 23900255 ).  In order to assess functional impact of non-synonymous (SO term:  missense_variant ) somatic mutations on protein coding genes, we used well-known prediction tools (currently  FatHMM , with more to be added such as  Mutation Assessor  and  SIFT ) to compute functional impact scores and assign impact categories. ICGC DCC defines the following four categories:  High ,  Medium ,  Low  and  Unknown .  We first compute original impact prediction with these different tools for all simple somatic mutations ( SSM ) that cause  missense  consequence, each mutation is expressed at amino acid level, e.g.,  ENSP00000358548 Q61R  to feed into individual functional impact prediction tools. When a mutation affects multiple splice forms of the same gene, prediction will be performed on all of them whenever possible. For a particular mutation, using a simple rule-based approach, predictions for each transcript isoform reported by different tools will then be summarized to a single impact category. The rule is straightforward: the highest impact category will be picked up from results of all tools. When no prediction is reported,  Unknown  is assigned.  For all other SSMs that cause consequence other than  missense , impact category will be assigned based on consequence type a mutation causes.  High  impact will be assigned for  frameshift_variant, non_conservative_missense_variant, initiator_codon_variant, stop_gained  and  stop_lost ,  Unknown  will be assigned for all other mutations.  In order to assess how often a particular simple somatic mutation (SSM) occurs in cancer patients, we establishes specific criteria to determine whether SSMs reported from different donors are considered to be the same. When all of these fields from two reported SSMs: chromosome, chromosome start, chromosome end, mutation type, DNA change, genome assembly version are identical, they are merged into one mutation entity. With this, we build a non-redundant collection of all simple somatic mutations. Each mutation entry in the collection is assigned a stable identifier for persisted referencing portal wide and across releases. Information for linking these non-redundant SSMs to the reported ones is also kept, enabling mutation counts across donors.  When a somatic mutation falls on the same position as a germline SNP, there is potential to leak a small amount of germline data. To prevent this, as of Release 15, ICGC DCC will be censoring the patient's germline genotype in the case where it does not match the reference genome allele:   the mutated allele from control genotype will be replaced with the reference gernome allele when we publish to the open-access tier.  the germline genotype that was censored will be flagged internally and the patient's true genotype will only be available to researchers' with access to controlled tier.   Upon a valid submission, a report will be generated indicating the total number of submitted simple somatic mutation observations, and the total number of controlled access simple somatic mutation observations:   Total number of the submitted SSM observations  Number of SSMs marked as controlled (containing germline data)  Percentage of observations marked as controlled   Example of open access simple somatic mutation:   The alleles in the control_genotype match the reference_genome_allele. This mutation will be accessible for both open-access and controlled-access tiers.      reference_genome_allele  control_genotype  tumour_genotype  mutated_from_allele  mutated_to_allele  masked_flag      A  A/A  A/G  A  G  Open     Example of controlled access simple somatic mutation:   The control_genotype contains an allele (T) which is different from the reference_genome_allele (G).  This mutation will only be accessible at the controlled-access tier      reference_genome_allele  control_genotype  tumour_genotype  mutated_from_allele  mutated_to_allele  masked_flag      G  G/T  G/C  T  C  Controlled      How this mutation will be censored in  open-access tier :  The mutated_from_allele (T) will be masked using the reference_genome_allele (G) so the true germline allele (T) will not be leaked. This masked mutation will be accessible in open-access tier.  Please be advised that the open-access tier contains a small fraction of mutations that are masked (ie. they are different from the original true mutations). To access the original true mutations, one must apply for access to controlled-access to  DACO  (Data Access Compliance Office)         reference_genome_allele  control_genotype  tumour_genotype  mutated_from_allele  mutated_to_allele  masked_flag      G    G  C  Masked", 
            "title": "Methods"
        }, 
        {
            "location": "/portal/methods/#gene-sets-source", 
            "text": "Reactome Pathways   Pathway entries:  http://www.reactome.org/ReactomeRESTfulAPI/RESTfulWS/pathwayHierarchy/ho...  Pathway to gene mapping file:  http://www.reactome.org/download/current/UniProt2Reactome.txt  Pathway summation file:  http://www.reactome.org/download/current/pathway2summation.txt   Gene Ontology  Note that ICGC does not display complete list of GO terms available on GO website (exclusion of obsolete GO and GO that are not annotated to human genes).   Inferred Trees:  http://geneontology.org/ontology/go.owl  GO Terms:  http://purl.obolibrary.org/obo/go.obo  GO Associations:  http://geneontology.org/gene-associations/gene_association.goa_human.gz   Curated Gene Sets   Cancer Gene Census:  http://cancer.sanger.ac.uk/cancergenome/projects/census/", 
            "title": "Gene sets source"
        }, 
        {
            "location": "/portal/methods/#gene-set-enrichment-analysis", 
            "text": "Gene Set Enrichment Analysis is a method to identify statistically significantly over-represented groups of gene sets (eg, pathways or GO terms) when comparing user input genes and genes from a chosen background (such as all genes annotated with GO biological process terms). You can launch Enrichment Analysis from the Gene tab in Advanced Search or from Set Analysis.  Statistical methods used in Gene Set Enrichment Analysis:   Hypergeometric test to calculate significance of over-representation.  Benjamini-Hochberg procedure is used for multiple test correction by controlling user selected FDR threshold.", 
            "title": "Gene Set Enrichment Analysis"
        }, 
        {
            "location": "/portal/projects/", 
            "text": "Projects\n\n\nOverview\n\n\nThis is the Projects documentation page", 
            "title": "Projects"
        }, 
        {
            "location": "/portal/projects/#projects", 
            "text": "", 
            "title": "Projects"
        }, 
        {
            "location": "/portal/projects/#overview", 
            "text": "This is the Projects documentation page", 
            "title": "Overview"
        }, 
        {
            "location": "/portal/publication/", 
            "text": "ICGC Publication Guidelines\n\n\nMembers of the ICGC are committed to the principles of rapid data release. However, like other large-scale genomic projects, members do not consider the deposition of its data into its own or public databases to be the equivalent of publication in a peer-reviewed journal. Therefore, although the data are available to others, the members still consider them to be formally unpublished.\n\n\nThe members of the ICGC have adopted data release policies that will accelerate the dissemination of datasets through rapid data releases that will precede publication of the global analyses of ICGC member datasets, anticipating the data will be useful for many investigators. The Consortium anticipates that the Project's data will be used in many ways, such as in developing new analytical methods, in understanding patterns of somatic mutations, and in guiding selection of mutations, genes, and other targets that will be used to develop biomarkers for cancer detection, diagnosis and prognosis, and new therapeutic interventions. Thus, the Consortium recognizes that the data are available to many users for a variety of purposes.\n\n\nFor more information on ICGC's Publication Policy, please see Section E3 of the Consortium Policies and Guidelines:\n\n\nTime limits for publication moratoriums\n\n\nAll data shall become free of a publication moratorium when either the data is published by the ICGC member project or one year after a specified quantity of data (e.g. genome dataset from 100 tumours per project) has been released via the ICGC database or other public databases. In all cases data shall be free of a publication moratorium two years after its initial release.\n\n\n\n\nLegend\n\n\nScenario 1:\n 1 genome is submitted and made available on the ICGC portal, and two years later the moratorium period is finished.\n\n\nScenario 2:\n 100 genomes are submitted and made available on the ICGC portal, and one year later the moratorium period is finished.\n\n\nScenario 3:\n 1 genome is submitted and a few months later, a total of 100 genomes are made available on the ICGC portal, and one year later the moratorium period is finished.\n\n\nScenario 4: \n1 genome is submitted and several months later, a total of 100 genomes are made available on the ICGC portal. When a total of two years from the time of the first genome is reached, then the moratorium period is finished.\n\n\nScenario 5:\n Any number of genomes are submitted and made available on the ICGC portal, and a paper about them is published by the submitting group, the moratorium period is finished.\n\n\nThe quantity of data on which the initial global analysis will be carried out will vary between tumour types but is likely to be data on 100 tumour samples for more common tumour types and fewer for rarer tumour types. Details of the status of a publication moratorium is specified for individual projects below:\n\n\nCurrent Moratorium Status for ICGC projects\n\n\n\n\n\n\n\n\nProject Key\n\n\nCountry\n\n\nProject Name\n\n\nEMBARGO STATUS\n\n\n\n\n\n\n\n\n\n\nPACA-AU\n\n\nAustralia\n\n\nPancreatic Cancer - AU\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nPACA-CA\n\n\nCanada\n\n\nPancreatic Cancer - CA\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nPRAD-CA\n\n\nCanada\n\n\nProstate Adenocarcinoma - CA\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nBLCA-CN\n\n\nChina\n\n\nBladder Urothelial carcinoma - CN\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nGACA-CN\n\n\nChina\n\n\nGastric Cancer - CN\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nLICA-FR\n\n\nFrance\n\n\nLiver Cancer - FR\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nEOPC-DE\n\n\nGermany\n\n\nEarly Onset Prostate Cancer - DE\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nMALY-DE\n\n\nGermany\n\n\nMalignant Lymphoma - DE\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nPBCA-DE\n\n\nGermany\n\n\nPediatric Brain Cancer - DE\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nLINC-JP\n\n\nJapan\n\n\nLiver Cancer - NCC, JP\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nLIRI-JP\n\n\nJapan\n\n\nLiver Cancer - RIKEN, JP\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nLUSC-KR\n\n\nSouth Korea\n\n\nLung Cancer - Squamous cell carcinoma - KR\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nCLLE-ES\n\n\nSpain\n\n\nChronic Lymphocytic Leukemia - ES\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nBRCA-UK\n\n\nUnited Kingdom\n\n\nBreast Triple Negative/Lobular Cancer - UK\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nCMDI-UK\n\n\nUnited Kingdom\n\n\nChronic Myeloid Disorders - UK\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nPRAD-UK\n\n\nUnited Kingdom\n\n\nProstate Adenocarcinoma - UK\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nORCA-IN\n\n\nIndia\n\n\nOral Cancer - IN\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nLAML-KR\n\n\nSouth Korea\n\n\nAcute Myeloid Leukemia - KR\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nBOCA-UK\n\n\nUnited Kingdom\n\n\nBone Cancer - UK\n\n\nNo Embargo. Data available without limitations\n\n\n\n\n\n\nOV-AU\n\n\nAustralia\n\n\nOvarian Cancer - AU\n\n\nPublication limitations in place until 2016-02-12\n\n\n\n\n\n\nPAEN-AU\n\n\nAustralia\n\n\nPancreatic Cancer Endocrine neoplasms - AU\n\n\nPublication limitations in place until 2016-02-12\n\n\n\n\n\n\nSKCA-BR\n\n\nBrazil\n\n\nSkin Adenocarcinoma - BR\n\n\nPublication limitations in place until 2017-06-15\n\n\n\n\n\n\nRECA-CN\n\n\nChina\n\n\nRenal clear cell carcinoma - CN\n\n\nPublication limitations in place until 2016-02-12\n\n\n\n\n\n\nESCA-CN\n\n\nChina\n\n\nEsophageal Cancer - CN\n\n\nPublication limitations in place until 2016-05-14\n\n\n\n\n\n\nCOCA-CN\n\n\nChina\n\n\nColorectal Cancer - CN\n\n\nPublication limitations in place until 2017-01-14\n\n\n\n\n\n\nLUSC-CN\n\n\nChina\n\n\nLung Squamous cell carcinoma - CN\n\n\nPublication limitations in place until 2017-01-14\n\n\n\n\n\n\nRECA-EU\n\n\nEuropean Union/France\n\n\nRenal Cell Cancer - EU/FR\n\n\nPublication limitations in place until 2016-02-12\n\n\n\n\n\n\nLIAD-FR\n\n\nFrance\n\n\nBenign Liver Tumour - FR\n\n\nPublication limitations in place until 2016-09-11\n\n\n\n\n\n\nBOCA-FR\n\n\nFrance\n\n\nBone Cancer - Ewing Sarcoma - FR\n\n\nPublication limitations in place until 2017-01-14\n\n\n\n\n\n\nLIHM-FR\n\n\nFrance\n\n\nLiver Hepatocellular Macronodules - FR\n\n\nPublication limitations in place until 2017-01-14\n\n\n\n\n\n\nPACA-IT\n\n\nItaly\n\n\nPancreatic Cancer - IT\n\n\nPublication limitations in place until 2017-01-14\n\n\n\n\n\n\nTHCA-SA\n\n\nSaudi Arabia\n\n\nThyroid Cancer - SA\n\n\nPublication limitations in place until 2016-02-12\n\n\n\n\n\n\nESAD-UK\n\n\nUnited Kingdom\n\n\nEsophageal Adenocarcinoma - UK\n\n\nPublication limitations in place until 2016-04-01\n\n\n\n\n\n\n\n\nFor Moratorium status on TCGA projects, please visit \nhttp://cancergenome.nih.gov/publications/publicationguidelines\n\n\nFor Moratorium status on TARGET projects, please visit \nhttps://ocg.cancer.gov/programs/target/target-publication-guidelines\n\n\nData users should freely analyze pre-publication data and act responsibly in publishing analyses of those data in a manner that respects the terms described by the data producers. Data users are responsible for accurately citing the source of pre-publication data, including the version of the dataset. Data users are encouraged to \ncontact the data producers\n to discuss publication plans in cases of uncertainty. For questions regarding moratorium status, please contact DCC HelpDesk at \ndcc-support@icgc.org", 
            "title": "Publication"
        }, 
        {
            "location": "/portal/publication/#icgc-publication-guidelines", 
            "text": "Members of the ICGC are committed to the principles of rapid data release. However, like other large-scale genomic projects, members do not consider the deposition of its data into its own or public databases to be the equivalent of publication in a peer-reviewed journal. Therefore, although the data are available to others, the members still consider them to be formally unpublished.  The members of the ICGC have adopted data release policies that will accelerate the dissemination of datasets through rapid data releases that will precede publication of the global analyses of ICGC member datasets, anticipating the data will be useful for many investigators. The Consortium anticipates that the Project's data will be used in many ways, such as in developing new analytical methods, in understanding patterns of somatic mutations, and in guiding selection of mutations, genes, and other targets that will be used to develop biomarkers for cancer detection, diagnosis and prognosis, and new therapeutic interventions. Thus, the Consortium recognizes that the data are available to many users for a variety of purposes.  For more information on ICGC's Publication Policy, please see Section E3 of the Consortium Policies and Guidelines:", 
            "title": "ICGC Publication Guidelines"
        }, 
        {
            "location": "/portal/publication/#time-limits-for-publication-moratoriums", 
            "text": "All data shall become free of a publication moratorium when either the data is published by the ICGC member project or one year after a specified quantity of data (e.g. genome dataset from 100 tumours per project) has been released via the ICGC database or other public databases. In all cases data shall be free of a publication moratorium two years after its initial release.", 
            "title": "Time limits for publication moratoriums"
        }, 
        {
            "location": "/portal/publication/#legend", 
            "text": "Scenario 1:  1 genome is submitted and made available on the ICGC portal, and two years later the moratorium period is finished.  Scenario 2:  100 genomes are submitted and made available on the ICGC portal, and one year later the moratorium period is finished.  Scenario 3:  1 genome is submitted and a few months later, a total of 100 genomes are made available on the ICGC portal, and one year later the moratorium period is finished.  Scenario 4:  1 genome is submitted and several months later, a total of 100 genomes are made available on the ICGC portal. When a total of two years from the time of the first genome is reached, then the moratorium period is finished.  Scenario 5:  Any number of genomes are submitted and made available on the ICGC portal, and a paper about them is published by the submitting group, the moratorium period is finished.  The quantity of data on which the initial global analysis will be carried out will vary between tumour types but is likely to be data on 100 tumour samples for more common tumour types and fewer for rarer tumour types. Details of the status of a publication moratorium is specified for individual projects below:", 
            "title": "Legend"
        }, 
        {
            "location": "/portal/publication/#current-moratorium-status-for-icgc-projects", 
            "text": "Project Key  Country  Project Name  EMBARGO STATUS      PACA-AU  Australia  Pancreatic Cancer - AU  No Embargo. Data available without limitations    PACA-CA  Canada  Pancreatic Cancer - CA  No Embargo. Data available without limitations    PRAD-CA  Canada  Prostate Adenocarcinoma - CA  No Embargo. Data available without limitations    BLCA-CN  China  Bladder Urothelial carcinoma - CN  No Embargo. Data available without limitations    GACA-CN  China  Gastric Cancer - CN  No Embargo. Data available without limitations    LICA-FR  France  Liver Cancer - FR  No Embargo. Data available without limitations    EOPC-DE  Germany  Early Onset Prostate Cancer - DE  No Embargo. Data available without limitations    MALY-DE  Germany  Malignant Lymphoma - DE  No Embargo. Data available without limitations    PBCA-DE  Germany  Pediatric Brain Cancer - DE  No Embargo. Data available without limitations    LINC-JP  Japan  Liver Cancer - NCC, JP  No Embargo. Data available without limitations    LIRI-JP  Japan  Liver Cancer - RIKEN, JP  No Embargo. Data available without limitations    LUSC-KR  South Korea  Lung Cancer - Squamous cell carcinoma - KR  No Embargo. Data available without limitations    CLLE-ES  Spain  Chronic Lymphocytic Leukemia - ES  No Embargo. Data available without limitations    BRCA-UK  United Kingdom  Breast Triple Negative/Lobular Cancer - UK  No Embargo. Data available without limitations    CMDI-UK  United Kingdom  Chronic Myeloid Disorders - UK  No Embargo. Data available without limitations    PRAD-UK  United Kingdom  Prostate Adenocarcinoma - UK  No Embargo. Data available without limitations    ORCA-IN  India  Oral Cancer - IN  No Embargo. Data available without limitations    LAML-KR  South Korea  Acute Myeloid Leukemia - KR  No Embargo. Data available without limitations    BOCA-UK  United Kingdom  Bone Cancer - UK  No Embargo. Data available without limitations    OV-AU  Australia  Ovarian Cancer - AU  Publication limitations in place until 2016-02-12    PAEN-AU  Australia  Pancreatic Cancer Endocrine neoplasms - AU  Publication limitations in place until 2016-02-12    SKCA-BR  Brazil  Skin Adenocarcinoma - BR  Publication limitations in place until 2017-06-15    RECA-CN  China  Renal clear cell carcinoma - CN  Publication limitations in place until 2016-02-12    ESCA-CN  China  Esophageal Cancer - CN  Publication limitations in place until 2016-05-14    COCA-CN  China  Colorectal Cancer - CN  Publication limitations in place until 2017-01-14    LUSC-CN  China  Lung Squamous cell carcinoma - CN  Publication limitations in place until 2017-01-14    RECA-EU  European Union/France  Renal Cell Cancer - EU/FR  Publication limitations in place until 2016-02-12    LIAD-FR  France  Benign Liver Tumour - FR  Publication limitations in place until 2016-09-11    BOCA-FR  France  Bone Cancer - Ewing Sarcoma - FR  Publication limitations in place until 2017-01-14    LIHM-FR  France  Liver Hepatocellular Macronodules - FR  Publication limitations in place until 2017-01-14    PACA-IT  Italy  Pancreatic Cancer - IT  Publication limitations in place until 2017-01-14    THCA-SA  Saudi Arabia  Thyroid Cancer - SA  Publication limitations in place until 2016-02-12    ESAD-UK  United Kingdom  Esophageal Adenocarcinoma - UK  Publication limitations in place until 2016-04-01     For Moratorium status on TCGA projects, please visit  http://cancergenome.nih.gov/publications/publicationguidelines  For Moratorium status on TARGET projects, please visit  https://ocg.cancer.gov/programs/target/target-publication-guidelines  Data users should freely analyze pre-publication data and act responsibly in publishing analyses of those data in a manner that respects the terms described by the data producers. Data users are responsible for accurately citing the source of pre-publication data, including the version of the dataset. Data users are encouraged to  contact the data producers  to discuss publication plans in cases of uncertainty. For questions regarding moratorium status, please contact DCC HelpDesk at  dcc-support@icgc.org", 
            "title": "Current Moratorium Status for ICGC projects"
        }, 
        {
            "location": "/portal/releases/", 
            "text": "Data Releases\n\n\nOverview\n\n\nA DCC data release is a curated data set produced from clinical and experimental data submitted through the ICGC Data Submission site. Such data releases happen on average three times a year and are cumulative in nature. Each release is denoted by a number, such as \nICGC 20\n or \nRelease 20\n.\n\n\n\n\nThe \nDCC Data Releases\n page is where you can browse and download archive data files for every DCC data release in the past. It can be located by clicking/tapping the blue disk icon on the top of the Data Portal site.\n\n\nOrganization\n\n\nPast data releases are listed in table form, from \nRelease 14\n to the most current release.\n\n\nClicking a directory link navigates to the directory containing the release data content. The breadcrumb on the top of the table provides a context of where you are currently within directory hierarchy, and a way to quickly jump back to a particular level in the directory path.\n\n\n\n\nRelease Directories\n\n\nEach directory has a README.txt file, whose content is displayed below the table for your viewing convenience. Starting from \nRelease 16\n, summary information is included in each release archive. For example, the \nRelease 16\n directory shows two sub-directories, \nSummary\n and \nProjects\n. Under the \nSummary\n directory, summary files are available for download; large data files are located in the \nProjects\n directory. Releases prior to \nRelease 16\n only provide large data files.\n\n\n\n\nLegacy Directories\n\n\nReleases prior to \nRelease 14\n can be located via the \"legacy_data_releases\" link below \"release_14\". These are copies of the FTP archives which were previously hosted at \nftp://data.dcc.icgc.org\n.\n\n\nDownloads\n\n\nClicking a file link initiates a download - most Web browsers prompt the user for where to save the file. Note that tools such as \nwget\n can also be used. Our API also supports the \n-c\n option to continue interrupted downloads.", 
            "title": "Releases"
        }, 
        {
            "location": "/portal/releases/#data-releases", 
            "text": "", 
            "title": "Data Releases"
        }, 
        {
            "location": "/portal/releases/#overview", 
            "text": "A DCC data release is a curated data set produced from clinical and experimental data submitted through the ICGC Data Submission site. Such data releases happen on average three times a year and are cumulative in nature. Each release is denoted by a number, such as  ICGC 20  or  Release 20 .   The  DCC Data Releases  page is where you can browse and download archive data files for every DCC data release in the past. It can be located by clicking/tapping the blue disk icon on the top of the Data Portal site.", 
            "title": "Overview"
        }, 
        {
            "location": "/portal/releases/#organization", 
            "text": "Past data releases are listed in table form, from  Release 14  to the most current release.  Clicking a directory link navigates to the directory containing the release data content. The breadcrumb on the top of the table provides a context of where you are currently within directory hierarchy, and a way to quickly jump back to a particular level in the directory path.", 
            "title": "Organization"
        }, 
        {
            "location": "/portal/releases/#release-directories", 
            "text": "Each directory has a README.txt file, whose content is displayed below the table for your viewing convenience. Starting from  Release 16 , summary information is included in each release archive. For example, the  Release 16  directory shows two sub-directories,  Summary  and  Projects . Under the  Summary  directory, summary files are available for download; large data files are located in the  Projects  directory. Releases prior to  Release 16  only provide large data files.", 
            "title": "Release Directories"
        }, 
        {
            "location": "/portal/releases/#legacy-directories", 
            "text": "Releases prior to  Release 14  can be located via the \"legacy_data_releases\" link below \"release_14\". These are copies of the FTP archives which were previously hosted at  ftp://data.dcc.icgc.org .", 
            "title": "Legacy Directories"
        }, 
        {
            "location": "/portal/releases/#downloads", 
            "text": "Clicking a file link initiates a download - most Web browsers prompt the user for where to save the file. Note that tools such as  wget  can also be used. Our API also supports the  -c  option to continue interrupted downloads.", 
            "title": "Downloads"
        }, 
        {
            "location": "/portal/repositories/", 
            "text": "Repositories\n\n\nOverview\n\n\nThis is the Repositories documentation page", 
            "title": "Repositories"
        }, 
        {
            "location": "/portal/repositories/#repositories", 
            "text": "", 
            "title": "Repositories"
        }, 
        {
            "location": "/portal/repositories/#overview", 
            "text": "This is the Repositories documentation page", 
            "title": "Overview"
        }, 
        {
            "location": "/portal/search/", 
            "text": "Search\n\n\nOverview\n\n\nSearch is a core component of the Portal", 
            "title": "Search"
        }, 
        {
            "location": "/portal/search/#search", 
            "text": "", 
            "title": "Search"
        }, 
        {
            "location": "/portal/search/#overview", 
            "text": "Search is a core component of the Portal", 
            "title": "Overview"
        }, 
        {
            "location": "/portal/software/", 
            "text": "Portal Software Release Notes\n\n\nChanges in Data Portal Software Release 3.8.20 - Nov 27, 2015\n\n\n\n\nAdded Drug/Compound entity page which correlates targeted genes and provides context into clinical trials, e.g. Go to Sprycel Compound page (\nhttps://dcc.icgc.org/compound/ZINC000003986735\n)\n\n\nAdded Drug/Compound section in Gene Entity Page, e.g. Go to Compound section in EGFR Gene page (\nhttps://dcc.icgc.org/genes/ENSG00000146648\n)\n\n\nAdded Quick Search support for Drug/Compound, e.g. Type Leukeran in the Quick Search\n\n\nIobio integration added to aligned BAM files stored in AWS/Collaboratory, e.g. Go to BAM Stats section in \nhttps://dcc.icgc.org/repositories/files/FI9974\n\n\nAdded highlight of genes overlapping with Enrichement Analysis input genes in Pathway Viewer, e.g. Look for R-HSA-5654716 Pathway Viewer in \nhttps://dcc.icgc.org/pathways/ea41722b-5f8f-4735-8830-4c2fb52b2ff3\n\n\n\n\nChanges in Data Portal Software Release 3.8.18.3 - Nov 18, 2015\n\n\n\n\nReleased ICGC in the Cloud (\nhttps://dcc.icgc.org/icgc-in-the-cloud\n), see Amazon post: \nhttps://aws.amazon.com/blogs/aws/\n\n\nDisplayed User Guide to explore and analyze ICGC data stored in Amazon AWS and Collaboratory (\nhttps://dcc.icgc.org/icgc-in-the-cloud/guide\n)\n\n\nSeparated DCC data releases (\nhttps://dcc.icgc.org/releases\n) from Data Repositories (\nhttps://dcc.icgc.org/repositories\n)\n\n\nRe-organized filters and added Analysis Software filter on Data Repositories browser\n\n\nImproved performance of the Advanced Search page\n\n\nVarious Bug fixes\n\n\n\n\nChanges in Data Portal Software Release 3.8.16.1 - Oct 28, 2015\n\n\n\n\nDisplayed Pathway Viewer from Reactome Pathway Entity Page, (e.g. \nhttps://dcc.icgc.org/genesets/R-HSA-392154\n, click on \"Pathway Viewer\" section in the navigation bar: mutated genes are highlighted and mutation count is displayed at the top-right corner of the entity. User should click on entity to view details about genes and mutation count)\n\n\nDisplayed Pathway Viewer from an Enrichment Analysis for all the enriched gene sets (e.g. \nhttps://icgc.org/Zir\n, click on \"Open in Pathway Viewer\" and navigate through the reactome pathways to view pathway diagrams)\n\n\nEnhanced data repositories, e.g. assigned a File ID FI99999, added Specimen Type facet (link: \nhttps://dcc.icgc.org/repository/external\n)\n\n\nUpdated File Entity Page layout (e.g. \nhttps://dcc.icgc.org/repository/external/files/FI9995\n)\n\n\nWhen navigating from Donor Entity page to Genome Viewer, the mutation sorting and filter is now carried over\n\n\nSignificantly reduced the load time of stacked bar chart in Project Summary page (\nhttps://dcc.icgc.org/projects\n)\n\n\nRefactored Browser API to fix various problems that could result in error 500s being returned\n\n\nBug fixes for Project Sample Sheet, Pie Chart colouring\n\n\n\n\nChanges in Data Portal Software Release 3.8.14.4 - Sept 22, 2015\n\n\n\n\nAdded functionality to view files in external repositories based on filters from advanced search (Go to \nhttps://dcc.icgc.org/search\n, select your filters then in Donor tab click on \"View in External Repositories\" ). Documentation is available here: \nhttps://docs.icgc.org/data-portal-usage#externalrepo\n\n\nAdded functionality to download donor data and view donor sets in external repositories browser from Data Analysis (icons are available for saved donor sets here: \nhttps://dcc.icgc.org/analysis/sets\n)\n\n\nAdded functionality to upload a donor set in Donor facet in Advanced Search (\nhttps://dcc.icgc.org/search\n) and External Repositories browser (\nhttps://dcc.icgc.org/repository/external\n)\n\n\nAdded full screen support for Genome Viewer\n\n\nAdded Tumor Types facet in Projects page (\nhttps://dcc.icgc.org/projects\n)\n\n\nBug fixes for gene query in the case of no donor analysis and for Pathway Viewer\n\n\n\n\nChanges in Data Portal Software Release 3.8.9.3 - July 3, 2015\n\n\n\n\nAdded PCAWG section to home page and footer\n\n\nAdded PCAWG page - \nhttps://pcawg.icgc.org\n\n\nMinor bug fixes\n\n\n\n\nChanges in Data Portal Software Release 3.8.8.0 - June 16, 2015\n\n\n\n\nAdded DCC - \nExternal Repository feature\n. User can search for ICGC-Donor files stored in external repository and create a manifest to download them. Documentation is available here: \nhttps://docs.icgc.org/data-portal-usage#externalrep\n\n\nAdded Study facet to filter PCAWG (Pan-Cancer Analysis of Whole Genome) Donors in Advanced Search - Donor tab, e.g. \n PCAWG Donors in Advanced Search \n\n\nAdded support for clinical supplementary files (family, exposure, therapy). Displayed in Donor Entity Page and exported in Donors files\n\n\nAdded support for pending donors and projects. Documentation is available here: \nhttps://docs.icgc.org/data-portal-usage#pendingdonors\n\n\nAdded preliminary UI / API support for \"donor states\". API documentation available here: \nhttps://dcc.icgc.org/docs/\n\n\nReduced project colour space to primary sites\n\n\nBug fixes and core javascript libraries upgrades\n\n\n\n\nChanges in Data Portal Software Release 3.8.2.3 - April 7, 2015\n\n\n\n\nRedesigned Data Analysis feature to improve user experience (\nhttps://dcc.icgc.org/analysis/sets\n). Documentation available here: \nhttps://docs.icgc.org/methods#dataanalysis\n\n\nAdded demo analyses: User can launch them from \nhttps://dcc.icgc.org/analysis\n\n\nAdded Phenotype Comparison analysis to Data Analysis feature (\nhttps://dcc.icgc.org/analysis\n)\n\n\nAdded functionality to upload a custom gene set and save it in Data Analysis (\nhttps://dcc.icgc.org/analysis/sets\n). User can then perform analysis on saved gene set\n\n\nAdded version control and version deprecation for data analyses: User will get a warning message on his analyses if ICGC data has been updated\n\n\nBug fixes and libraries upgrade\n\n\n\n\nChanges in Data Portal Software Release 3.8.2.2 - March 16, 2015\n\n\n\n\nAdded new visualization to show \"Donor Count History\" (\nhttps://dcc.icgc.org/projects/history\n)\n\n\nBug fixes\n\n\n\n\nChanges in Data Portal Software Release 3.7.6.6 - February 11, 2015\n\n\n\n\nAdded \"GA4GH Beacon\" feature (\nhttps://dcc.icgc.org/ga4gh/beacon\n)\n\n\nAdded \"Saved Sets\" feature (\nhttps://dcc.icgc.org/analysis\n)\n\n\nAdded \"Set Analysis\" feature (\nhttps://dcc.icgc.org/analysis\n)\n\n\nAdded \"Enrichment Analysis\" feature (\nhttps://dcc.icgc.org/analysis\n)\n\n\nProjects page layout update and optimization (\nhttps://dcc.icgc.org/projects\n)\n\n\nVarious bug fixes\n\n\n\n\nChanges in Data Portal Software Release 3.7.6.2 - January 21, 2015\n\n\n\n\n\"Gene Ontology\" quick search (\nhttps://dcc.icgc.org/q?q=GO:1901662\n)\n\n\n\"Gene Ontology\" advanced search (\nhttps://dcc.icgc.org/search/g?filters=%7B%22gene%22%3A%7B%22goTermId%22%...\n)\n\n\n\"Gene Ontology\" entity pages (see \nhttps://dcc.icgc.org/genesets/GO:0008195\n)\n\n\nUpdated \"Reactome Pathway\" data (see \nhttps://dcc.icgc.org/genesets/REACT_13797\n)\n\n\nUpdate \"Cancer Gene Census\" data (see \nhttps://dcc.icgc.org/genesets/GS1\n)\n\n\nGeneralized \"Pathway\", \"Cancer Gene Census\" and \"Gene Ontology\" into unified \"Gene Set\" integration\n\n\nVarious small fixes\n\n\n\n\nChanges in Data Portal Software Release 3.7.4.1 - December 3, 2014\n\n\n\n\nAdded new visualization showing \"Number of Somatic Mutations in Donor's Exomes Across Cancer Projects\" (see \nhttps://dcc.icgc.org/projects\n)\n\n\nUsers can now upload their own custom gene list in Advanced Search (see \nhttps://dcc.icgc.org/search/g\n)\n\n\nAdded Markdown support for data repository for inline viewing of README files (see \nhttps://dcc.icgc.org/repository\n)\n\n\nImproved general client-side page responsiveness of chart rendering\n\n\nMinor bug fixes\n\n\n\n\nChanges in Data Portal Software Release 3.5.12 - September 29, 2014\n\n\n\n\nFixed bug wherein a DACO authorization was being denied to ICGC.org (non-OpenID) users with granted access\n\n\nImproved general client-side page responsiveness\n\n\n\n\nChanges in Data Portal Software Release 3.5 - September 12, 2014\n\n\n\n\nUpgraded to Genome Maps 1.1.7\n\n\nImproved site performance through better caching\n\n\nAdded \"Multiple Observations per Donor Mutation Occurrence\" feature\n\n\nAdded \"Short URL\" feature\n\n\nAdded \"Repository URL Right-click to Copy\" feature\n\n\n\n\nChanges in Data Portal Software Release 3.2 - May 15, 2014\n\n\n\n\nAdded \"Aggregated SSM VCF\" feature\n\n\nAdded \"Pathway Entity Page\" feature\n\n\nAdded \"Pathway Search\" feature\n\n\nAdded \"Gene Sets\" feature\n\n\nAdded \"Functional Impact\" feature\n\n\nAdded \"Project Search\" feature\n\n\nAdded \"Authentication and Authorization\" feature\n\n\nAdded \"Controlled Access Download\" feature\n\n\nAdded \"Asynchronous Download\" feature\n\n\nAdded \"Public RESTful API\" feature", 
            "title": "Software"
        }, 
        {
            "location": "/portal/software/#portal-software-release-notes", 
            "text": "", 
            "title": "Portal Software Release Notes"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3820-nov-27-2015", 
            "text": "Added Drug/Compound entity page which correlates targeted genes and provides context into clinical trials, e.g. Go to Sprycel Compound page ( https://dcc.icgc.org/compound/ZINC000003986735 )  Added Drug/Compound section in Gene Entity Page, e.g. Go to Compound section in EGFR Gene page ( https://dcc.icgc.org/genes/ENSG00000146648 )  Added Quick Search support for Drug/Compound, e.g. Type Leukeran in the Quick Search  Iobio integration added to aligned BAM files stored in AWS/Collaboratory, e.g. Go to BAM Stats section in  https://dcc.icgc.org/repositories/files/FI9974  Added highlight of genes overlapping with Enrichement Analysis input genes in Pathway Viewer, e.g. Look for R-HSA-5654716 Pathway Viewer in  https://dcc.icgc.org/pathways/ea41722b-5f8f-4735-8830-4c2fb52b2ff3", 
            "title": "Changes in Data Portal Software Release 3.8.20 - Nov 27, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-38183-nov-18-2015", 
            "text": "Released ICGC in the Cloud ( https://dcc.icgc.org/icgc-in-the-cloud ), see Amazon post:  https://aws.amazon.com/blogs/aws/  Displayed User Guide to explore and analyze ICGC data stored in Amazon AWS and Collaboratory ( https://dcc.icgc.org/icgc-in-the-cloud/guide )  Separated DCC data releases ( https://dcc.icgc.org/releases ) from Data Repositories ( https://dcc.icgc.org/repositories )  Re-organized filters and added Analysis Software filter on Data Repositories browser  Improved performance of the Advanced Search page  Various Bug fixes", 
            "title": "Changes in Data Portal Software Release 3.8.18.3 - Nov 18, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-38161-oct-28-2015", 
            "text": "Displayed Pathway Viewer from Reactome Pathway Entity Page, (e.g.  https://dcc.icgc.org/genesets/R-HSA-392154 , click on \"Pathway Viewer\" section in the navigation bar: mutated genes are highlighted and mutation count is displayed at the top-right corner of the entity. User should click on entity to view details about genes and mutation count)  Displayed Pathway Viewer from an Enrichment Analysis for all the enriched gene sets (e.g.  https://icgc.org/Zir , click on \"Open in Pathway Viewer\" and navigate through the reactome pathways to view pathway diagrams)  Enhanced data repositories, e.g. assigned a File ID FI99999, added Specimen Type facet (link:  https://dcc.icgc.org/repository/external )  Updated File Entity Page layout (e.g.  https://dcc.icgc.org/repository/external/files/FI9995 )  When navigating from Donor Entity page to Genome Viewer, the mutation sorting and filter is now carried over  Significantly reduced the load time of stacked bar chart in Project Summary page ( https://dcc.icgc.org/projects )  Refactored Browser API to fix various problems that could result in error 500s being returned  Bug fixes for Project Sample Sheet, Pie Chart colouring", 
            "title": "Changes in Data Portal Software Release 3.8.16.1 - Oct 28, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-38144-sept-22-2015", 
            "text": "Added functionality to view files in external repositories based on filters from advanced search (Go to  https://dcc.icgc.org/search , select your filters then in Donor tab click on \"View in External Repositories\" ). Documentation is available here:  https://docs.icgc.org/data-portal-usage#externalrepo  Added functionality to download donor data and view donor sets in external repositories browser from Data Analysis (icons are available for saved donor sets here:  https://dcc.icgc.org/analysis/sets )  Added functionality to upload a donor set in Donor facet in Advanced Search ( https://dcc.icgc.org/search ) and External Repositories browser ( https://dcc.icgc.org/repository/external )  Added full screen support for Genome Viewer  Added Tumor Types facet in Projects page ( https://dcc.icgc.org/projects )  Bug fixes for gene query in the case of no donor analysis and for Pathway Viewer", 
            "title": "Changes in Data Portal Software Release 3.8.14.4 - Sept 22, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3893-july-3-2015", 
            "text": "Added PCAWG section to home page and footer  Added PCAWG page -  https://pcawg.icgc.org  Minor bug fixes", 
            "title": "Changes in Data Portal Software Release 3.8.9.3 - July 3, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3880-june-16-2015", 
            "text": "Added DCC -  External Repository feature . User can search for ICGC-Donor files stored in external repository and create a manifest to download them. Documentation is available here:  https://docs.icgc.org/data-portal-usage#externalrep  Added Study facet to filter PCAWG (Pan-Cancer Analysis of Whole Genome) Donors in Advanced Search - Donor tab, e.g.   PCAWG Donors in Advanced Search   Added support for clinical supplementary files (family, exposure, therapy). Displayed in Donor Entity Page and exported in Donors files  Added support for pending donors and projects. Documentation is available here:  https://docs.icgc.org/data-portal-usage#pendingdonors  Added preliminary UI / API support for \"donor states\". API documentation available here:  https://dcc.icgc.org/docs/  Reduced project colour space to primary sites  Bug fixes and core javascript libraries upgrades", 
            "title": "Changes in Data Portal Software Release 3.8.8.0 - June 16, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3823-april-7-2015", 
            "text": "Redesigned Data Analysis feature to improve user experience ( https://dcc.icgc.org/analysis/sets ). Documentation available here:  https://docs.icgc.org/methods#dataanalysis  Added demo analyses: User can launch them from  https://dcc.icgc.org/analysis  Added Phenotype Comparison analysis to Data Analysis feature ( https://dcc.icgc.org/analysis )  Added functionality to upload a custom gene set and save it in Data Analysis ( https://dcc.icgc.org/analysis/sets ). User can then perform analysis on saved gene set  Added version control and version deprecation for data analyses: User will get a warning message on his analyses if ICGC data has been updated  Bug fixes and libraries upgrade", 
            "title": "Changes in Data Portal Software Release 3.8.2.3 - April 7, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3822-march-16-2015", 
            "text": "Added new visualization to show \"Donor Count History\" ( https://dcc.icgc.org/projects/history )  Bug fixes", 
            "title": "Changes in Data Portal Software Release 3.8.2.2 - March 16, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3766-february-11-2015", 
            "text": "Added \"GA4GH Beacon\" feature ( https://dcc.icgc.org/ga4gh/beacon )  Added \"Saved Sets\" feature ( https://dcc.icgc.org/analysis )  Added \"Set Analysis\" feature ( https://dcc.icgc.org/analysis )  Added \"Enrichment Analysis\" feature ( https://dcc.icgc.org/analysis )  Projects page layout update and optimization ( https://dcc.icgc.org/projects )  Various bug fixes", 
            "title": "Changes in Data Portal Software Release 3.7.6.6 - February 11, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3762-january-21-2015", 
            "text": "\"Gene Ontology\" quick search ( https://dcc.icgc.org/q?q=GO:1901662 )  \"Gene Ontology\" advanced search ( https://dcc.icgc.org/search/g?filters=%7B%22gene%22%3A%7B%22goTermId%22%... )  \"Gene Ontology\" entity pages (see  https://dcc.icgc.org/genesets/GO:0008195 )  Updated \"Reactome Pathway\" data (see  https://dcc.icgc.org/genesets/REACT_13797 )  Update \"Cancer Gene Census\" data (see  https://dcc.icgc.org/genesets/GS1 )  Generalized \"Pathway\", \"Cancer Gene Census\" and \"Gene Ontology\" into unified \"Gene Set\" integration  Various small fixes", 
            "title": "Changes in Data Portal Software Release 3.7.6.2 - January 21, 2015"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3741-december-3-2014", 
            "text": "Added new visualization showing \"Number of Somatic Mutations in Donor's Exomes Across Cancer Projects\" (see  https://dcc.icgc.org/projects )  Users can now upload their own custom gene list in Advanced Search (see  https://dcc.icgc.org/search/g )  Added Markdown support for data repository for inline viewing of README files (see  https://dcc.icgc.org/repository )  Improved general client-side page responsiveness of chart rendering  Minor bug fixes", 
            "title": "Changes in Data Portal Software Release 3.7.4.1 - December 3, 2014"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-3512-september-29-2014", 
            "text": "Fixed bug wherein a DACO authorization was being denied to ICGC.org (non-OpenID) users with granted access  Improved general client-side page responsiveness", 
            "title": "Changes in Data Portal Software Release 3.5.12 - September 29, 2014"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-35-september-12-2014", 
            "text": "Upgraded to Genome Maps 1.1.7  Improved site performance through better caching  Added \"Multiple Observations per Donor Mutation Occurrence\" feature  Added \"Short URL\" feature  Added \"Repository URL Right-click to Copy\" feature", 
            "title": "Changes in Data Portal Software Release 3.5 - September 12, 2014"
        }, 
        {
            "location": "/portal/software/#changes-in-data-portal-software-release-32-may-15-2014", 
            "text": "Added \"Aggregated SSM VCF\" feature  Added \"Pathway Entity Page\" feature  Added \"Pathway Search\" feature  Added \"Gene Sets\" feature  Added \"Functional Impact\" feature  Added \"Project Search\" feature  Added \"Authentication and Authorization\" feature  Added \"Controlled Access Download\" feature  Added \"Asynchronous Download\" feature  Added \"Public RESTful API\" feature", 
            "title": "Changes in Data Portal Software Release 3.2 - May 15, 2014"
        }, 
        {
            "location": "/cloud/about/", 
            "text": "About\n\n\nOverview\n\n\nThe ICGC has joined forces with commercial and academic compute cloud partners to remove many of the barriers that prevent researchers from using the ICGC's vast genomic database. The large size of the ICGC datasets means that they can take months to download and analysing them requires computing power that many research groups do not have. These partnerships will allow scientists to access and analyze ICGC datasets through multiple cloud computing platforms, enhancing collaboration and accelerating the development of new tools and treatments for cancer patients.\n\n\nThe Data Coordination Center has developed a unified interface for searching and accessing data across all supported clouds. Authorized users can now access the ICGC BAM, VCF and other types of files through the \nRepository search tool\n on the Portal and retrieve manifest files that allow for bulk file downloads from the cloud repositories. User authentication and authorization is achieved through the standard ICGC DACO controlled access mechanism ensuring safe access to these datasets.\n\n\nICCG Compute Cloud Partners\n\n\nAWS\n\n\nAmazon Web Services\n is a well established commercial cloud providing a highly reliable, scalable, low-cost infrastructure platform in the cloud in 190 countries around the world. ICGC datasets are currently hosted at the US East (Northern Virginia) EC2 facility.\n\n\nCollaboratory\n\n\nThe \nCancer Genome Collaboratory\n is an academic compute cloud resource built by the Ontario Institute for Cancer Research and hosted at the Compute Canada facilities. This infrastructure is still under intensive development and is currently storing only a small subset of the ICGC data for beta testing.", 
            "title": "About"
        }, 
        {
            "location": "/cloud/about/#about", 
            "text": "", 
            "title": "About"
        }, 
        {
            "location": "/cloud/about/#overview", 
            "text": "The ICGC has joined forces with commercial and academic compute cloud partners to remove many of the barriers that prevent researchers from using the ICGC's vast genomic database. The large size of the ICGC datasets means that they can take months to download and analysing them requires computing power that many research groups do not have. These partnerships will allow scientists to access and analyze ICGC datasets through multiple cloud computing platforms, enhancing collaboration and accelerating the development of new tools and treatments for cancer patients.  The Data Coordination Center has developed a unified interface for searching and accessing data across all supported clouds. Authorized users can now access the ICGC BAM, VCF and other types of files through the  Repository search tool  on the Portal and retrieve manifest files that allow for bulk file downloads from the cloud repositories. User authentication and authorization is achieved through the standard ICGC DACO controlled access mechanism ensuring safe access to these datasets.", 
            "title": "Overview"
        }, 
        {
            "location": "/cloud/about/#iccg-compute-cloud-partners", 
            "text": "", 
            "title": "ICCG Compute Cloud Partners"
        }, 
        {
            "location": "/cloud/about/#aws", 
            "text": "Amazon Web Services  is a well established commercial cloud providing a highly reliable, scalable, low-cost infrastructure platform in the cloud in 190 countries around the world. ICGC datasets are currently hosted at the US East (Northern Virginia) EC2 facility.", 
            "title": "AWS"
        }, 
        {
            "location": "/cloud/about/#collaboratory", 
            "text": "The  Cancer Genome Collaboratory  is an academic compute cloud resource built by the Ontario Institute for Cancer Research and hosted at the Compute Canada facilities. This infrastructure is still under intensive development and is currently storing only a small subset of the ICGC data for beta testing.", 
            "title": "Collaboratory"
        }, 
        {
            "location": "/cloud/guide/", 
            "text": "Overview\n\n\nThis user guide describes the steps to securely explore and analyze ICGC data stored in \nAmazon (\nAWS\n)\n or \nCollaboratory (\nOpenStack\n)\n cloud environments. For more information about ICGC cloud initiatives, please see \nICGC in the Cloud\n.\n\n\nPlease see \nTerms\n for a glossary of terms used in this guide.\n\n\nProcess\n\n\nThe figure below illustrates the overall process and systems involved:\n\n\n\n\nAuthorization\n\n    Apply for DACO \nCloud Access\n if not already approved\n    Upon approval, login to the \nData Portal\n\n    Generate an \nAccess Token\n for cloud download\n\n\nCompute Prerequistes\n\n    Provision a \nCompute Instance\n in the target cloud\n\n\nInstallation\n\n    Download and install the ICGC \nStorage Client\n\n\nConfiguration\n\n    Configure the Storage Client to use the generated Access Token\n\n\nFile Search\n\n    Identify files of interest using the Data Portal\n\n\nStorage Client Usage\n\n    Download or view data with the provided Storage Client or via an external tool\n\n\n\n\n\n\nThe subsequent sections will provide additional details on each of these topics.\n\n\nSecurity\n\n\nThe usage of the distributed \nStorage Client\n is required to provide additional security while operating in participating cloud environments and to enhance user download speeds.\n\n\nAWS\n\n\nSecurity is enforced by a coordinating ICGC storage server. The client communicates with the server which brokers downloads and converts ICGC Access Tokens into Amazon \npre-signed urls\n. Once a successful authorization handshake between the client and the server is established, downloads will be transferred directly from \nS3\n to the client, maintaining fast access to the data.\n\n\nIt is important to note that the provided software only functions within the \nus-east-1\n EC2 region of AWS located in Northern Virginia, U.S. where the data is physically stored. Attempting to use the software outside of this region will be denied data access.\n\n\nCollaboratory\n\n\nDownloads only function inside Collaboratory's OpenStack environment.\n\n\nLastly, it is the user\u2019s responsibility to protect the data after it has been attained. This includes any subsequent analyses and storage on cloud and downstream resources.\n\n\nAuthorization\n\n\nThere are two prerequesites to using the Storage Client: DACO Cloud Access status and a self-provisioned Access Token.\n\n\nDACO Cloud Access\n\n\nDACO Cloud Access is prerequisite to using the Storage Client. To apply for DACO access please follow the instructions provided at \nhttps://icgc.org/daco\n. Once approved, you will be able to \nlogin\n to the Data Portal to generate an \nAccess Token\n. To login, click on the \u201cLogin\u201d link in the upper right-hand corner of the page. When prompted, choose to login with either your \nICGC.org login\n or one of the supported OpenID providers (e.g. Google). After successful authentication, you will know that you have Cloud Access to the controlled tier if the \u201clogin\u201d link is replaced with a green cloud icon ().\n\n\nAccess Tokens\n\n\nThe Access Token model used for protecting the cloud data set follows a similar process to Github\u2019s \npersonal access tokens\n. Tokens are used instead of a username / password to securely access ICGC resources.\n\n\nRelated to Access Tokens is the concept of \nScopes\n. Tokens allow you to associate Scopes which limit access to that needed for the target environment. This enhances security by following the \nPrinciple of Least Privilege\n. Cloud specific Scopes will become available after acquiring DACO Cloud Access. An instance of a cloud download token will grant access to all of the available data in that environment.\n\n\nToken Manager\n\n\nTo acquire an Access Token, you must first obtain DACO Clould Access and login to the Data Portal. After a successful login, there will be \nToken Manager\n link in the upper right corner of the page. Clicking on this link will display the Token Manager dialog:\n\n\n\n\nFrom this dialog, you can manage the Access Tokens associated with your account. Importantly, you may delete and regenerate an access token if you believe that it has been compromised.\n\n\n\n\nWhen creating an Access Token, you will need to specify the Scope associated with the target cloud(s).\n\n\nAWS\n\n\nIn the case of the ICGC AWS data set, an access token with the \naws.download\n scope is required to access the \ncontrolled access data\n\n\nCollaboratory\n\n\nIn the case of the ICGC Collaboratory data set, an access token with the \ncollab.download\n scope is required to access the \ncontrolled access data\n\n\nYou can verify that your Access Token has the desired scopes by inspecting it in the table at the bottom of the dialog. For security purposes, Access Tokens must remain private and not be shared with anyone.\n\n\nFollowing the creation of a Compute Instance, discussed in the next section, you will need to edit the Storage Client client configuration file to include the generated Access Token. See the \nConfiguration\n section for additional information.\n\n\nCompute Prerequisites\n\n\nCompute Instance\n\n\nAs a first step in analyzing data, you will need to create a Compute Instance to run the Storage Client and any other supporting software.\n\n\nAWS\n\n\nIn order to run within \nEC2\n, you will need your own AWS account to provision a running EC2 instance. Any data processing will be charged to this account. Note that ICGC data download from S3 to the same EC2 region is free of charge. Please see Amazon's documentation for detailed instructions.\n\n\nCollaboratory\n\n\nIn order to run within \nCollaboratory\n, you will need to be enrolled. To begin the enrollment process, please send an email to \nhelp@cancercollaboratory.org\n.\n\n\nThe following sections provide guidance on selecting and configuring the chosen instance type.\n\n\nResources\n\n\nAs data files are quite large, users should have enough local disk space to store files downloaded from the remote repository.\n\n\nMore processing cores will give greater parallelism, and therefore, better thoughput of downloads.\n\n\nBy default the storage client is configured to use a maximum of 3G of RAM. Most of time this is more than sufficient.\n\n\nOperating System\n\n\nThe Storage Client has been designed to work on modern Mac and Linux distributions. Windows should work as well but remains untested.\n\n\nDependencies\n\n\nThe Storage Client requires Java 8 to be installed. It has been tested using the Oracle distribution. The procedure for installing Java 8 will vary depending on the operating system and package manager used.\n\n\nIn order to use the mount feature, \nFUSE\n is required. On most Linux based systems this will require installing \nlibfuse-dev\n and \nfuse\n packages.\n\n\nInstallation\n\n\nThis section describes how to install the Storage Client. The are two options: (a) from a tarball and (b) from a Docker image hosted on Dockerhub.\n\n\nInstall from Tarball\n\n\nTo begin using the Storage Client, the first step is to download the distribution. The latest version can be downloaded from \nhere\n.\n\n\nwget -O icgc-storage-client.tar.gz https://dcc.icgc.org/api/v1/ui/software/icgc-storage-client/latest\ntar -xvzf icgc-storage-client.tar.gz\n\n\n\n\nAfter untaring the archive, the Storage Client will be available at \nbin/icgc-storage-client\n. Steps to verify the authenticity and integrity of the download can be found on our \nsoftware\n page.\n\n\nInstall from Docker Image\n\n\nWe also support a Docker image of the Storage Client that is bundled with Java 8 for easy deployment.\n\n\nThe image is hosted at \nhttps://hub.docker.com/r/icgc/icgc-storage-client/\n and downloaded by issuing the following command:\n\n\ndocker pull icgc/icgc-storage-client\n\n\n\n\nOnce pulled, you can open a shell in the container by executing:\n\n\ndocker run -it icgc/icgc-storage-client\n\n\n\n\nThere is no entry point or command defined for the image. The software may be located at \n/icgc/icgc-storage-client\n which is also the working directory of the container. All other steps for \nusing the Storage Client\n will be the same for both Docker and tarball installations.\n\n\nConfiguration\n\n\nThe configuration of the Storage Client is stored in the \nconf/application.properties\n file of the distribution.\n\n\nAccess Configuration\n\n\nThe main configuration element is the access token generated in \nAccess Token\n above. Configuration is stored in the \nconf/\n directory of the distribution.\n\n\nEdit \napplication.properties\n and add the generated accesss token to the line:\n\n\naccessToken=\naccess token\n\n\n\n\n\nWhen using Docker, this can also be set with an environmental variable:\n\n\ndocker run -it -e ACCESSTOKEN=\naccess token\n icgc/icgc-storage-client\n\n\n\n\nCollaboratory\n\n\nIn addition to the above, you will need to change the \nbin/icgc-storage-client\n script to set \nSTORAGE_PROFILE=collab\n. This can also performed externally via the environmental variable of the same name. Note that it is also possible to override this per execution using \nbin/icgc-storage-client\n's \n--profile collab\n argument.\n\n\nTransport Configuration\n\n\nBased on the target Compute Instance defined in \nCompute Prerequisites\n and transfer speed requirements, it may be necessary to make changes to how the Storage Client transfers data. This is achieved by setting \ntransport.parallel\n and \ntransport.memory\n:\n\n\n\n\ntransport.parallel\n controls the number of concurrent threads for multi-part data transfers. It is recommended to set this to the number of cores of the Compute Instance.\n\n\ntransport.memory\n is the amount of non-heap memory per thread, in gigabytes. It is recommended set this to a value of \n1\n (1 GB). Be sure to leave enough memory for the operating system and any other software that may be running on the Compute Instance.\n\n\n\n\nFile Search\n\n\nFinding files of interest can be done via the Data Portal. Objects are identified by their \nObject ID\n.\n\n\n\n\nNavigate to \nrepository file search\n\n\nClick on the \nAWS\n or \nCollaboratory\n filter in the left hand pane\n\n\nFilter based on properties of interest (e.g. donor id, specimen id, etc.)\n\n\nExport a \nManifest\n for future use with the Storage Client\n\n\n\n\nThe Manifest is the main way to define what files should be downloaded by the Storage Client. However, knowing the Object ID is sufficient for a single file download. To generate a Manifest, click on the \"Download manifests\" link the the Data Repository browser. You will be prompted with a \"Download manifests\" dialog:\n\n\n\n\nManifests downloaded from the Data Portal can be transferred to the Storage Client instance by using SFTP or SCP. For convenience, it is also possible to use a Manifest ID saved on the Data Portal by clicking on the \"Manifest ID\" button. See the \nStorage Client Usage\n section for usage information.\n\n\nStorage Client Usage\n\n\nThis section provides information on how to use the Storage Client once it has been properly downloaded and configured. It assumes the user possesses and has configured the requisite access token discussed previously.\n\n\nThe Storage Client has the general syntax:\n\n\nicgc-storage-client [options] [command] [command options]\n\n\n\n\nIt offers a set of commands, where each command has its own set of options to influence its operation.\n\n\nHelp\n\n\nThe Storage Client provides a \n--help\n option to list the available commands and a brief description of their supported options:\n\n\nbin/icgc-storage-client --help\n\n\n\n\nIt is also possible to get information on a specific command using the \nhelp\n command:\n\n\nbin/icgc-storage-client help download\n\n\n\n\nURL Command\n\n\nThe \nurl\n command is the most basic command supported by the Storage Client. It allows one to resolve the underyling S3 URL for the requested object. This is useful if one wants to directly access the URL via HTTPS with an external client or tool (e.g. \ncurl\n, \nwget\n, etc.)\n\n\nbin/icgc-storage-client url --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd\n\n\n\n\nAn example of using \nwget\n:\n\n\nbin/icgc-storage-client url --object-id \nObject ID\n\nResolving URL for object: ddcdd044-adda-5f09-8849-27d6038f8ccd (offset = 0, length = -1)\nhttps://s3-external-1.amazonaws.com/snip\n\n\nwget https://s3-external-1.amazonaws.com/snip\n\n\n\n\n\nDownload Command\n\n\nThe \ndownload\n command allows fast parallel download of remote objects. It can be run in one of two modes: (a) single object mode and (b) Manifest driven mode\n\n\nNote that the Storage Client is able to resume an interrupted download session. Simply rerun the same command again and it will continue.\n\n\nSingle Object\n\n\nThis mode is most useful when downloading a single object given a known Object ID, perhaps acquired from the Data Portal:\n\n\nbin/icgc-storage-client download --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd --output-dir data\n\n\n\n\nDownloads will be stored in the \n--output-dir\n.\n\n\nManifest\n\n\nUsing a Manifest is ideal for downloading multiple files identified through the Data Portal. The \nrepository file search\n allows one to generate a Manifest file that can be supplied for bulk downloading files. It also provides some additional metadata for selected files that gives the donor, specimen and sample context.\n\n\nbin/icgc-storage-client download --manifest manifest.txt --output-dir data\n\n\n\n\nThe optional \n--output-layout\n option can be used to organize the downloads into a couple of predefined directory layouts. See the \n--help\n for addional information.\n\n\nManifest Command\n\n\nThe \nmanifest\n command allows a user to quickly view the contents of a download Manifest produced by the Data Portal. A Manifest can come from:\n\n\n\n\nThe local file system\n\n\nA Manifest ID that is hosted on the Data Portal\n\n\nAny URL\n\n\n\n\nA Manifest is a TSV file that contains both file identifying fields and satellite metadata for understanding the relationships to other data including donor, project and study.\n\n\nManifest from a Local File\n\n\nAn example of using a local file system Manifest:\n\n\nbin/icgc-storage-client manifest --manifest manifest.aws-virginia.1444232116728.txt\n\n\n\n\nManifest from the Data Portal\n\n\nAn example of using a Data Portal hosted Manifest:\n\n\nbin/icgc-storage-client manifest --manifest 49e91614-7811-11e5-8a58-34363bcf803c\n\n\n\n\nManifest from a URL\n\n\nAn example of using a URL hosted Manifest:\n\n\nbin/icgc-storage-client manifest --manifest http://hastebin.com/raw/ujajodilih\n\n\n\n\nView Command\n\n\nThe \nview\n command is a minimal version of \nsamtools view\n. It allows to request a \u201cgenomic slice\u201d of the remote BAM file, freeing the user from having to download the entire file locally, saving bytes and time.\n\n\nThe following example will download reads overlapping the region 1 - 100000 in chromosome 1:\n\n\nbin/icgc-storage-client view --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd --query 1:1-100000\n\n\n\n\nThe BAI is automatically discovered and streamed as part of the operation.\n\n\nFor quickly accessing the only the BAM header one can issue:\n\n\nbin/icgc-storage-client view --header-only --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd\n\n\n\n\nIt is also possible to pipe the output of the above to \nsamtools\n, etc. for pipelining a workflow:\n\n\nbin/icgc-storage-client view --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd | samtools mpileup -\n\n\n\n\nMount Command\n\n\nThe \nmount\n command can be used to mount the remote S3 bucket as a read-only \nFUSE\n file system. This is very useful to browse and explore the available files, as well as quickly see their size and date of modification using common commands such as \nls\n, \nfind\n, \ndu\n and \ntree\n. It also works very well with standard analysis tools such as \nsamtools\n.\n\n\nFiles are organized into a virtual directory structure. The following shows the default \nbundle\n layout:\n\n\n/bundleId1/fileName1\n/bundleId1/fileName2\n...\n/bundleId1/fileNamei\n...\n/bundleIdn/fileName1\n/bundleIdn/fileName2\n...\n/bundleIdn/fileNamej\n\n\n\n\nwhere \nbundleId\n and \nfileName\n are the original \nBundle ID\n and file name of the file respectively. It possible to control the layout using the \n--layout\n option. Using \n--layout object-id\n will instead produce a flat list of files named by their associated Object ID.\n\n\nThe file system implementation's performance is optimized for serial reads. Frequent random access patterns will lead to very poor performance. Under the covers, each random seek requires a new HTTP connection to S3 with the appropriate \nRange\n header set which is an expensive operation. For this reason, it is only recommended for streaming analysis (e.g. \nsamtools view\n like functionality).\n\n\nMount All Files\n\n\nTo mount all available files locally, issue the following:\n\n\n# Create the mount point\nmkdir /mnt/icgc\n\n# Mount\nbin/icgc-storage-client mount --mount-point /mnt/icgc\n\n\n\n\nTo speed up subsequent mounts, one can specify the \n--cache-metadata\n flag above which will locally store an index of the file system.\n\n\nOnce mounted, you can use standard analysis tools against files found under the mount point:\n\n\n# Slice\nsamtools view /mnt/icgc/fff75930-0f8c-4c99-9b48-732e7ed4c625/443a7a6ab964e41c011cc9a303bc086c.bam 1:10000-20000\n\n\n\n\nMount Only Manifest Entries\n\n\nTo filter the mount to only include the files specified in a Manifest, issue the following:\n\n\n# Create the mount point\nmkdir /mnt/icgc\n\n# Mount\nbin/icgc-storage-client mount --mount-point /mnt/icgc --manfiest manifest\n\n\n\n\n\nSee the \nmanifest\n command for more details on how to specify a Manifest.\n\n\nMount in Docker\n\n\nTo avoid having to install the FUSE and Java dependencies when working with the \nmount\n command, it is very convenient to mount from within a Docker container. This is also useful for creating a custom image for analysis that derives from the one published by ICGC. First, ensure that Docker and the Storage Client image is installed. See the \nInstallation\n section for details.\n\n\nNext, export the access token generated from the portal:\n\n\n# Export access token\nexport ACCESSTOKEN=accessToken\n\n\n\n\n\nAnd then mount the file system inside the container against the empty \n/mnt\n directory:\n\n\n# Alias for ease of use\nalias icgc-storage-client=\ndocker run -it --rm -e ACCESSTOKEN --privileged icgc/icgc-storage-client bin/icgc-storage-client\n\n\n\n\n\n# Mount the file system in the container\nicgc-storage-client mount --mount-point /mnt\n\n\n\n\nNote that the \n--privileged\n Docker option is required for FUSE in order to access the host's \n/dev/fuse\n device.\n\n\nIn another terminal, you can access the newly mounted file system:\n\n\n# List all files recursively\ndocker exec -it $(docker ps -lq) find /mnt\n\n\n\n\nTo perform analysis within the container:\n\n\n# Open a shell in the previously created container\ndocker exec -it $(docker ps -lq) bash\n\n# Install samtools\napt-get install samtools\n\n# Slice\nsamtools view /mnt/fff75930-0f8c-4c99-9b48-732e7ed4c625/443a7a6ab964e41c011cc9a303bc086c.bam 1:10000-20000\n\n\n\n\nDue to a limitation of Docker it is not possible to access a FUSE mounted file system from the host operating system. Please see \nhere\n for more details.\n\n\nFAQs\n\n\nWhere can I find the Bundle ID associated with an Object ID?\n\n\nCurrently the only way to retrieve the Bundle ID of an Object ID is by viewing the file entity page in the Data Portal. Navigate to the Data Repository browser and enter the Object ID in the \"File\" filter and click on the resulting record.\n\n\nWhere are detailed Storage Client logs stored?\n\n\nThe Storage Client log file is stored at \nlogs/client.log\n\n\nHow long will pre-signed URLs remain valid?\n\n\nPre-signed URLs are valid for 1 day from the time they are issued. For security purposes, a URL issued to one user must not be used by another and must be kept private.\n\n\nDoes the client maintain state?\n\n\nYes, the client maintains state in the working directory in a hidden file \n.\nObject ID\n/meta\n. This file includes cached pre-signed URLS. If your downloads fail unexpectedly, then try deleting this directory to purge pre-signed URLs that may have expired. Also, when using the \nmount\n command with the \n--cache-metadata\n option, \n.entities.cache\n and \n.objects.cache\n are stored in the current working directory.\n\n\nWhy do I get a security exception when I try to download an object?\n\n\nIf you are targeting the AWS cloud, ensure that you are running within the \nus-east-1\n \nregion\n. If you are targeting Collaboratory, make sure you are inside the OpenStack environment.\n\n\nI can\u2019t use the result of a \nurl\n command with \nsamtools\n:\n\n\nsamtools\n doesn\u2019t support the HTTPS protocol\n*\n, which is required by ICGC to access S3-stored data files. Use the client \nview\n command to pipe data to samtools, download the desired files locally, or use the mount command to create a FUSE mount of the ICGC data files.\n\n\n*\n \nUpdate\n: As of commit \nfe1f08a\n \nsamtools\n now supports file access over HTTPS and Amazon S3.\n\n\nHow do I report a bug in the software?\n\n\nPlease contact \ndcc-support@icgc.org\n and include the version of the software in the body of the message (\nbin/icgc-storage-client --version\n).\n\n\nTerms\n\n\nRelated terms and their defintions are given below:\n\n\n\n\n\n\n\n\nTerm\n\n\nMeaning\n\n\n\n\n\n\n\n\n\n\nAccess Token\n\n\nAn authorization mechanism created by the \nData Portal\n to access data.\n\n\n\n\n\n\nBundle ID\n\n\nAn identifier that refers to a submission bundle of related files. Typically the files produced by analysis workflows are packaged as a single unit. However, when a bundle is imported into a cloud repository each file in the bundle is given its own Object ID.\n\n\n\n\n\n\nCompute Instance\n\n\nA user virtual machine operating in a cloud environment.\n\n\n\n\n\n\nDACO\n\n\nThe Data Access Compliance Office which handles requests from researchers for access to controlled data from the ICGC.\n\n\n\n\n\n\nDACO Cloud Access\n\n\nDACO access with supplemental approved Cloud Access status.\n\n\n\n\n\n\nDCC\n\n\nThe ICGC Data Coordination Center (\nDCC\n) performs quality assessment, curation and data releases and also manages the data flow from projects and centers to the central ICGC database and public repositories.\n\n\n\n\n\n\nData Portal\n\n\nThe ICGC data portal located at \nhttps://dcc.icgc.org\n.\n\n\n\n\n\n\nFUSE\n\n\nFilesystem in Userspace\n is an operating system mechanism for Unix-like computer operating systems that lets non-privileged users create their own file systems without editing kernel code.\n\n\n\n\n\n\nManifest\n\n\nA file used as input to the Storage Client to describe and identify files to be downloaded.\n\n\n\n\n\n\nObject ID\n\n\nThe unique identifier of an object expressed as a UUID. In the command line interface this is refered to as \n--object-id\n.\n\n\n\n\n\n\nOpenStack\n\n\nOpenStack is a cloud operating system that controls large pools of compute, storage, and networking resources throughout a datacenter, all managed through a dashboard that gives administrators control while empowering their users to provision resources through a web interface.\n\n\n\n\n\n\nScope\n\n\nA user permission or authorization to access a resource.\n\n\n\n\n\n\nStorage Client\n\n\nSofware provided by ICGC required to download data from AWS S3.\n\n\n\n\n\n\nS3\n\n\nAmazon Simple Storage Service\n, the physical store of the ICGC AWS data.\n\n\n\n\n\n\nToken Manager\n\n\nSection of the portal used to manage Access Tokens.", 
            "title": "Guide"
        }, 
        {
            "location": "/cloud/guide/#overview", 
            "text": "This user guide describes the steps to securely explore and analyze ICGC data stored in  Amazon ( AWS )  or  Collaboratory ( OpenStack )  cloud environments. For more information about ICGC cloud initiatives, please see  ICGC in the Cloud .  Please see  Terms  for a glossary of terms used in this guide.", 
            "title": "Overview"
        }, 
        {
            "location": "/cloud/guide/#process", 
            "text": "The figure below illustrates the overall process and systems involved:   Authorization \n    Apply for DACO  Cloud Access  if not already approved\n    Upon approval, login to the  Data Portal \n    Generate an  Access Token  for cloud download  Compute Prerequistes \n    Provision a  Compute Instance  in the target cloud  Installation \n    Download and install the ICGC  Storage Client  Configuration \n    Configure the Storage Client to use the generated Access Token  File Search \n    Identify files of interest using the Data Portal  Storage Client Usage \n    Download or view data with the provided Storage Client or via an external tool    The subsequent sections will provide additional details on each of these topics.", 
            "title": "Process"
        }, 
        {
            "location": "/cloud/guide/#security", 
            "text": "The usage of the distributed  Storage Client  is required to provide additional security while operating in participating cloud environments and to enhance user download speeds.", 
            "title": "Security"
        }, 
        {
            "location": "/cloud/guide/#aws", 
            "text": "Security is enforced by a coordinating ICGC storage server. The client communicates with the server which brokers downloads and converts ICGC Access Tokens into Amazon  pre-signed urls . Once a successful authorization handshake between the client and the server is established, downloads will be transferred directly from  S3  to the client, maintaining fast access to the data.  It is important to note that the provided software only functions within the  us-east-1  EC2 region of AWS located in Northern Virginia, U.S. where the data is physically stored. Attempting to use the software outside of this region will be denied data access.", 
            "title": "AWS"
        }, 
        {
            "location": "/cloud/guide/#collaboratory", 
            "text": "Downloads only function inside Collaboratory's OpenStack environment.  Lastly, it is the user\u2019s responsibility to protect the data after it has been attained. This includes any subsequent analyses and storage on cloud and downstream resources.", 
            "title": "Collaboratory"
        }, 
        {
            "location": "/cloud/guide/#authorization", 
            "text": "There are two prerequesites to using the Storage Client: DACO Cloud Access status and a self-provisioned Access Token.", 
            "title": "Authorization"
        }, 
        {
            "location": "/cloud/guide/#daco-cloud-access", 
            "text": "DACO Cloud Access is prerequisite to using the Storage Client. To apply for DACO access please follow the instructions provided at  https://icgc.org/daco . Once approved, you will be able to  login  to the Data Portal to generate an  Access Token . To login, click on the \u201cLogin\u201d link in the upper right-hand corner of the page. When prompted, choose to login with either your  ICGC.org login  or one of the supported OpenID providers (e.g. Google). After successful authentication, you will know that you have Cloud Access to the controlled tier if the \u201clogin\u201d link is replaced with a green cloud icon ().", 
            "title": "DACO Cloud Access"
        }, 
        {
            "location": "/cloud/guide/#access-tokens", 
            "text": "The Access Token model used for protecting the cloud data set follows a similar process to Github\u2019s  personal access tokens . Tokens are used instead of a username / password to securely access ICGC resources.  Related to Access Tokens is the concept of  Scopes . Tokens allow you to associate Scopes which limit access to that needed for the target environment. This enhances security by following the  Principle of Least Privilege . Cloud specific Scopes will become available after acquiring DACO Cloud Access. An instance of a cloud download token will grant access to all of the available data in that environment.", 
            "title": "Access Tokens"
        }, 
        {
            "location": "/cloud/guide/#token-manager", 
            "text": "To acquire an Access Token, you must first obtain DACO Clould Access and login to the Data Portal. After a successful login, there will be  Token Manager  link in the upper right corner of the page. Clicking on this link will display the Token Manager dialog:   From this dialog, you can manage the Access Tokens associated with your account. Importantly, you may delete and regenerate an access token if you believe that it has been compromised.   When creating an Access Token, you will need to specify the Scope associated with the target cloud(s).", 
            "title": "Token Manager"
        }, 
        {
            "location": "/cloud/guide/#aws_1", 
            "text": "In the case of the ICGC AWS data set, an access token with the  aws.download  scope is required to access the  controlled access data", 
            "title": "AWS"
        }, 
        {
            "location": "/cloud/guide/#collaboratory_1", 
            "text": "In the case of the ICGC Collaboratory data set, an access token with the  collab.download  scope is required to access the  controlled access data  You can verify that your Access Token has the desired scopes by inspecting it in the table at the bottom of the dialog. For security purposes, Access Tokens must remain private and not be shared with anyone.  Following the creation of a Compute Instance, discussed in the next section, you will need to edit the Storage Client client configuration file to include the generated Access Token. See the  Configuration  section for additional information.", 
            "title": "Collaboratory"
        }, 
        {
            "location": "/cloud/guide/#compute-prerequisites", 
            "text": "", 
            "title": "Compute Prerequisites"
        }, 
        {
            "location": "/cloud/guide/#compute-instance", 
            "text": "As a first step in analyzing data, you will need to create a Compute Instance to run the Storage Client and any other supporting software.", 
            "title": "Compute Instance"
        }, 
        {
            "location": "/cloud/guide/#aws_2", 
            "text": "In order to run within  EC2 , you will need your own AWS account to provision a running EC2 instance. Any data processing will be charged to this account. Note that ICGC data download from S3 to the same EC2 region is free of charge. Please see Amazon's documentation for detailed instructions.", 
            "title": "AWS"
        }, 
        {
            "location": "/cloud/guide/#collaboratory_2", 
            "text": "In order to run within  Collaboratory , you will need to be enrolled. To begin the enrollment process, please send an email to  help@cancercollaboratory.org .  The following sections provide guidance on selecting and configuring the chosen instance type.", 
            "title": "Collaboratory"
        }, 
        {
            "location": "/cloud/guide/#resources", 
            "text": "As data files are quite large, users should have enough local disk space to store files downloaded from the remote repository.  More processing cores will give greater parallelism, and therefore, better thoughput of downloads.  By default the storage client is configured to use a maximum of 3G of RAM. Most of time this is more than sufficient.", 
            "title": "Resources"
        }, 
        {
            "location": "/cloud/guide/#operating-system", 
            "text": "The Storage Client has been designed to work on modern Mac and Linux distributions. Windows should work as well but remains untested.", 
            "title": "Operating System"
        }, 
        {
            "location": "/cloud/guide/#dependencies", 
            "text": "The Storage Client requires Java 8 to be installed. It has been tested using the Oracle distribution. The procedure for installing Java 8 will vary depending on the operating system and package manager used.  In order to use the mount feature,  FUSE  is required. On most Linux based systems this will require installing  libfuse-dev  and  fuse  packages.", 
            "title": "Dependencies"
        }, 
        {
            "location": "/cloud/guide/#installation", 
            "text": "This section describes how to install the Storage Client. The are two options: (a) from a tarball and (b) from a Docker image hosted on Dockerhub.", 
            "title": "Installation"
        }, 
        {
            "location": "/cloud/guide/#install-from-tarball", 
            "text": "To begin using the Storage Client, the first step is to download the distribution. The latest version can be downloaded from  here .  wget -O icgc-storage-client.tar.gz https://dcc.icgc.org/api/v1/ui/software/icgc-storage-client/latest\ntar -xvzf icgc-storage-client.tar.gz  After untaring the archive, the Storage Client will be available at  bin/icgc-storage-client . Steps to verify the authenticity and integrity of the download can be found on our  software  page.", 
            "title": "Install from Tarball"
        }, 
        {
            "location": "/cloud/guide/#install-from-docker-image", 
            "text": "We also support a Docker image of the Storage Client that is bundled with Java 8 for easy deployment.  The image is hosted at  https://hub.docker.com/r/icgc/icgc-storage-client/  and downloaded by issuing the following command:  docker pull icgc/icgc-storage-client  Once pulled, you can open a shell in the container by executing:  docker run -it icgc/icgc-storage-client  There is no entry point or command defined for the image. The software may be located at  /icgc/icgc-storage-client  which is also the working directory of the container. All other steps for  using the Storage Client  will be the same for both Docker and tarball installations.", 
            "title": "Install from Docker Image"
        }, 
        {
            "location": "/cloud/guide/#configuration", 
            "text": "The configuration of the Storage Client is stored in the  conf/application.properties  file of the distribution.", 
            "title": "Configuration"
        }, 
        {
            "location": "/cloud/guide/#access-configuration", 
            "text": "The main configuration element is the access token generated in  Access Token  above. Configuration is stored in the  conf/  directory of the distribution.  Edit  application.properties  and add the generated accesss token to the line:  accessToken= access token   When using Docker, this can also be set with an environmental variable:  docker run -it -e ACCESSTOKEN= access token  icgc/icgc-storage-client", 
            "title": "Access Configuration"
        }, 
        {
            "location": "/cloud/guide/#collaboratory_3", 
            "text": "In addition to the above, you will need to change the  bin/icgc-storage-client  script to set  STORAGE_PROFILE=collab . This can also performed externally via the environmental variable of the same name. Note that it is also possible to override this per execution using  bin/icgc-storage-client 's  --profile collab  argument.", 
            "title": "Collaboratory"
        }, 
        {
            "location": "/cloud/guide/#transport-configuration", 
            "text": "Based on the target Compute Instance defined in  Compute Prerequisites  and transfer speed requirements, it may be necessary to make changes to how the Storage Client transfers data. This is achieved by setting  transport.parallel  and  transport.memory :   transport.parallel  controls the number of concurrent threads for multi-part data transfers. It is recommended to set this to the number of cores of the Compute Instance.  transport.memory  is the amount of non-heap memory per thread, in gigabytes. It is recommended set this to a value of  1  (1 GB). Be sure to leave enough memory for the operating system and any other software that may be running on the Compute Instance.", 
            "title": "Transport Configuration"
        }, 
        {
            "location": "/cloud/guide/#file-search", 
            "text": "Finding files of interest can be done via the Data Portal. Objects are identified by their  Object ID .   Navigate to  repository file search  Click on the  AWS  or  Collaboratory  filter in the left hand pane  Filter based on properties of interest (e.g. donor id, specimen id, etc.)  Export a  Manifest  for future use with the Storage Client   The Manifest is the main way to define what files should be downloaded by the Storage Client. However, knowing the Object ID is sufficient for a single file download. To generate a Manifest, click on the \"Download manifests\" link the the Data Repository browser. You will be prompted with a \"Download manifests\" dialog:   Manifests downloaded from the Data Portal can be transferred to the Storage Client instance by using SFTP or SCP. For convenience, it is also possible to use a Manifest ID saved on the Data Portal by clicking on the \"Manifest ID\" button. See the  Storage Client Usage  section for usage information.", 
            "title": "File Search"
        }, 
        {
            "location": "/cloud/guide/#storage-client-usage", 
            "text": "This section provides information on how to use the Storage Client once it has been properly downloaded and configured. It assumes the user possesses and has configured the requisite access token discussed previously.  The Storage Client has the general syntax:  icgc-storage-client [options] [command] [command options]  It offers a set of commands, where each command has its own set of options to influence its operation.", 
            "title": "Storage Client Usage"
        }, 
        {
            "location": "/cloud/guide/#help", 
            "text": "The Storage Client provides a  --help  option to list the available commands and a brief description of their supported options:  bin/icgc-storage-client --help  It is also possible to get information on a specific command using the  help  command:  bin/icgc-storage-client help download", 
            "title": "Help"
        }, 
        {
            "location": "/cloud/guide/#url-command", 
            "text": "The  url  command is the most basic command supported by the Storage Client. It allows one to resolve the underyling S3 URL for the requested object. This is useful if one wants to directly access the URL via HTTPS with an external client or tool (e.g.  curl ,  wget , etc.)  bin/icgc-storage-client url --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd  An example of using  wget :  bin/icgc-storage-client url --object-id  Object ID \nResolving URL for object: ddcdd044-adda-5f09-8849-27d6038f8ccd (offset = 0, length = -1)\nhttps://s3-external-1.amazonaws.com/snip \n\nwget https://s3-external-1.amazonaws.com/snip", 
            "title": "URL Command"
        }, 
        {
            "location": "/cloud/guide/#download-command", 
            "text": "The  download  command allows fast parallel download of remote objects. It can be run in one of two modes: (a) single object mode and (b) Manifest driven mode  Note that the Storage Client is able to resume an interrupted download session. Simply rerun the same command again and it will continue.", 
            "title": "Download Command"
        }, 
        {
            "location": "/cloud/guide/#single-object", 
            "text": "This mode is most useful when downloading a single object given a known Object ID, perhaps acquired from the Data Portal:  bin/icgc-storage-client download --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd --output-dir data  Downloads will be stored in the  --output-dir .", 
            "title": "Single Object"
        }, 
        {
            "location": "/cloud/guide/#manifest", 
            "text": "Using a Manifest is ideal for downloading multiple files identified through the Data Portal. The  repository file search  allows one to generate a Manifest file that can be supplied for bulk downloading files. It also provides some additional metadata for selected files that gives the donor, specimen and sample context.  bin/icgc-storage-client download --manifest manifest.txt --output-dir data  The optional  --output-layout  option can be used to organize the downloads into a couple of predefined directory layouts. See the  --help  for addional information.", 
            "title": "Manifest"
        }, 
        {
            "location": "/cloud/guide/#manifest-command", 
            "text": "The  manifest  command allows a user to quickly view the contents of a download Manifest produced by the Data Portal. A Manifest can come from:   The local file system  A Manifest ID that is hosted on the Data Portal  Any URL   A Manifest is a TSV file that contains both file identifying fields and satellite metadata for understanding the relationships to other data including donor, project and study.", 
            "title": "Manifest Command"
        }, 
        {
            "location": "/cloud/guide/#manifest-from-a-local-file", 
            "text": "An example of using a local file system Manifest:  bin/icgc-storage-client manifest --manifest manifest.aws-virginia.1444232116728.txt", 
            "title": "Manifest from a Local File"
        }, 
        {
            "location": "/cloud/guide/#manifest-from-the-data-portal", 
            "text": "An example of using a Data Portal hosted Manifest:  bin/icgc-storage-client manifest --manifest 49e91614-7811-11e5-8a58-34363bcf803c", 
            "title": "Manifest from the Data Portal"
        }, 
        {
            "location": "/cloud/guide/#manifest-from-a-url", 
            "text": "An example of using a URL hosted Manifest:  bin/icgc-storage-client manifest --manifest http://hastebin.com/raw/ujajodilih", 
            "title": "Manifest from a URL"
        }, 
        {
            "location": "/cloud/guide/#view-command", 
            "text": "The  view  command is a minimal version of  samtools view . It allows to request a \u201cgenomic slice\u201d of the remote BAM file, freeing the user from having to download the entire file locally, saving bytes and time.  The following example will download reads overlapping the region 1 - 100000 in chromosome 1:  bin/icgc-storage-client view --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd --query 1:1-100000  The BAI is automatically discovered and streamed as part of the operation.  For quickly accessing the only the BAM header one can issue:  bin/icgc-storage-client view --header-only --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd  It is also possible to pipe the output of the above to  samtools , etc. for pipelining a workflow:  bin/icgc-storage-client view --object-id ddcdd044-adda-5f09-8849-27d6038f8ccd | samtools mpileup -", 
            "title": "View Command"
        }, 
        {
            "location": "/cloud/guide/#mount-command", 
            "text": "The  mount  command can be used to mount the remote S3 bucket as a read-only  FUSE  file system. This is very useful to browse and explore the available files, as well as quickly see their size and date of modification using common commands such as  ls ,  find ,  du  and  tree . It also works very well with standard analysis tools such as  samtools .  Files are organized into a virtual directory structure. The following shows the default  bundle  layout:  /bundleId1/fileName1\n/bundleId1/fileName2\n...\n/bundleId1/fileNamei\n...\n/bundleIdn/fileName1\n/bundleIdn/fileName2\n...\n/bundleIdn/fileNamej  where  bundleId  and  fileName  are the original  Bundle ID  and file name of the file respectively. It possible to control the layout using the  --layout  option. Using  --layout object-id  will instead produce a flat list of files named by their associated Object ID.  The file system implementation's performance is optimized for serial reads. Frequent random access patterns will lead to very poor performance. Under the covers, each random seek requires a new HTTP connection to S3 with the appropriate  Range  header set which is an expensive operation. For this reason, it is only recommended for streaming analysis (e.g.  samtools view  like functionality).", 
            "title": "Mount Command"
        }, 
        {
            "location": "/cloud/guide/#mount-all-files", 
            "text": "To mount all available files locally, issue the following:  # Create the mount point\nmkdir /mnt/icgc\n\n# Mount\nbin/icgc-storage-client mount --mount-point /mnt/icgc  To speed up subsequent mounts, one can specify the  --cache-metadata  flag above which will locally store an index of the file system.  Once mounted, you can use standard analysis tools against files found under the mount point:  # Slice\nsamtools view /mnt/icgc/fff75930-0f8c-4c99-9b48-732e7ed4c625/443a7a6ab964e41c011cc9a303bc086c.bam 1:10000-20000", 
            "title": "Mount All Files"
        }, 
        {
            "location": "/cloud/guide/#mount-only-manifest-entries", 
            "text": "To filter the mount to only include the files specified in a Manifest, issue the following:  # Create the mount point\nmkdir /mnt/icgc\n\n# Mount\nbin/icgc-storage-client mount --mount-point /mnt/icgc --manfiest manifest   See the  manifest  command for more details on how to specify a Manifest.", 
            "title": "Mount Only Manifest Entries"
        }, 
        {
            "location": "/cloud/guide/#mount-in-docker", 
            "text": "To avoid having to install the FUSE and Java dependencies when working with the  mount  command, it is very convenient to mount from within a Docker container. This is also useful for creating a custom image for analysis that derives from the one published by ICGC. First, ensure that Docker and the Storage Client image is installed. See the  Installation  section for details.  Next, export the access token generated from the portal:  # Export access token\nexport ACCESSTOKEN=accessToken   And then mount the file system inside the container against the empty  /mnt  directory:  # Alias for ease of use\nalias icgc-storage-client= docker run -it --rm -e ACCESSTOKEN --privileged icgc/icgc-storage-client bin/icgc-storage-client   # Mount the file system in the container\nicgc-storage-client mount --mount-point /mnt  Note that the  --privileged  Docker option is required for FUSE in order to access the host's  /dev/fuse  device.  In another terminal, you can access the newly mounted file system:  # List all files recursively\ndocker exec -it $(docker ps -lq) find /mnt  To perform analysis within the container:  # Open a shell in the previously created container\ndocker exec -it $(docker ps -lq) bash\n\n# Install samtools\napt-get install samtools\n\n# Slice\nsamtools view /mnt/fff75930-0f8c-4c99-9b48-732e7ed4c625/443a7a6ab964e41c011cc9a303bc086c.bam 1:10000-20000  Due to a limitation of Docker it is not possible to access a FUSE mounted file system from the host operating system. Please see  here  for more details.", 
            "title": "Mount in Docker"
        }, 
        {
            "location": "/cloud/guide/#faqs", 
            "text": "", 
            "title": "FAQs"
        }, 
        {
            "location": "/cloud/guide/#where-can-i-find-the-bundle-id-associated-with-an-object-id", 
            "text": "Currently the only way to retrieve the Bundle ID of an Object ID is by viewing the file entity page in the Data Portal. Navigate to the Data Repository browser and enter the Object ID in the \"File\" filter and click on the resulting record.", 
            "title": "Where can I find the Bundle ID associated with an Object ID?"
        }, 
        {
            "location": "/cloud/guide/#where-are-detailed-storage-client-logs-stored", 
            "text": "The Storage Client log file is stored at  logs/client.log", 
            "title": "Where are detailed Storage Client logs stored?"
        }, 
        {
            "location": "/cloud/guide/#how-long-will-pre-signed-urls-remain-valid", 
            "text": "Pre-signed URLs are valid for 1 day from the time they are issued. For security purposes, a URL issued to one user must not be used by another and must be kept private.", 
            "title": "How long will pre-signed URLs remain valid?"
        }, 
        {
            "location": "/cloud/guide/#does-the-client-maintain-state", 
            "text": "Yes, the client maintains state in the working directory in a hidden file  . Object ID /meta . This file includes cached pre-signed URLS. If your downloads fail unexpectedly, then try deleting this directory to purge pre-signed URLs that may have expired. Also, when using the  mount  command with the  --cache-metadata  option,  .entities.cache  and  .objects.cache  are stored in the current working directory.", 
            "title": "Does the client maintain state?"
        }, 
        {
            "location": "/cloud/guide/#why-do-i-get-a-security-exception-when-i-try-to-download-an-object", 
            "text": "If you are targeting the AWS cloud, ensure that you are running within the  us-east-1   region . If you are targeting Collaboratory, make sure you are inside the OpenStack environment.", 
            "title": "Why do I get a security exception when I try to download an object?"
        }, 
        {
            "location": "/cloud/guide/#i-cant-use-the-result-of-a-url-command-with-samtools", 
            "text": "samtools  doesn\u2019t support the HTTPS protocol * , which is required by ICGC to access S3-stored data files. Use the client  view  command to pipe data to samtools, download the desired files locally, or use the mount command to create a FUSE mount of the ICGC data files.  *   Update : As of commit  fe1f08a   samtools  now supports file access over HTTPS and Amazon S3.", 
            "title": "I can\u2019t use the result of a url command with samtools:"
        }, 
        {
            "location": "/cloud/guide/#how-do-i-report-a-bug-in-the-software", 
            "text": "Please contact  dcc-support@icgc.org  and include the version of the software in the body of the message ( bin/icgc-storage-client --version ).", 
            "title": "How do I report a bug in the software?"
        }, 
        {
            "location": "/cloud/guide/#terms", 
            "text": "Related terms and their defintions are given below:     Term  Meaning      Access Token  An authorization mechanism created by the  Data Portal  to access data.    Bundle ID  An identifier that refers to a submission bundle of related files. Typically the files produced by analysis workflows are packaged as a single unit. However, when a bundle is imported into a cloud repository each file in the bundle is given its own Object ID.    Compute Instance  A user virtual machine operating in a cloud environment.    DACO  The Data Access Compliance Office which handles requests from researchers for access to controlled data from the ICGC.    DACO Cloud Access  DACO access with supplemental approved Cloud Access status.    DCC  The ICGC Data Coordination Center ( DCC ) performs quality assessment, curation and data releases and also manages the data flow from projects and centers to the central ICGC database and public repositories.    Data Portal  The ICGC data portal located at  https://dcc.icgc.org .    FUSE  Filesystem in Userspace  is an operating system mechanism for Unix-like computer operating systems that lets non-privileged users create their own file systems without editing kernel code.    Manifest  A file used as input to the Storage Client to describe and identify files to be downloaded.    Object ID  The unique identifier of an object expressed as a UUID. In the command line interface this is refered to as  --object-id .    OpenStack  OpenStack is a cloud operating system that controls large pools of compute, storage, and networking resources throughout a datacenter, all managed through a dashboard that gives administrators control while empowering their users to provision resources through a web interface.    Scope  A user permission or authorization to access a resource.    Storage Client  Sofware provided by ICGC required to download data from AWS S3.    S3  Amazon Simple Storage Service , the physical store of the ICGC AWS data.    Token Manager  Section of the portal used to manage Access Tokens.", 
            "title": "Terms"
        }, 
        {
            "location": "/submission/about/", 
            "text": "About\n\n\nOverview\n\n\nThis is the documentation page for the ICGC submission system", 
            "title": "About"
        }, 
        {
            "location": "/submission/about/#about", 
            "text": "", 
            "title": "About"
        }, 
        {
            "location": "/submission/about/#overview", 
            "text": "This is the documentation page for the ICGC submission system", 
            "title": "Overview"
        }, 
        {
            "location": "/submission/api/", 
            "text": "API\n\n\nOverview\n\n\nThis is the API documentation page", 
            "title": "API"
        }, 
        {
            "location": "/submission/api/#api", 
            "text": "", 
            "title": "API"
        }, 
        {
            "location": "/submission/api/#overview", 
            "text": "This is the API documentation page", 
            "title": "Overview"
        }, 
        {
            "location": "/submission/dictionary/", 
            "text": "Data Dictionary Release Notes\n\n\n\n\nDictionary v0.12e (August 2015, Current for Release 20)\n\n\nDictionary v0.11c (April., 2015, Release 19)\n\n\nDictionary v0.10a (October., 2014, Release 18)\n\n\nDictionary v0.9a (June., 2014. Release 17)\n\n\nDictionary v0.8d (Mar., 2014. Release 16)\n\n\nDictionary v0.7e (Jan., 2014. Release 15)", 
            "title": "Dictionary"
        }, 
        {
            "location": "/submission/dictionary/#data-dictionary-release-notes", 
            "text": "Dictionary v0.12e (August 2015, Current for Release 20)  Dictionary v0.11c (April., 2015, Release 19)  Dictionary v0.10a (October., 2014, Release 18)  Dictionary v0.9a (June., 2014. Release 17)  Dictionary v0.8d (Mar., 2014. Release 16)  Dictionary v0.7e (Jan., 2014. Release 15)", 
            "title": "Data Dictionary Release Notes"
        }, 
        {
            "location": "/submission/dictionary/20/", 
            "text": "Dictionary v0.12e (August 2015, Current for Release 20)\n\n\nSeptember 25, 2015:\n\nUpdated to dictionary version 0.12e. Change between 0.12d and 0.12e:\n\n\n\n\nRemoved validation check requiring \"donor_age_at_last_followup\" to be less than or equal to 90.\n\n\n\n\nSeptember 22, 2015:\n\nUpdated to dictionary version 0.12d. Change between 0.12c and 0.12d:\n\n\n\n\nRemoved validation check requiring \"donor_interval_of_last_followup\" to be greater than or equal to \"donor_survival_time\" when donor is deceased. \n\n\n\n\nReasoning: In some cases, information on a donor's vital status after they died was obtained via phone calls from/to families or from obituaries rather than a full clinical followup. A full followup was done prior while the donor was alive, and this followup interval is more informative rather than the followup phone call done after the donor died. The removal of this validation check will allow \"donor_interval_of_last_followup\" to be less than \"donor_survival_time\" if the donor is deceased.\n\n\nSeptember 18, 2015:\n\n\n\n\nAdded new term to stsm_p.0.evidence.v1 controlled vocabulary: \"Partner breakpoint found, and paired sequence either side of breakpoint\".\n\n\n\n\nSeptember 9, 2015:\n\nUpdated to dictionary version 0.12c. Change between 0.12b and 0.12c:\n\n\n\n\nUpdated regex for \"raw_data_accession\" to accept EGA Experiment (EGAX\n) and EGA Run (EGAR\n) IDs\n\n\n\n\nSeptember 8, 2015:\n\n\n\n\nAdded new term to GLOBAL.0.platform.v1: \"Illumina HiSeq X Ten\".\n\n\n\n\nSeptember 2, 2015:\n\n\n\n\nAdded new term to GLOBAL.0.platform.v1: \"Ion Torrent Proton\".\n\n\n\n\nAugust 12, 2015:\n\nChange between 0.12a and 0.12b\n\n\n\n\nAdded cross-field validation check for \"donor_primary_treatment_interval\"\n\n\n\n\nChanges to Specifications Since Version 0.11c (April, 2015)\n\n\nRevisions to Data Elements: Changes\n\n\nDonor Clinical File\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\ndonor_primary_treatment_interval\n\n\nNew clinical field\n\n\n\n\n\n\ndonor_survival_time\n\n\nNew cross-field validation check requiring value if donor is deceased\n\n\n\n\n\n\ndonor_age_at_diagnosis, donor_age_at_enrollment, donor_age_at_last_followup\n\n\nUpdated validation script to use default age of 90 if donor is 90 years or older\n\n\n\n\n\n\ndonor_relapse_interval\n\n\nNew cross-field validation check requiring value if disease_status_at_last_followup is progression or relapse\n\n\n\n\n\n\ndonor_interval_of_last_followup\n\n\nNew cross-field validation check requiring value if disease_status_at_last_followup is progression or relapse", 
            "title": "Dictionary - Release 20"
        }, 
        {
            "location": "/submission/dictionary/20/#dictionary-v012e-august-2015-current-for-release-20", 
            "text": "September 25, 2015: \nUpdated to dictionary version 0.12e. Change between 0.12d and 0.12e:   Removed validation check requiring \"donor_age_at_last_followup\" to be less than or equal to 90.   September 22, 2015: \nUpdated to dictionary version 0.12d. Change between 0.12c and 0.12d:   Removed validation check requiring \"donor_interval_of_last_followup\" to be greater than or equal to \"donor_survival_time\" when donor is deceased.    Reasoning: In some cases, information on a donor's vital status after they died was obtained via phone calls from/to families or from obituaries rather than a full clinical followup. A full followup was done prior while the donor was alive, and this followup interval is more informative rather than the followup phone call done after the donor died. The removal of this validation check will allow \"donor_interval_of_last_followup\" to be less than \"donor_survival_time\" if the donor is deceased.  September 18, 2015:   Added new term to stsm_p.0.evidence.v1 controlled vocabulary: \"Partner breakpoint found, and paired sequence either side of breakpoint\".   September 9, 2015: \nUpdated to dictionary version 0.12c. Change between 0.12b and 0.12c:   Updated regex for \"raw_data_accession\" to accept EGA Experiment (EGAX ) and EGA Run (EGAR ) IDs   September 8, 2015:   Added new term to GLOBAL.0.platform.v1: \"Illumina HiSeq X Ten\".   September 2, 2015:   Added new term to GLOBAL.0.platform.v1: \"Ion Torrent Proton\".   August 12, 2015: \nChange between 0.12a and 0.12b   Added cross-field validation check for \"donor_primary_treatment_interval\"   Changes to Specifications Since Version 0.11c (April, 2015)  Revisions to Data Elements: Changes  Donor Clinical File     Data Element ID  Comment      donor_primary_treatment_interval  New clinical field    donor_survival_time  New cross-field validation check requiring value if donor is deceased    donor_age_at_diagnosis, donor_age_at_enrollment, donor_age_at_last_followup  Updated validation script to use default age of 90 if donor is 90 years or older    donor_relapse_interval  New cross-field validation check requiring value if disease_status_at_last_followup is progression or relapse    donor_interval_of_last_followup  New cross-field validation check requiring value if disease_status_at_last_followup is progression or relapse", 
            "title": "Dictionary v0.12e (August 2015, Current for Release 20)"
        }, 
        {
            "location": "/submission/dictionary/20/analyzed-sample-data-file-sample/", 
            "text": "Analyzed Sample Data File (sample)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            \n\n             File Type: \nAnalyzed Sample Data File (sample)\n\n            \n\n            \n\n             File Key: \nsample\n\n            \n\n            \n\n             File Name\n             \n\n              Pattern\n             \n\n             : \n^sample(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n            \n\n            \n\n            \n\n            \n\n             \n\n              \n\n               \n\n                Data Element ID\n               \n\n               \n\n                Name\n               \n\n               \n\n                Description\n               \n\n               \n\n                Data Type\n               \n\n               \n\n                CV Codes\n               \n\n               \n\n                Required?\n               \n\n               \n\n                N/A Code Valid?\n               \n\n               \n\n                Controlled Access?\n               \n\n               \n\n                Regexp\n               \n\n               \n\n                Example\n               \n\n               \n\n                Additional Notes\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                analyzed_sample_id\n               \n\n               \n\n                Analyzed Sample ID\n               \n\n               \n\n                \n\n                 A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Invalid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                 ^[\\w+\\-\\_]+$\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   hnc_12\n                  \n\n                  \n\n                   CCG_34_94583\n                  \n\n                  \n\n                   BRCA47832-3239\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                specimen_id\n               \n\n               \n\n                Specimen ID\n               \n\n               \n\n                \n\n                 Unique identifier for a collected specimen assigned by data provider.\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Invalid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                 ^([\\w+\\-\\_]+)$\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   LAML_PO_00445\n                  \n\n                  \n\n                   THY_099-tumour\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                analyzed_sample_interval\n               \n\n               \n\n                Analyzed Sample Interval\n               \n\n               \n\n                \n\n                 Interval from specimen acquisition to sample use in an analytic procedure (e.g. DNA extraction), in days\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Optional\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                percentage_cellularity\n               \n\n               \n\n                Percentage Cellularity\n               \n\n               \n\n                \n\n                 The cellularity (ratio of tumour nuclei to total number of nuclei in a given sample) of the analyzed sample assessed by methods other than the pathologist\ns report (ie. cellularity derived from sequencing data). Can populate information in either this field or level_of_cellularity\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                level_of_cellularity\n               \n\n               \n\n                Level of Cellularity\n               \n\n               \n\n                \n\n                 The cellularity (proportion of tumour nuclei to total number of nuclei in a given sample) of the analyzed sample assessed by methods other than the pathologist\ns report (ie. cellularity derived from sequencing data). If exact percentage cellularity cannot be determined, submitter has option to use this field to specify a level that defines a range of percentages\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   specimen.0.cellularity.v2\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    1-20%\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    21-40%\n                   \n\n                  \n\n                  \n\n                   \n\n                    3\n                   \n\n                  \n\n                  \n\n                   \n\n                    41-60%\n                   \n\n                  \n\n                  \n\n                   \n\n                    4\n                   \n\n                  \n\n                  \n\n                   \n\n                    61-80%\n                   \n\n                  \n\n                  \n\n                   \n\n                    5\n                   \n\n                  \n\n                  \n\n                   \n\n                    \n81%\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                analyzed_sample_notes\n               \n\n               \n\n                Analyzed Sample Notes\n               \n\n               \n\n                \n\n                 Freetext notes about sample allowed\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Optional\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 Controlled\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                study\n               \n\n               \n\n                Study\n               \n\n               \n\n                \n\n                 Indicate if sample is part of a study\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   sample.0.study.v3\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    PCAWG\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Optional\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n             \n\n            \n\n            \n\n            \n\n            \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Specimen Data File (specimen)\n            \n\n            \n\n             up\n            \n\n            \n\n             Simple Somatic Mutations (ssm) - Analysis Metadata File (m) \u203a", 
            "title": "Analyzed Sample Data File (sample)"
        }, 
        {
            "location": "/submission/dictionary/20/array-based-dna-methylation-metharray-analysis-metadata-file-m/", 
            "text": "Array-based DNA Methylation (meth_array) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nArray-based DNA Methylation (meth_array) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nmeth_array_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^meth_array_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^([\\w+\\-\\_]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^([\\w+\\-\\_]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               fraction_wg_cpg_sites_covered\n              \n\n              \n\n               Fraction Wg Cpg Sites Covered\n              \n\n              \n\n               \n\n                fraction of whole genome CpG sites is covered in the assay\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               conversion_rate\n              \n\n              \n\n               Conversion Rate\n              \n\n              \n\n               \n\n                bisulfite conversion rate\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.()]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_:\\/\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Array-based Gene Expression (exp_array) - Primary File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Array-based DNA Methylation (meth_array) - Primary File (p) \u203a", 
            "title": "Array-based DNA Methylation (meth_array) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/array-based-dna-methylation-metharray-primary-file-p/", 
            "text": "Array-based DNA Methylation (meth_array) - Primary File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nArray-based DNA Methylation (meth_array) - Primary File (p)\n\n           \n\n           \n\n            File Key: \nmeth_array_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^meth_array_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               array_platform\n              \n\n              \n\n               Array Platform\n              \n\n              \n\n               \n\n                Controlled vocabulary for methylation array platform\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.meth_array_platform.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanMethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanMethylation450_before_2011_08_03\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanMethylation450_after_2011_08_02\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   IlluminaDNAMethylation_OMA002_CPI\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   IlluminaDNAMethylation_OMA003_CPI\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               probe_id\n              \n\n              \n\n               Probe ID\n              \n\n              \n\n               \n\n                Methylation array probe ID\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               methylation_value\n              \n\n              \n\n               Methylation Value\n              \n\n              \n\n               \n\n                Methylation value\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               metric_used\n              \n\n              \n\n               Metric Used\n              \n\n              \n\n               \n\n                Metric used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.methylation_metric.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   beta\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   ratio\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               methylated_probe_intensity\n              \n\n              \n\n               Methylated Probe Intensity\n              \n\n              \n\n               \n\n                Methylated probe intensity (Ex. Illumina Signal A)\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               unmethylated_probe_intensity\n              \n\n              \n\n               Unmethylated Probe Intensity\n              \n\n              \n\n               \n\n                Unmethylated probe intensity (Ex. Illumina Signal B)\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the methylation status has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the methylation status is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified (cannot be -777/-888)\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Array-based DNA Methylation (meth_array) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Sequencing-based Gene Expression (exp_seq) - Analysis Metadata File (m) \u203a", 
            "title": "Array-based DNA Methylation (meth_array) - Primary File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/array-based-gene-expression-exparray-analysis-metadata-file-m/", 
            "text": "Array-based Gene Expression (exp_array) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nArray-based Gene Expression (exp_array) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nexp_array_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^exp_array_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalization_algorithm\n              \n\n              \n\n               Normalization Algorithm\n              \n\n              \n\n               \n\n                Name of normalization algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  RPKM http://www.ncbi.nlm.nih.gov/pubmed/18516045\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               reference_sample_type\n              \n\n              \n\n               Reference Sample Type\n              \n\n              \n\n               \n\n                Type of sample used as reference for calculating fold change\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.reference_sample_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   matched normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   unrelated normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   cell line derived from matched normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   pooled samples\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   other\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Splice Variation (jcn) - Primary Analysis File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Array-based Gene Expression (exp_array) - Primary File (p) \u203a", 
            "title": "Array-based Gene Expression (exp_array) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/array-based-gene-expression-exparray-primary-file-p/", 
            "text": "Array-based Gene Expression (exp_array) - Primary File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nArray-based Gene Expression (exp_array) - Primary File (p)\n\n           \n\n           \n\n            File Key: \nexp_array_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^exp_array_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_model\n              \n\n              \n\n               Gene Model\n              \n\n              \n\n               \n\n                Gene model used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.gene_db.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ensembl\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   GAF\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   RefSeq\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_id\n              \n\n              \n\n               Gene ID\n              \n\n              \n\n               \n\n                Gene ID provided in the chosen gene model, eg, ENSG00000157764\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalized_expression_value\n              \n\n              \n\n               Normalized Expression Value\n              \n\n              \n\n               \n\n                Normalized gene expression value\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               fold_change\n              \n\n              \n\n               Fold Change\n              \n\n              \n\n               \n\n                Gene expression fold change\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Array-based Gene Expression (exp_array) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Array-based DNA Methylation (meth_array) - Analysis Metadata File (m) \u203a", 
            "title": "Array-based Gene Expression (exp_array) - Primary File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/controlled-vocabulary/", 
            "text": "Controlled Vocabulary (CV) Tables\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             Controlled Vocabulary (CV) Tables\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.assembly_version.v2\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                GRCh37\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.biological_validation_status.v3\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                tested and valid\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                not tested\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                tested and not valid\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                tested and inconclusive\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.chromosome.v3\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                Y\n               \n\n               \n\n                Y\n               \n\n              \n\n              \n\n               \n\n                X\n               \n\n               \n\n                X\n               \n\n              \n\n              \n\n               \n\n                MT\n               \n\n               \n\n                MT\n               \n\n              \n\n              \n\n               \n\n                1\n               \n\n               \n\n                1\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                2\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                3\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                4\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                5\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                6\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                7\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                8\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                9\n               \n\n              \n\n              \n\n               \n\n                10\n               \n\n               \n\n                10\n               \n\n              \n\n              \n\n               \n\n                11\n               \n\n               \n\n                11\n               \n\n              \n\n              \n\n               \n\n                12\n               \n\n               \n\n                12\n               \n\n              \n\n              \n\n               \n\n                13\n               \n\n               \n\n                13\n               \n\n              \n\n              \n\n               \n\n                14\n               \n\n               \n\n                14\n               \n\n              \n\n              \n\n               \n\n                15\n               \n\n               \n\n                15\n               \n\n              \n\n              \n\n               \n\n                16\n               \n\n               \n\n                16\n               \n\n              \n\n              \n\n               \n\n                17\n               \n\n               \n\n                17\n               \n\n              \n\n              \n\n               \n\n                18\n               \n\n               \n\n                18\n               \n\n              \n\n              \n\n               \n\n                19\n               \n\n               \n\n                19\n               \n\n              \n\n              \n\n               \n\n                20\n               \n\n               \n\n                20\n               \n\n              \n\n              \n\n               \n\n                21\n               \n\n               \n\n                21\n               \n\n              \n\n              \n\n               \n\n                22\n               \n\n               \n\n                22\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.gene_db.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                Ensembl\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                GAF\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                RefSeq\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.is_annotated.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                annotated\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                not annotated\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.is_isomir.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                yes\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                no\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                unknown\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.meth_array_platform.v2\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                HumanMethylation27\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                HumanMethylation450_before_2011_08_03\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                HumanMethylation450_after_2011_08_02\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                IlluminaDNAMethylation_OMA002_CPI\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                IlluminaDNAMethylation_OMA003_CPI\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.methylation_metric.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                beta\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                ratio\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.mirna_db.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                miRBase\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.platform.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                PCR\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                qPCR\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                capillary sequencing\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                SOLiD sequencing\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                Illumina GA sequencing\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                454 sequencing\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                Helicos sequencing\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                Affymetrix Genome-Wide Human SNP Array 6.0\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                Affymetrix Genome-Wide Human SNP Array 5.0\n               \n\n              \n\n              \n\n               \n\n                10\n               \n\n               \n\n                Affymetrix Mapping 100K Array Set\n               \n\n              \n\n              \n\n               \n\n                11\n               \n\n               \n\n                Affymetrix Mapping 500K Array Set\n               \n\n              \n\n              \n\n               \n\n                12\n               \n\n               \n\n                Affymetrix Mapping 10K 2.0 Array Set\n               \n\n              \n\n              \n\n               \n\n                13\n               \n\n               \n\n                Affymetrix EMET Plus Premier Pack\n               \n\n              \n\n              \n\n               \n\n                14\n               \n\n               \n\n                Agilent Whole Human Genome Oligo Microarray Kit\n               \n\n              \n\n              \n\n               \n\n                15\n               \n\n               \n\n                Agilent Human Genome 244A\n               \n\n              \n\n              \n\n               \n\n                16\n               \n\n               \n\n                Agilent Human Genome 105A\n               \n\n              \n\n              \n\n               \n\n                17\n               \n\n               \n\n                Agilent Human CNV Association 2x105K\n               \n\n              \n\n              \n\n               \n\n                18\n               \n\n               \n\n                Agilent Human Genome 44K\n               \n\n              \n\n              \n\n               \n\n                19\n               \n\n               \n\n                Agilent Human CGH 1x1M\n               \n\n              \n\n              \n\n               \n\n                20\n               \n\n               \n\n                Agilent Human CGH 2x400K\n               \n\n              \n\n              \n\n               \n\n                21\n               \n\n               \n\n                Agilent Human CGH 4x180K\n               \n\n              \n\n              \n\n               \n\n                22\n               \n\n               \n\n                Agilent Human CGH 8x60K\n               \n\n              \n\n              \n\n               \n\n                23\n               \n\n               \n\n                Agilent Human CNV 2x400K\n               \n\n              \n\n              \n\n               \n\n                24\n               \n\n               \n\n                Agilent Human miRNA Microarray Kit (v2)\n               \n\n              \n\n              \n\n               \n\n                25\n               \n\n               \n\n                Agilent Human CpG Island Microarray Kit\n               \n\n              \n\n              \n\n               \n\n                26\n               \n\n               \n\n                Agilent Human Promoter ChIP-on-chip Microarray Set\n               \n\n              \n\n              \n\n               \n\n                27\n               \n\n               \n\n                Agilent Human SpliceArray\n               \n\n              \n\n              \n\n               \n\n                28\n               \n\n               \n\n                Illumina human1m-duo\n               \n\n              \n\n              \n\n               \n\n                29\n               \n\n               \n\n                Illumina human660w-quad\n               \n\n              \n\n              \n\n               \n\n                30\n               \n\n               \n\n                Illumina humancytosnp-12\n               \n\n              \n\n              \n\n               \n\n                31\n               \n\n               \n\n                Illumina human510s-duo\n               \n\n              \n\n              \n\n               \n\n                32\n               \n\n               \n\n                Illumina humanmethylation27\n               \n\n              \n\n              \n\n               \n\n                33\n               \n\n               \n\n                Illumina goldengate methylation\n               \n\n              \n\n              \n\n               \n\n                34\n               \n\n               \n\n                Illumina HumanHT-12 v4.0 beadchip\n               \n\n              \n\n              \n\n               \n\n                35\n               \n\n               \n\n                Illumina HumanWG-6 v3.0 beadchip\n               \n\n              \n\n              \n\n               \n\n                36\n               \n\n               \n\n                Illumina HumanRef-8 v3.0 beadchip\n               \n\n              \n\n              \n\n               \n\n                37\n               \n\n               \n\n                Illumina microRNA Expression Profiling Panel\n               \n\n              \n\n              \n\n               \n\n                38\n               \n\n               \n\n                Illumina humanht-16\n               \n\n              \n\n              \n\n               \n\n                39\n               \n\n               \n\n                Illumina humanht-17\n               \n\n              \n\n              \n\n               \n\n                40\n               \n\n               \n\n                Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n               \n\n              \n\n              \n\n               \n\n                41\n               \n\n               \n\n                Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n               \n\n              \n\n              \n\n               \n\n                42\n               \n\n               \n\n                Nimblegen Gene Expression 385K\n               \n\n              \n\n              \n\n               \n\n                43\n               \n\n               \n\n                Nimblegen Gene Expression 4x72K\n               \n\n              \n\n              \n\n               \n\n                44\n               \n\n               \n\n                Nimblegen Gene Expression 12x135K\n               \n\n              \n\n              \n\n               \n\n                45\n               \n\n               \n\n                Nimblegen Human Methylation 2.1M Whole-Genome sets\n               \n\n              \n\n              \n\n               \n\n                46\n               \n\n               \n\n                Nimblegen Human Methylation 385K Whole-Genome sets\n               \n\n              \n\n              \n\n               \n\n                47\n               \n\n               \n\n                Nimblegen CGS\n               \n\n              \n\n              \n\n               \n\n                48\n               \n\n               \n\n                Illumina Human1M OmniQuad chip\n               \n\n              \n\n              \n\n               \n\n                49\n               \n\n               \n\n                PCR and capillary sequencing\n               \n\n              \n\n              \n\n               \n\n                50\n               \n\n               \n\n                Custom-designed gene expression array\n               \n\n              \n\n              \n\n               \n\n                51\n               \n\n               \n\n                Affymetrix HT Human Genome U133A Array Plate Set\n               \n\n              \n\n              \n\n               \n\n                52\n               \n\n               \n\n                Agilent 244K Custom Gene Expression G4502A-07-1\n               \n\n              \n\n              \n\n               \n\n                53\n               \n\n               \n\n                Agilent 244K Custom Gene Expression G4502A-07-2\n               \n\n              \n\n              \n\n               \n\n                54\n               \n\n               \n\n                Agilent 244K Custom Gene Expression G4502A-07-3\n               \n\n              \n\n              \n\n               \n\n                55\n               \n\n               \n\n                Agilent Human Genome CGH Custom Microaary 2x415K\n               \n\n              \n\n              \n\n               \n\n                56\n               \n\n               \n\n                Affymetrix Human U133 Plus PM\n               \n\n              \n\n              \n\n               \n\n                57\n               \n\n               \n\n                Affymetrix Human U133 Plus 2.0\n               \n\n              \n\n              \n\n               \n\n                58\n               \n\n               \n\n                Affymetrix Human Exon 1.0 ST\n               \n\n              \n\n              \n\n               \n\n                59\n               \n\n               \n\n                Almac Human CRC\n               \n\n              \n\n              \n\n               \n\n                60\n               \n\n               \n\n                Illumina HiSeq\n               \n\n              \n\n              \n\n               \n\n                61\n               \n\n               \n\n                Affymetrix Human MIP 330K\n               \n\n              \n\n              \n\n               \n\n                62\n               \n\n               \n\n                Affymetrix Human Gene 1.0 ST\n               \n\n              \n\n              \n\n               \n\n                63\n               \n\n               \n\n                Illumina Human Omni1-Quad beadchip\n               \n\n              \n\n              \n\n               \n\n                64\n               \n\n               \n\n                Sequenom MassARRAY\n               \n\n              \n\n              \n\n               \n\n                65\n               \n\n               \n\n                Custom-designed cDNA array\n               \n\n              \n\n              \n\n               \n\n                66\n               \n\n               \n\n                Illumina HumanHap550\n               \n\n              \n\n              \n\n               \n\n                67\n               \n\n               \n\n                Ion Torrent PGM\n               \n\n              \n\n              \n\n               \n\n                68\n               \n\n               \n\n                Illumina GoldenGate Methylation Cancer Panel I\n               \n\n              \n\n              \n\n               \n\n                69\n               \n\n               \n\n                Illumina Infinium HumanMethylation450\n               \n\n              \n\n              \n\n               \n\n                70\n               \n\n               \n\n                Agilent 8 x 15K Human miRNA-specific microarray\n               \n\n              \n\n              \n\n               \n\n                71\n               \n\n               \n\n                M.D. Anderson Reverse Phase Protein Array Core\n               \n\n              \n\n              \n\n               \n\n                72\n               \n\n               \n\n                Microsatellite Instability Analysis\n               \n\n              \n\n              \n\n               \n\n                73\n               \n\n               \n\n                Agilent 244K Custom Gene Expression G4502A-07\n               \n\n              \n\n              \n\n               \n\n                74\n               \n\n               \n\n                Illumina HumanCNV370-Duo v1.0 BeadChip\n               \n\n              \n\n              \n\n               \n\n                75\n               \n\n               \n\n                Illumina HumanOmniExpress BeadChip\n               \n\n              \n\n              \n\n               \n\n                76\n               \n\n               \n\n                PacBio RS sequencing\n               \n\n              \n\n              \n\n               \n\n                77\n               \n\n               \n\n                Affymetrix OncoScan FFPE Express 2.0\n               \n\n              \n\n              \n\n               \n\n                78\n               \n\n               \n\n                Illumina MiSeq Personal Sequencer\n               \n\n              \n\n              \n\n               \n\n                79\n               \n\n               \n\n                Affymetrix Human Genome U219 Array Plate\n               \n\n              \n\n              \n\n               \n\n                80\n               \n\n               \n\n                HumanOmni2.5-8 BeadChip Kit\n               \n\n              \n\n              \n\n               \n\n                81\n               \n\n               \n\n                Complete Genomics\n               \n\n              \n\n              \n\n               \n\n                82\n               \n\n               \n\n                nanoString\n               \n\n              \n\n              \n\n               \n\n                83\n               \n\n               \n\n                Ion Torrent Proton\n               \n\n              \n\n              \n\n               \n\n                84\n               \n\n               \n\n                Illumina HiSeq X Ten\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.raw_data_repository.v2\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                EGA\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                dbSNP\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                TCGA\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                CGHub\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                GEO\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                TARGET\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.reference_sample_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                matched normal\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                unrelated normal\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                cell line derived from matched normal\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                pooled samples\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                other\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.sequencing_strategy.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                WGS\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                WGA\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                WXS\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                RNA-Seq\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                miRNA-Seq\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                ncRNA-Seq\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                WCS\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                CLONE\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                POOLCLONE\n               \n\n              \n\n              \n\n               \n\n                10\n               \n\n               \n\n                AMPLICON\n               \n\n              \n\n              \n\n               \n\n                11\n               \n\n               \n\n                CLONEEND\n               \n\n              \n\n              \n\n               \n\n                12\n               \n\n               \n\n                FINISHING\n               \n\n              \n\n              \n\n               \n\n                13\n               \n\n               \n\n                ChIP-Seq\n               \n\n              \n\n              \n\n               \n\n                14\n               \n\n               \n\n                MNase-Seq\n               \n\n              \n\n              \n\n               \n\n                15\n               \n\n               \n\n                DNase-Hypersensitivity\n               \n\n              \n\n              \n\n               \n\n                16\n               \n\n               \n\n                Bisulfite-Seq\n               \n\n              \n\n              \n\n               \n\n                17\n               \n\n               \n\n                EST\n               \n\n              \n\n              \n\n               \n\n                18\n               \n\n               \n\n                FL-cDNA\n               \n\n              \n\n              \n\n               \n\n                19\n               \n\n               \n\n                CTS\n               \n\n              \n\n              \n\n               \n\n                20\n               \n\n               \n\n                MRE-Seq\n               \n\n              \n\n              \n\n               \n\n                21\n               \n\n               \n\n                MeDIP-Seq\n               \n\n              \n\n              \n\n               \n\n                22\n               \n\n               \n\n                MBD-Seq\n               \n\n              \n\n              \n\n               \n\n                23\n               \n\n               \n\n                Tn-Seq\n               \n\n              \n\n              \n\n               \n\n                24\n               \n\n               \n\n                VALIDATION\n               \n\n              \n\n              \n\n               \n\n                25\n               \n\n               \n\n                FAIRE-seq\n               \n\n              \n\n              \n\n               \n\n                26\n               \n\n               \n\n                SELEX\n               \n\n              \n\n              \n\n               \n\n                27\n               \n\n               \n\n                RIP-Seq\n               \n\n              \n\n              \n\n               \n\n                28\n               \n\n               \n\n                ChIA-PET\n               \n\n              \n\n              \n\n               \n\n                29\n               \n\n               \n\n                OTHER\n               \n\n              \n\n              \n\n               \n\n                30\n               \n\n               \n\n                non-NGS\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.strand.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                -1\n               \n\n               \n\n                -1\n               \n\n              \n\n              \n\n               \n\n                1\n               \n\n               \n\n                1\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.validation_status.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                validated\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                not tested\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                not valid\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                inconclusive\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.verification_status.v2\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                tested and verified\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                not tested\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                tested and verified to be false\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                tested and inconclusive\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nGLOBAL.0.yes_no.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                yes\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                no\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nbiomarker.0.biomarker_positive.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                ambiguous\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                absent\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                present\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n             CV Table: \ncnsm_p.0.mutation_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                -1\n               \n\n               \n\n                undetermined\n               \n\n              \n\n              \n\n               \n\n                1\n               \n\n               \n\n                gain\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                loss\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                copy neutral LOH\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                copy neutral\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                hemizygous del LOH\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                amp LOH\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ndonor.0.disease_status_last_followup.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                complete remission\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                partial remission\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                progression\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                relapse\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                stable\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                no evidence of disease\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ndonor.0.donor_relapse_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                local recurrence\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                distant recurrence/metastasis\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                progression (liquid tumours)\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                local recurrence and distant metastasis\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ndonor.0.donor_sex.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                male\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                female\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ndonor.0.donor_vital_status.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                alive\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                deceased\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ndonor.0.prior_malignancy.v1\n\n             \n\n            \n\n            \n\n             \n\n              \n\n               \n\n                \n\n                 ID\n                \n\n                \n\n                 Term\n                \n\n                \n\n                 DB Xref\n                \n\n                \n\n                 URI\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 1\n                \n\n                \n\n                 yes\n                \n\n                \n\n                 \n\n                  N/A\n                 \n\n                \n\n                \n\n                 \n\n                  N/A\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 2\n                \n\n                \n\n                 no\n                \n\n                \n\n                 \n\n                  N/A\n                 \n\n                \n\n                \n\n                 \n\n                  N/A\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 3\n                \n\n                \n\n                 unknown\n                \n\n                \n\n                 \n\n                  N/A\n                 \n\n                \n\n                \n\n                 \n\n                  N/A\n                 \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nalcohol_history_intensity\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n               \n\n                DB Xref\n               \n\n               \n\n                URI\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                None\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                Social Drinker (\n once a month, \n once a week)\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                Weekly Drinker (\n=1x a week)\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                Daily Drinker\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                Occassional Drinker (\n once a month)\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                Not Documented\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nexposure.0.alcohol_history.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n               \n\n                DB Xref\n               \n\n               \n\n                URI\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                yes\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                no\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                Don\nt know/Not sure\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nexposure.0.tobacco_smoking_history_indicator.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n               \n\n                DB Xref\n               \n\n               \n\n                URI\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                Lifelong non-smoker (\n100 cigarettes smoked in lifetime)\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                Current smoker (includes daily smokers non-daily/occasional smokers)\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                Current reformed smoker for \n 15 years\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                Current reformed smoker for \n= 15 years\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                Current reformed smoker, duration not specified\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                Smoking history not documented\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nfamily.0.cancer_history_first_degree_relative.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n               \n\n                DB Xref\n               \n\n               \n\n                URI\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                yes\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                no\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                unknown\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nfamily.0.donor_has_relative_with_cancer_history.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n               \n\n                DB Xref\n               \n\n               \n\n                URI\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                yes\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                no\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                unknown\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nfamily.0.relationship_sex.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                male\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                female\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                unknown\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nfamily.0.relationship_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                sibling\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                parent\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                grandparent\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                uncle/aunt\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                cousin\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                other\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                unknown\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \njcn_p.0.junction_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                canonical\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                non-canonical\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                U12\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nsample.0.study.v3\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                PCAWG\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nsgv_p.0.variant_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                single base substitution\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                insertion of \n= 200 bp\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                deletion of \n= 200 bp\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                multiple base substitution (\n= 2bp and \n= 200bp)\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nspecimen.0.cellularity.v2\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                1-20%\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                21-40%\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                41-60%\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                61-80%\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                \n81%\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nspecimen.0.specimen_donor_treatment_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                no treatment\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                chemotherapy\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                radiation therapy\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                combined chemo+radiation therapy\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                immunotherapy\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                combined chemo+immunotherapy\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                surgery\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                other therapy\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nspecimen.0.specimen_processing.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                cryopreservation in liquid nitrogen (dead tissue)\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                cryopreservation in dry ice (dead tissue)\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                cryopreservation of live cells in liquid nitrogen\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                cryopreservation, other\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                formalin fixed, unbuffered\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                formalin fixed, buffered\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                formalin fixed \n paraffin embedded\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                fresh\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                other technique\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nspecimen.0.specimen_storage.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                frozen, liquid nitrogen\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                frozen, -70 freezer\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                frozen, vapor phase\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                RNA later frozen\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                paraffin block\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                cut slide\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                other\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nspecimen.0.specimen_type.v3\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                101\n               \n\n               \n\n                Normal - solid tissue\n               \n\n              \n\n              \n\n               \n\n                102\n               \n\n               \n\n                Normal - blood derived\n               \n\n              \n\n              \n\n               \n\n                103\n               \n\n               \n\n                Normal - bone marrow\n               \n\n              \n\n              \n\n               \n\n                104\n               \n\n               \n\n                Normal - tissue adjacent to primary\n               \n\n              \n\n              \n\n               \n\n                105\n               \n\n               \n\n                Normal - buccal cell\n               \n\n              \n\n              \n\n               \n\n                106\n               \n\n               \n\n                Normal - EBV immortalized\n               \n\n              \n\n              \n\n               \n\n                107\n               \n\n               \n\n                Normal - lymph node\n               \n\n              \n\n              \n\n               \n\n                108\n               \n\n               \n\n                Normal - other\n               \n\n              \n\n              \n\n               \n\n                109\n               \n\n               \n\n                Primary tumour - solid tissue\n               \n\n              \n\n              \n\n               \n\n                110\n               \n\n               \n\n                Primary tumour - blood derived (peripheral blood)\n               \n\n              \n\n              \n\n               \n\n                111\n               \n\n               \n\n                Primary tumour - blood derived (bone marrow)\n               \n\n              \n\n              \n\n               \n\n                112\n               \n\n               \n\n                Primary tumour - additional new primary\n               \n\n              \n\n              \n\n               \n\n                113\n               \n\n               \n\n                Primary tumour - other\n               \n\n              \n\n              \n\n               \n\n                114\n               \n\n               \n\n                Recurrent tumour - solid tissue\n               \n\n              \n\n              \n\n               \n\n                115\n               \n\n               \n\n                Recurrent tumour - blood derived (peripheral blood)\n               \n\n              \n\n              \n\n               \n\n                116\n               \n\n               \n\n                Recurrent tumour - blood derived (bone marrow)\n               \n\n              \n\n              \n\n               \n\n                117\n               \n\n               \n\n                Recurrent tumour - other\n               \n\n              \n\n              \n\n               \n\n                118\n               \n\n               \n\n                Metastatic tumour - NOS\n               \n\n              \n\n              \n\n               \n\n                119\n               \n\n               \n\n                Metastatic tumour - lymph node\n               \n\n              \n\n              \n\n               \n\n                120\n               \n\n               \n\n                Metastatic tumour - metastasis local to lymph node\n               \n\n              \n\n              \n\n               \n\n                121\n               \n\n               \n\n                Metastatic tumour - metastasis to distant location\n               \n\n              \n\n              \n\n               \n\n                122\n               \n\n               \n\n                Metastatic tumour - additional metastatic\n               \n\n              \n\n              \n\n               \n\n                123\n               \n\n               \n\n                Xenograft - derived from primary tumour\n               \n\n              \n\n              \n\n               \n\n                124\n               \n\n               \n\n                Xenograft - derived from tumour cell line\n               \n\n              \n\n              \n\n               \n\n                125\n               \n\n               \n\n                Cell line - derived from tumour\n               \n\n              \n\n              \n\n               \n\n                126\n               \n\n               \n\n                Primary tumour - lymph node\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nssm_p.0.mutation_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                single base substitution\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                insertion of \n=200bp\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                deletion of \n=200bp\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                multiple base substitution (\n=2bp and \n=200bp)\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nstsm_p.0.evidence.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                Copy number change\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                FISH\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                Flow-sorted chromosome evidence\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                Paired sequence either side of breakpoint\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                Partner breakpoint found\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                PCR product across breakpoint\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                Protein evidence\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                Seen in multiple samples\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                Sequence across breakpoint\n               \n\n              \n\n              \n\n               \n\n                10\n               \n\n               \n\n                Partner breakpoint found, and paired sequence either side of breakpoint\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nstsm_p.0.variant_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                deletion\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                tandem duplication\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                inversion\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                inverted duplication - head-to-head\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                inverted duplication - tail-to-tail\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                insertion\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                intrachromosomal rearrangement with inverted orientation\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                intrachromosomal rearrangement with non-inverted orientation\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                fold-back inversion\n               \n\n              \n\n              \n\n               \n\n                10\n               \n\n               \n\n                complex intrachromosomal rearrangement\n               \n\n              \n\n              \n\n               \n\n                11\n               \n\n               \n\n                reciprocal translocation\n               \n\n              \n\n              \n\n               \n\n                12\n               \n\n               \n\n                unbalanced translocation\n               \n\n              \n\n              \n\n               \n\n                13\n               \n\n               \n\n                interchromosomal insertion\n               \n\n              \n\n              \n\n               \n\n                14\n               \n\n               \n\n                interchromosomal rearrangement - unknown type\n               \n\n              \n\n              \n\n               \n\n                15\n               \n\n               \n\n                complex interchromosomal rearrangement\n               \n\n              \n\n              \n\n               \n\n                16\n               \n\n               \n\n                intrachromosomal amplicon-to-amplicon\n               \n\n              \n\n              \n\n               \n\n                17\n               \n\n               \n\n                intrachromosomal amplicon-to-nonamplified dna\n               \n\n              \n\n              \n\n               \n\n                18\n               \n\n               \n\n                interchromosomal amplicon-to-amplicon\n               \n\n              \n\n              \n\n               \n\n                19\n               \n\n               \n\n                interchromosomal amplicon-to-nonamplified dna\n               \n\n              \n\n              \n\n               \n\n                20\n               \n\n               \n\n                extrachromosomal\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nstsm_p.0.zygosity.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                homozygous\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                heterozygous\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                hemizygous\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                nullizygous\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nsurgery.0.procedure_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                surgical resection of primary\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                surgical resection of local recurrence\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                surgical resection of distant recurrence (metastasis)\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                lymph node dissection performed at time of resection of primary.\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                biopsy of primary\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                biopsy of local recurrence\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                biopsy of distant recurrence.\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                other\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \nsurgery.0.resection_status.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                R0 - no apparent residual disease.\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                R1 - microscopic residual disease.\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                R2 - gross residual disease.\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ntherapy.0.therapeutic_intent.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n               \n\n                DB Xref\n               \n\n               \n\n                URI\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                not applicable\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                adjuvant\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                curative\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                palliative\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n               \n\n                \n\n                 N/A\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ntherapy.0.therapy_type.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                no treatment\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                chemotherapy\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                radiation therapy\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                combined chemo+radiation therapy\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                immunotherapy\n               \n\n              \n\n              \n\n               \n\n                6\n               \n\n               \n\n                combined chemo+immunotherapy\n               \n\n              \n\n              \n\n               \n\n                7\n               \n\n               \n\n                surgery\n               \n\n              \n\n              \n\n               \n\n                8\n               \n\n               \n\n                other therapy\n               \n\n              \n\n              \n\n               \n\n                9\n               \n\n               \n\n                bone marrow transplant\n               \n\n              \n\n              \n\n               \n\n                10\n               \n\n               \n\n                stem cell transplant\n               \n\n              \n\n              \n\n               \n\n                11\n               \n\n               \n\n                monoclonal antibodies (for liquid tumours)\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n            \n\n            \n\n            \n\n            \n\n             CV Table: \ntherapy.0.therapy_response.v1\n\n            \n\n            \n\n             \n\n              \n\n               \n\n                ID\n               \n\n               \n\n                Term\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                1\n               \n\n               \n\n                complete response\n               \n\n              \n\n              \n\n               \n\n                2\n               \n\n               \n\n                partial response\n               \n\n              \n\n              \n\n               \n\n                3\n               \n\n               \n\n                disease progression\n               \n\n              \n\n              \n\n               \n\n                4\n               \n\n               \n\n                stable disease\n               \n\n              \n\n              \n\n               \n\n                5\n               \n\n               \n\n                unknown\n               \n\n              \n\n             \n\n            \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Sequencing-based miRNA Expression (mirna_seq) - Primary File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Protein Expression (pexp) - Analysis Metadata File (m) \u203a", 
            "title": "Controlled Vocabulary (CV) Tables"
        }, 
        {
            "location": "/submission/dictionary/20/copy-number-somatic-mutations-cnsm-analysis-metadata-file-m/", 
            "text": "Copy Number Somatic Mutations (cnsm) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nCopy Number Somatic Mutations (cnsm) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \ncnsm_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^cnsm_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed non-normal sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular non-normal sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               matched_sample_id\n              \n\n              \n\n               Matched Sample ID\n              \n\n              \n\n               \n\n                Unique identifier for the matched normal sample used in the analysis; must exist in the sample file\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  mut19\n                 \n\n                 \n\n                  LH12-fb\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The sample identifiers used for matched_sample_id and analyzed_sample_id cannot be identical\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               base_calling_algorithm\n              \n\n              \n\n               Base Calling Algorithm\n              \n\n              \n\n               \n\n                Name of base calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  CASAVA http://support.illumina.com/sequencing/sequencing_software/casava.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Tophat 2.0.10\n                  \n\n                   http://tophat.cbcb.umd.edu\n                  \n\n                  tophat -p 3 -o s1_guided -G BH_WGS.gtf --no-novel-juncs sequence.txt\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variation_calling_algorithm\n              \n\n              \n\n               Variation Calling Algorithm\n              \n\n              \n\n               \n\n                Name of variation calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Samtools http://samtools.sourceforge.net\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library. Use of N/A reserved for when a non-sequencing strategy is used (example: comparative hybridization array)\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               seq_coverage\n              \n\n              \n\n               Seq Coverage\n              \n\n              \n\n               \n\n                Sequence coverage if analyzed by sequencing platforms\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Simple Somatic Mutations (ssm) - Primary Analysis File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Copy Number Somatic Mutations (cnsm) - Primary Analysis File (p) \u203a", 
            "title": "Copy Number Somatic Mutations (cnsm) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/copy-number-somatic-mutations-cnsm-primary-analysis-file-p/", 
            "text": "Copy Number Somatic Mutations (cnsm) - Primary Analysis File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nCopy Number Somatic Mutations (cnsm) - Primary Analysis File (p)\n\n           \n\n           \n\n            File Key: \ncnsm_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^cnsm_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutation_id\n              \n\n              \n\n               Mutation ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a single mutation observation; must be unique within the scope of all data produced by a project\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  mut19\n                 \n\n                 \n\n                  LH12-fb\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               start_probe_id\n              \n\n              \n\n               Start Probe ID\n              \n\n              \n\n               \n\n                Probe id containing the chromosome_start if array platform was used\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               end_probe_id\n              \n\n              \n\n               End Probe ID\n              \n\n              \n\n               \n\n                Probe id containing the chromosome_end if array platform was used\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome\n              \n\n              \n\n               Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_start\n              \n\n              \n\n               Chromosome Start\n              \n\n              \n\n               \n\n                Chromosome start position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  243198475\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome start position must be equal or greater than 1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_end\n              \n\n              \n\n               Chromosome End\n              \n\n              \n\n               \n\n                Chromosome end position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  243198479\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome end position must be less than or equal to the length of the chromosome\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_start_range\n              \n\n              \n\n               Chromosome Start Range\n              \n\n              \n\n               \n\n                Number of bases around chromosome_start that may contain the start position\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_end_range\n              \n\n              \n\n               Chromosome End Range\n              \n\n              \n\n               \n\n                Number of bases around chromosome_end that may contain the end position\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutation_type\n              \n\n              \n\n               Mutation Type\n              \n\n              \n\n               \n\n                Type of mutation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  cnsm_p.0.mutation_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   undetermined\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   gain\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   loss\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   copy neutral LOH\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   copy neutral\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   hemizygous del LOH\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   amp LOH\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               copy_number\n              \n\n              \n\n               Copy Number\n              \n\n              \n\n               \n\n                DNA copy number estimated\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               segment_mean\n              \n\n              \n\n               Segment Mean\n              \n\n              \n\n               \n\n                Mean LRR per segment\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               segment_median\n              \n\n              \n\n               Segment Median\n              \n\n              \n\n               \n\n                Median LRR per segment\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               quality_score\n              \n\n              \n\n               Quality Score\n              \n\n              \n\n               \n\n                Quality score of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               probability\n              \n\n              \n\n               Probability\n              \n\n              \n\n               \n\n                Probability of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               is_annotated\n              \n\n              \n\n               Is Annotated\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation is annotated in dbSNP\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.is_annotated.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   annotated\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not annotated\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the mutation/variant is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified (cannot be -777/-888)\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_status\n              \n\n              \n\n               Biological Validation Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.biological_validation_status.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and not valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_platform\n              \n\n              \n\n               Biological Validation Platform\n              \n\n              \n\n               \n\n                Identifier of assay platform or technology used to validate the mutation/variant\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is biologically validated, the biological validation platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Copy Number Somatic Mutations (cnsm) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Copy Number Somatic Mutations (cnsm) - Secondary Analysis File (s) \u203a", 
            "title": "Copy Number Somatic Mutations (cnsm) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/copy-number-somatic-mutations-cnsm-secondary-analysis-file-s/", 
            "text": "Copy Number Somatic Mutations (cnsm) - Secondary Analysis File (s)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nCopy Number Somatic Mutations (cnsm) - Secondary Analysis File (s)\n\n           \n\n           \n\n            File Key: \ncnsm_s\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^cnsm_s(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutation_id\n              \n\n              \n\n               Mutation ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a single mutation observation; must be unique within the scope of all data produced by a project\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  mut19\n                 \n\n                 \n\n                  LH12-fb\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_affected\n              \n\n              \n\n               Gene Affected\n              \n\n              \n\n               \n\n                Gene(s) containing the mutation/variation.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               transcript_affected\n              \n\n              \n\n               Transcript Affected\n              \n\n              \n\n               \n\n                Transcript(s) containing the mutation/variation.  Use Ensembl transcript id.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_build_version\n              \n\n              \n\n               Gene Build Version\n              \n\n              \n\n               \n\n                Gene build version associated with the platform, tools or other methods used in the analysis; Supports the following syntax: \nDB:VERSION\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^(\\w+)\\:(\\w+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Ensembl:69\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               note\n              \n\n              \n\n               Note\n              \n\n              \n\n               \n\n                Optional field to leave notes\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Copy Number Somatic Mutations (cnsm) - Primary Analysis File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Structural Somatic Mutations (stsm) - Analysis Metadata File (m) \u203a", 
            "title": "Copy Number Somatic Mutations (cnsm) - Secondary Analysis File (s)"
        }, 
        {
            "location": "/submission/dictionary/20/donor-biomarker/", 
            "text": "Donor Biomarkers (biomarker)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Key: \nbiomarker\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^biomarker(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               donor_id\n              \n\n              \n\n               Donor ID\n              \n\n              \n\n               \n\n                Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  90234\n                 \n\n                 \n\n                  BLD_donor_89\n                 \n\n                 \n\n                  AML-90\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_id\n              \n\n              \n\n               Specimen ID\n              \n\n              \n\n               \n\n                Unique identifier for a collected specimen assigned by data provider.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^([\\w+\\-\\_]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  LAML_PO_00445\n                 \n\n                 \n\n                  THY_099-tumour\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biomarker_name\n              \n\n              \n\n               Biomarker Name\n              \n\n              \n\n               \n\n                Biomarker name\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biomarker_threshold\n              \n\n              \n\n               Biomarker Threshold\n              \n\n              \n\n               \n\n                Threshold value for the biomarker for calling a result positive. Please include units.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biomarker_positive\n              \n\n              \n\n               Biomarker Positive\n              \n\n              \n\n               \n\n                Whether test is positive for named biomarker\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  biomarker.0.biomarker_positive.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   ambiguous\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   absent\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   present\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Donor Surgery (surgery)\n            \n\n            \n\n             up\n            \n\n            \n\n             Specimen Data File (specimen) \u203a", 
            "title": "Donor Biomarkers (biomarker)"
        }, 
        {
            "location": "/submission/dictionary/20/donor-data-file-donor/", 
            "text": "Donor Data File (donor)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            \n\n             File Type: \nDonor Data File (donor)\n\n            \n\n            \n\n             File Key: \ndonor\n\n            \n\n            \n\n             File Name\n             \n\n              Pattern\n             \n\n             : \n^donor(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n            \n\n            \n\n            \n\n            \n\n             \n\n              \n\n               \n\n                Data Element ID\n               \n\n               \n\n                Name\n               \n\n               \n\n                Description\n               \n\n               \n\n                Data Type\n               \n\n               \n\n                CV Codes\n               \n\n               \n\n                Required?\n               \n\n               \n\n                N/A Code Valid?\n               \n\n               \n\n                Controlled Access?\n               \n\n               \n\n                Regexp\n               \n\n               \n\n                Example\n               \n\n               \n\n                Additional Notes\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                donor_id\n               \n\n               \n\n                Donor ID\n               \n\n               \n\n                \n\n                 Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Invalid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                 ^[\\w+\\-\\_]+$\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   90234\n                  \n\n                  \n\n                   BLD_donor_89\n                  \n\n                  \n\n                   AML-90\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   donor_id cannot begin with \nDO*\n\n                   \n\n                  \n\n                  \n\n                   This prefix is reserved for ICGC IDs\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_sex\n               \n\n               \n\n                Donor Sex\n               \n\n               \n\n                \n\n                 Donor biological sex. \nOther\n has been removed from the controlled vocabulary due to identifiability concerns.\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   donor.0.donor_sex.v1\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    male\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    female\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_region_of_residence\n               \n\n               \n\n                Donor Region of Residence\n               \n\n               \n\n                \n\n                 Country, and optionally state or province code, but not city.\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Controlled\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_vital_status\n               \n\n               \n\n                Donor Vital Status\n               \n\n               \n\n                \n\n                 Donor\ns last known vital status\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   donor.0.donor_vital_status.v1\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    alive\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    deceased\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                disease_status_last_followup\n               \n\n               \n\n                Disease Status Last Followup\n               \n\n               \n\n                \n\n                 Donor\ns last known disease status.\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   donor.0.disease_status_last_followup.v1\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    complete remission\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    partial remission\n                   \n\n                  \n\n                  \n\n                   \n\n                    3\n                   \n\n                  \n\n                  \n\n                   \n\n                    progression\n                   \n\n                  \n\n                  \n\n                   \n\n                    4\n                   \n\n                  \n\n                  \n\n                   \n\n                    relapse\n                   \n\n                  \n\n                  \n\n                   \n\n                    5\n                   \n\n                  \n\n                  \n\n                   \n\n                    stable\n                   \n\n                  \n\n                  \n\n                   \n\n                    6\n                   \n\n                  \n\n                  \n\n                   \n\n                    no evidence of disease\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_relapse_type\n               \n\n               \n\n                Donor Relapse Type\n               \n\n               \n\n                \n\n                 Type of relapse or progression (for liquid tumours), if applicable\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   donor.0.donor_relapse_type.v1\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    local recurrence\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    distant recurrence/metastasis\n                   \n\n                  \n\n                  \n\n                   \n\n                    3\n                   \n\n                  \n\n                  \n\n                   \n\n                    progression (liquid tumours)\n                   \n\n                  \n\n                  \n\n                   \n\n                    4\n                   \n\n                  \n\n                  \n\n                   \n\n                    local recurrence and distant metastasis\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_age_at_diagnosis\n               \n\n               \n\n                Donor Age at Diagnosis\n               \n\n               \n\n                \n\n                 Age at primary diagnosis in years.\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   The donor\ns age at diagnosis must be expressed in years\n                   \n\n                  \n\n                  \n\n                   If donor is older than 90 years, submit value of 90\n                   \n\n                  \n\n                  \n\n                   The donor\ns age at diagnosis should be less than or equal to the donor\ns age at enrollment\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_age_at_enrollment\n               \n\n               \n\n                Donor Age at Enrollment\n               \n\n               \n\n                \n\n                 Age (in years) at which first specimen was collected.\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   The donor\ns age at enrollment must be expressed in years\n                   \n\n                  \n\n                  \n\n                   If donor is older than 90 years old, submit value of 90\n                   \n\n                  \n\n                  \n\n                   The donor age at enrollment should be greater than or equal to the donor\ns age at last followup\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_age_at_last_followup\n               \n\n               \n\n                Donor Age at Last Followup\n               \n\n               \n\n                \n\n                 Age (in years) at last followup\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   The donor\ns age at last followup must be expressed in years\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_relapse_interval\n               \n\n               \n\n                Donor Relapse Interval\n               \n\n               \n\n                \n\n                 If the donor was clinically disease free following primary therapy, and then relapse or progression (for liquid tumours) occurred afterwards, then donor_relapse_interval is the length of disease free interval, in days.\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   If donor_vital_status is alive and disease_status_last_followup is relapse or progression, the donor_relapse_interval should be less than or equal to the donor interval of last followup\n                   \n\n                  \n\n                  \n\n                   If the donor is deceased and disease_status_last_followup is relapse or progression, the donor_relapse_interval should be less than or equal to the donor_survival_time\n                   \n\n                  \n\n                  \n\n                   Please see\n                   \n\n                    documentation\n                   \n\n                   for more details\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_diagnosis_icd10\n               \n\n               \n\n                Donor Diagnosis ICD-10\n               \n\n               \n\n                \n\n                 ICD-10 diagnostic code\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_tumour_staging_system_at_diagnosis\n               \n\n               \n\n                Donor Tumour Staging System at Diagnosis\n               \n\n               \n\n                \n\n                 Clinical staging system used at time of diagnosis, if determined. Note that this is supplementary to specimen\ns pathological staging.\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_tumour_stage_at_diagnosis\n               \n\n               \n\n                Donor Tumour Stage at Diagnosis\n               \n\n               \n\n                \n\n                 Stage at diagnosis using indicated staging system. Note that this is supplementary to specimen\ns pathological staging.\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_tumour_stage_at_diagnosis_supplemental\n               \n\n               \n\n                Donor Tumour Stage at Diagnosis Supplemental\n               \n\n               \n\n                \n\n                 Optional additional staging provided as a comma-delimited list of \nstaging system:stage\n\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_survival_time\n               \n\n               \n\n                Donor Survival Time\n               \n\n               \n\n                \n\n                 How long has the donor survived since primary diagnosis, in days. If source data was collected in months, use a multiplier value of \n30.44\n to convert values to days when preparing your submission.\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Donor survival time must be submitted if donor_vital_status is deceased\n                   \n\n                  \n\n                  \n\n                   If donor is alive, donor_survival_time should be equal to the donor_interval_of_last_followup\n                   \n\n                  \n\n                  \n\n                   Please see\n                   \n\n                    documentation\n                   \n\n                   for more details\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_interval_of_last_followup\n               \n\n               \n\n                Donor Interval of Last Followup\n               \n\n               \n\n                \n\n                 Interval from the primary diagnosis date to the last followup date. ICGC requests that patients be followed up every 6 months while alive.\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   If donor\ns disease_status_last_followup is progression or relapse, donor_interval_of_last_followup is required\n                   \n\n                  \n\n                  \n\n                   Please see\n                   \n\n                    documentation\n                   \n\n                   for more details\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_notes\n               \n\n               \n\n                Donor Notes\n               \n\n               \n\n                \n\n                 Free text notes concerning donor\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Optional\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 Controlled\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                prior_malignancy\n               \n\n               \n\n                Prior Malignancy\n               \n\n               \n\n                \n\n                 Prior malignancy affecting patient.\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   donor.0.prior_malignancy.v1\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    yes\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    no\n                   \n\n                  \n\n                  \n\n                   \n\n                    3\n                   \n\n                  \n\n                  \n\n                   \n\n                    unknown\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                cancer_type_prior_malignancy\n               \n\n               \n\n                Cancer Type Prior Malignancy\n               \n\n               \n\n                \n\n                 ICD-10 diagnostic code for type of cancer in a prior malignancy.\n                \n\n               \n\n               \n\n                TEXT\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                cancer_history_first_degree_relative\n               \n\n               \n\n                Cancer History First Degree Relative\n               \n\n               \n\n                \n\n                 Does patient have a first degree relative that has a history of cancer? If yes, please provide clincial information about relative\ns cancer history in Donor Family file\n                \n\n               \n\n               \n\n                CV\n               \n\n               \n\n                \n\n                 \n\n                  [\n                  \n\n                   family.0.cancer_history_first_degree_relative.v1\n                  \n\n                  ]\n                 \n\n                \n\n                \n\n                 \n\n                  \n\n                   \n\n                    1\n                   \n\n                  \n\n                  \n\n                   \n\n                    yes\n                   \n\n                  \n\n                  \n\n                   \n\n                    2\n                   \n\n                  \n\n                  \n\n                   \n\n                    no\n                   \n\n                  \n\n                  \n\n                   \n\n                    3\n                   \n\n                  \n\n                  \n\n                   \n\n                    unknown\n                   \n\n                  \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                donor_primary_treatment_interval\n               \n\n               \n\n                Donor Primary Treatment Interval\n               \n\n               \n\n                \n\n                 Interval between primary diagnosis and primary treatment, in days\n                \n\n               \n\n               \n\n                INTEGER\n               \n\n               \n\n                N/A\n               \n\n               \n\n                \n\n                 Required\n                \n\n               \n\n               \n\n                \n\n                 N/A Valid\n                \n\n               \n\n               \n\n                \n\n                 Open Access\n                \n\n               \n\n               \n\n                \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   The donor\ns primary treatment interval must be less than or equal to the donor\ns survival time\n                   \n\n                  \n\n                  \n\n                   If donor\ns disease_status_last_followup is progression or relapse and the donor is alive, the combination of the donor\ns primary treatment interval and relapse interval should be less than or equal to the donor\ns interval of last followup\n                   \n\n                  \n\n                  \n\n                   However, if the donor is deceased and had progressed or relapsed, the combination of the donor\ns primary treatment interval and relapse interval should be less than or equal to the donor\ns survival time\n                   \n\n                  \n\n                  \n\n                   Please see\n                   \n\n                    documentation\n                   \n\n                   for more details\n                  \n\n                 \n\n                 \n\n                 \n\n                \n\n               \n\n              \n\n             \n\n            \n\n            \n\n            \n\n            \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Dictionary v0.12e (August 2015, Current for Release 20)\n            \n\n            \n\n             up\n            \n\n            \n\n             Donor Exposure (exposure) \u203a", 
            "title": "Donor Data File (donor)"
        }, 
        {
            "location": "/submission/dictionary/20/donor-exposure/", 
            "text": "Donor Exposure (exposure)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nDonor Exposure (exposure)\n\n           \n\n           \n\n            File Key: \nexposure\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^exposure(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               \n\n                donor_id\n                \n\n               \n\n              \n\n              \n\n               Donor ID\n              \n\n              \n\n               \n\n                Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  90234\n                 \n\n                 \n\n                  BLD_donor_89\n                 \n\n                 \n\n                  AML-90\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  donor_id cannot begin with \nDO*\n\n                  \n\n                 \n\n                 \n\n                  This prefix is reserved for ICGC IDs\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exposure_type\n              \n\n              \n\n               Exposure Type\n              \n\n              \n\n               \n\n                Type of exposure.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exposure_intensity\n              \n\n              \n\n               Exposure Intensity\n              \n\n              \n\n               \n\n                Extent of the exposure.\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exposure_notes\n              \n\n              \n\n               Exposure Notes\n              \n\n              \n\n               \n\n                Free text notes.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tobacco_smoking_history_indicator\n              \n\n              \n\n               Tobacco Smoking History Indicator\n              \n\n              \n\n               \n\n                Donor\ns smoking history\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  exposure.0.tobacco_smoking_history_indicator.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   Lifelong non-smoker (\n100 cigarettes smoked in lifetime)\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   Current smoker (includes daily smokers non-daily/occasional smokers)\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   Current reformed smoker for \n 15 years\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   Current reformed smoker for \n= 15 years\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Current reformed smoker, duration not specified\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   Smoking history not documented\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tobacco_smoking_intensity\n              \n\n              \n\n               Tobacco Smoking Intensity\n              \n\n              \n\n               \n\n                Smoking intensity in Pack Years: Number of pack years defined as the number of cigarettes smoked per day times (x) the number of years smoked divided (/) by 20. If patient has no tobacco smoking history (ie. tobacco_smoking_history_indicator is either \n1\n (non-smoker) or \n6\n (not documented), enter \n-888\n (not applicable) in this field.\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  This field is required if the tobacoo_smoking_history_indicator field is 2-5 (smoker)\n                  \n\n                 \n\n                 \n\n                  If patient is a non-smoker (tobacco_smoking_history_indicator = 1) or smoking history has not been documented (tobacco_smoking_history_indicator = 6), submit \n-888\n (not applicable) for this field\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alcohol_history\n              \n\n              \n\n               Alcohol History\n              \n\n              \n\n               \n\n                A response to a question that asks whether the patient has consumed at least 12 drinks of any alcoholic beverage in their lifetime.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  exposure.0.alcohol_history.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   Don\nt know/Not sure\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alcohol_history_intensity\n              \n\n              \n\n               Alcohol History Intensity\n              \n\n              \n\n               \n\n                Alcohol exposure intensity. If patient does not have alcohol history (ie. alcohol_history field is \n2\n - no), enter \n1\n (None) in this field. If alcohol_history is not known (\n3\n), enter \n6\n (not documented) for this field\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  alcohol_history_intensity\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   None\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   Social Drinker (\n once a month, \n once a week)\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   Weekly Drinker (\n=1x a week)\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   Daily Drinker\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Occassional Drinker (\n once a month)\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   Not Documented\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  This field is required if alcohol_history was specified as \n1\n (yes)\n                  \n\n                 \n\n                 \n\n                  If patient has no alcohol history (non-drinker), indicate value \n1\n (none) for this field\n                  \n\n                 \n\n                 \n\n                  If alcohol history has not been documented, indicate \n6\n for this field\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Donor Data File (donor)\n            \n\n            \n\n             up\n            \n\n            \n\n             Donor Family (family) \u203a", 
            "title": "Donor Exposure (exposure)"
        }, 
        {
            "location": "/submission/dictionary/20/donor-family/", 
            "text": "Donor Family (family)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nDonor Family (family)\n\n           \n\n           \n\n            File Key: \nfamily\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^family(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               donor_id\n              \n\n              \n\n               Donor ID\n              \n\n              \n\n               \n\n                Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  90234\n                 \n\n                 \n\n                  BLD_donor_89\n                 \n\n                 \n\n                  AML-90\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  donor_id cannot begin with \nDO*\n\n                  \n\n                 \n\n                 \n\n                  This prefix is reserved for ICGC IDs\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               donor_has_relative_with_cancer_history\n              \n\n              \n\n               Donor Has Relative with Cancer History\n              \n\n              \n\n               \n\n                Does patient have any relatives with a history of cancer?\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  family.0.donor_has_relative_with_cancer_history.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   unknown\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               relationship_type\n              \n\n              \n\n               Relationship Type\n              \n\n              \n\n               \n\n                Relationship to the donor\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  family.0.relationship_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   sibling\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   parent\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   grandparent\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   uncle/aunt\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   cousin\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   other\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   unknown\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If there is a history of cancer in a relative, this field must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               relationship_type_other\n              \n\n              \n\n               Relationship Type Other\n              \n\n              \n\n               \n\n                If \nother\n answered in relationship_type field, specify the relationship type here\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If \nother\n answered in relationship_type field, specifiy the relationship type here\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               relationship_sex\n              \n\n              \n\n               Relationship Sex\n              \n\n              \n\n               \n\n                Biological sex of related individual\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  family.0.relationship_sex.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   male\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   female\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   unknown\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Indicate sex of family member specified in the the \nrelationship_type\n field\n                  \n\n                 \n\n                 \n\n                  If no family history of cancer, then -888 (not applicable) can be used in this field\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               relationship_age\n              \n\n              \n\n               Relationship Age\n              \n\n              \n\n               \n\n                Age of relative at primary diagnosis (in years)\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               relationship_disease_icd10\n              \n\n              \n\n               Relationship Disease ICD-10\n              \n\n              \n\n               \n\n                ICD-10 code for the relative\ns disease\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Indicate ICD10 code of disease affecting family member specified in the the \nrelationship_type\n field\n                  \n\n                 \n\n                 \n\n                  If no family history of cancer, then -888 (not applicable) can be used in this field\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               relationship_disease\n              \n\n              \n\n               Relationship Disease\n              \n\n              \n\n               \n\n                Disease name\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Indicate name of disease affecting family member specified in the the \nrelationship_type\n field\n                  \n\n                 \n\n                 \n\n                  If no family history of cancer, then -888 (not applicable) can be used in this field\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Donor Exposure (exposure)\n            \n\n            \n\n             up\n            \n\n            \n\n             Donor Postresection Therapy (therapy) \u203a", 
            "title": "Donor Family (family)"
        }, 
        {
            "location": "/submission/dictionary/20/donor-postresection-therapy/", 
            "text": "Donor Postresection Therapy (therapy)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nDonor Postresection Therapy (therapy)\n\n           \n\n           \n\n            File Key: \ntherapy\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^therapy(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               donor_id\n              \n\n              \n\n               Donor ID\n              \n\n              \n\n               \n\n                Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  90234\n                 \n\n                 \n\n                  BLD_donor_89\n                 \n\n                 \n\n                  AML-90\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  donor_id cannot begin with \nDO*\n\n                  \n\n                 \n\n                 \n\n                  This prefix is reserved for ICGC IDs\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               first_therapy_start_interval\n              \n\n              \n\n               First Therapy Start Interval\n              \n\n              \n\n               \n\n                Interval between primary diagnosis and initiation of the first postresection therapy, in days\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               first_therapy_duration\n              \n\n              \n\n               First Therapy Duration\n              \n\n              \n\n               \n\n                Duration of first postresection therapy, in days\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               first_therapy_type\n              \n\n              \n\n               First Therapy Type\n              \n\n              \n\n               \n\n                Type of first postresection therapy\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.specimen_donor_treatment_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   no treatment\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   chemotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   radiation therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   combined chemo+radiation therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   immunotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   combined chemo+immunotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   surgery\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   other therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   bone marrow transplant\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   stem cell transplant\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   monoclonal antibodies (for liquid tumours)\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               first_therapy_response\n              \n\n              \n\n               First Therapy Response\n              \n\n              \n\n               \n\n                What was the clinical effect of the first postresection therapy?\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  therapy.0.therapy_response.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   complete response\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   partial response\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   disease progression\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   stable disease\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   unknown\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use this field to describe the clinical effect of the type of therapy described in \nfirst_therapy_type\n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               first_therapy_therapeutic_intent\n              \n\n              \n\n               First Therapy Therapeutic Intent\n              \n\n              \n\n               \n\n                The therapeutic intent of the first post resection therapy\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  therapy.0.therapeutic_intent.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   not applicable\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   adjuvant\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   curative\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   palliative\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use this field to describe the therapeutic intent of the type of therapy described in \nfirst_therapy_type\n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               second_therapy_start_interval\n              \n\n              \n\n               Second Therapy Start Interval\n              \n\n              \n\n               \n\n                Interval between primary diagnosis and initiation of the second postresection therapy, in days\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               second_therapy_duration\n              \n\n              \n\n               Second Therapy Duration\n              \n\n              \n\n               \n\n                Duration of second postresection therapy, in days\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               second_therapy_type\n              \n\n              \n\n               Second Therapy Type\n              \n\n              \n\n               \n\n                Type of second postresection therapy\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.specimen_donor_treatment_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   no treatment\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   chemotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   radiation therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   combined chemo+radiation therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   immunotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   combined chemo+immunotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   surgery\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   other therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   bone marrow transplant\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   stem cell transplant\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   monoclonal antibodies (for liquid tumours)\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               second_therapy_response\n              \n\n              \n\n               Second Therapy Response\n              \n\n              \n\n               \n\n                What was the clinical effect of the second postresection therapy?\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  therapy.0.therapy_response.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   complete response\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   partial response\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   disease progression\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   stable disease\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   unknown\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use this field to describe the clinical effect of the type of therapy described in \nsecond_therapy_type\n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               second_therapy_therapeutic_intent\n              \n\n              \n\n               Second Therapy Therapeutic Intent\n              \n\n              \n\n               \n\n                The therapeutic intent of the second postresection therapy\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  therapy.0.therapeutic_intent.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   not applicable\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   adjuvant\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   curative\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   palliative\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use this field to describe the therapeutic intent of the type of therapy described in \nsecond_therapy_type\n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_therapy\n              \n\n              \n\n               Other Therapy\n              \n\n              \n\n               \n\n                Other postresection therapy\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use this field to describe other therapies if either \nfirst_therapy_type\n or \nsecond_therapy_type\n are specified as \nother therapy\n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_therapy_response\n              \n\n              \n\n               Other Therapy Response\n              \n\n              \n\n               \n\n                What is the clinical effect of the postresection therapy\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use this field to describe the response to the other therapy described in \nother_therapy\n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               therapy_notes\n              \n\n              \n\n               Therapy Notes\n              \n\n              \n\n               \n\n                Further description of therapy, such as dosing schedule.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Donor Family (family)\n            \n\n            \n\n             up\n            \n\n            \n\n             Donor Surgery (surgery) \u203a", 
            "title": "Donor Postresection Therapy (therapy)"
        }, 
        {
            "location": "/submission/dictionary/20/donor-surgery/", 
            "text": "Donor Surgery (surgery)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Key: \nsurgery\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^surgery(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               donor_id\n              \n\n              \n\n               Donor ID\n              \n\n              \n\n               \n\n                Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  90234\n                 \n\n                 \n\n                  BLD_donor_89\n                 \n\n                 \n\n                  AML-90\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               procedure_interval\n              \n\n              \n\n               Procedure Interval\n              \n\n              \n\n               \n\n                Interval between primary diagnosis and procedure, in days\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               procedure_type\n              \n\n              \n\n               Procedure Type\n              \n\n              \n\n               \n\n                Controlled vocabulary description of the procedure type. Vocabulary can be extended by disease-specific projects. Prefix extensions with 3-digit center code, e.g. 008.1 Beijing Cancer Hospital, fine needle aspiration of primary\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  surgery.0.procedure_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   surgical resection of primary\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   surgical resection of local recurrence\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   surgical resection of distant recurrence (metastasis)\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   lymph node dissection performed at time of resection of primary.\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   biopsy of primary\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   biopsy of local recurrence\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   biopsy of distant recurrence.\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   other\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               procedure_site\n              \n\n              \n\n               Procedure Site\n              \n\n              \n\n               \n\n                Anatomical site of the procedure.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               resection_status\n              \n\n              \n\n               Resection Status\n              \n\n              \n\n               \n\n                For resection procedures, an indication of the extent of residual disease.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  surgery.0.resection_status.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   R0 - no apparent residual disease.\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   R1 - microscopic residual disease.\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   R2 - gross residual disease.\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_id\n              \n\n              \n\n               Specimen ID\n              \n\n              \n\n               \n\n                ID of ICGC specimen resulting from procedure. If present, must match specimen_id in specimen data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^([\\w+\\-\\_]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  LAML_PO_00445\n                 \n\n                 \n\n                  THY_099-tumour\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Donor Postresection Therapy (therapy)\n            \n\n            \n\n             up\n            \n\n            \n\n             Donor Biomarkers (biomarker) \u203a", 
            "title": "Donor Surgery (surgery)"
        }, 
        {
            "location": "/submission/dictionary/20/protein-expression-pexp-analysis-metadata-file-m/", 
            "text": "Protein Expression (pexp) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nProtein Expression (pexp) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \npexp_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^pexp_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               \n\n                analysis_id\n               \n\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               \n\n                analyzed_sample_id\n               \n\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Controlled Vocabulary (CV) Tables\n            \n\n            \n\n             up\n            \n\n            \n\n             Protein Expression (pexp) - Primary Analysis File (p) \u203a", 
            "title": "Protein Expression (pexp) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/protein-expression-pexp-primary-analysis-file-p/", 
            "text": "Protein Expression (pexp) - Primary Analysis File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Key: \npexp_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^pexp_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               antibody_id\n              \n\n              \n\n               Antibody ID\n              \n\n              \n\n               \n\n                ID of the antibody probe used in expression platform\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_name\n              \n\n              \n\n               Gene Name\n              \n\n              \n\n               \n\n                For providing HGNC approved gene symbol or ID use the DB Xref syntax: \nHGNC:x\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_stable_id\n              \n\n              \n\n               Gene Stable ID\n              \n\n              \n\n               \n\n                For providing Ensembl gene or transcript annotation use the DB Xref syntax: \nEnsembl:ENSGxxx\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_build_version\n              \n\n              \n\n               Gene Build Version\n              \n\n              \n\n               \n\n                Gene build version associated with the platform, tools or other methods used in the analysis; Supports the following syntax: \nDB:VERSION\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^(\\w+)\\:(\\w+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Ensembl:69\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalized_expression_level\n              \n\n              \n\n               Normalized Expression Level\n              \n\n              \n\n               \n\n                Normalized expression level\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the mutation/variant is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_status\n              \n\n              \n\n               Biological Validation Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.biological_validation_status.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and not valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_platform\n              \n\n              \n\n               Biological Validation Platform\n              \n\n              \n\n               \n\n                Identifier of assay platform or technology used to validate the mutation/variant\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is biologically validated, the biological validation platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Protein Expression (pexp) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Dictionary v0.11c (April., 2015, Release 19) \u203a", 
            "title": "Protein Expression (pexp) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/sequencing-based-dna-methylation-methseq-analysis-metadata-file-m/", 
            "text": "Sequencing-based DNA Methylation (meth_seq) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSequencing-based DNA Methylation (meth_seq) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nmeth_seq_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^meth_seq_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a group of analyzed samples and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_platform\n              \n\n              \n\n               Sequencing Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               fraction_wg_cpg_sites_covered\n              \n\n              \n\n               Fraction Wg Cpg Sites Covered\n              \n\n              \n\n               \n\n                Fraction of whole genome CpG sites covered in the assay\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               conversion_rate\n              \n\n              \n\n               Conversion Rate\n              \n\n              \n\n               \n\n                Bisulfite conversion rate of the analyzed sample in the assay\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               base_quality_score_threshold\n              \n\n              \n\n               Base Quality Score Threshold\n              \n\n              \n\n               \n\n                Filtering threshold of base quality score\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  BWA 0.6.2\n                  \n\n                   http://bio-bwa.sourceforge.net\n                  \n\n                  bwa aln -q20 HGref s1.fastq \n s1_bwa.sai\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms. Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Sequencing-based Gene Expression (exp_seq) - Primary File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Sequencing-based DNA Methylation (meth_seq) - Primary File (p) \u203a", 
            "title": "Sequencing-based DNA Methylation (meth_seq) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/sequencing-based-dna-methylation-methseq-primary-file-p/", 
            "text": "Sequencing-based DNA Methylation (meth_seq) - Primary File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSequencing-base DNA Methylation (meth_seq) - Primary File (p)\n\n           \n\n           \n\n            File Key: \nmeth_seq_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^meth_seq_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome\n              \n\n              \n\n               Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_start\n              \n\n              \n\n               Chromosome Start\n              \n\n              \n\n               \n\n                Chromosome start position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  243198475\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome start position must be equal or greater than 1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_end\n              \n\n              \n\n               Chromosome End\n              \n\n              \n\n               \n\n                Chromosome end position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  243198479\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome end position must be less than or equal to the length of the chromosome\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_strand\n              \n\n              \n\n               Chromosome Strand\n              \n\n              \n\n               \n\n                Chromosome strand of mutation. Only accept positive strand (1)\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^(1)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               methylation_ratio\n              \n\n              \n\n               Methylation Ratio\n              \n\n              \n\n               \n\n                Values ranging from 0 (completely unmethylated) to 1 (completely methylated). Methylation_ratio = methylated_read_count / (methylated_read_count + unmethylated_read_count). Value should be number with two decimal places.\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               methylated_read_count\n              \n\n              \n\n               Methylated Read Count\n              \n\n              \n\n               \n\n                Count of methylated reads at the specified genomic location\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               unmethylated_read_count\n              \n\n              \n\n               Unmethylated Read Count\n              \n\n              \n\n               \n\n                Count of unmethylated reads at the specified genomic location\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the detected methylation status of this location is confirmed by using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the detected methylation status is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified (cannot be -777/-888)\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Sequencing-based DNA Methylation (meth_seq) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Sequencing-based miRNA Expression (mirna_seq) - Analysis Metadata File (m) \u203a", 
            "title": "Protein Expression (pexp) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/sequencing-based-gene-expression-expseq-analysis-metadata-file-m/", 
            "text": "Sequencing-based Gene Expression (exp_seq) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSequencing-based Gene Expression (exp_seq) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nexp_seq_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^exp_seq_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               total_read_count\n              \n\n              \n\n               Total Read Count\n              \n\n              \n\n               \n\n                Total number of reads from RNA-Seq, an indication of sequencing depth\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  BWA 0.6.2\n                  \n\n                   http://bio-bwa.sourceforge.net\n                  \n\n                  bwa aln -q20 HGref s1.fastq \n s1_bwa.sai\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalization_algorithm\n              \n\n              \n\n               Normalization Algorithm\n              \n\n              \n\n               \n\n                Name of normalization algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Cufflinks 2.1.0 http://cufflinks.cbcb.umd.edu\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms. Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               reference_sample_type\n              \n\n              \n\n               Reference Sample Type\n              \n\n              \n\n               \n\n                Type of sample used as reference for calculating fold change\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.reference_sample_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   matched normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   unrelated normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   cell line derived from matched normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   pooled samples\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   other\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Array-based DNA Methylation (meth_array) - Primary File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Sequencing-based Gene Expression (exp_seq) - Primary File (p) \u203a", 
            "title": "Sequencing-based Gene Expression (exp_seq) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/sequencing-based-gene-expression-expseq-primary-file-p/", 
            "text": "Sequencing-based Gene Expression (exp_seq) - Primary File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSequencing-based Gene Expression (exp_seq) - Primary File (p)\n\n           \n\n           \n\n            File Key: \nexp_seq_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^exp_seq_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_model\n              \n\n              \n\n               Gene Model\n              \n\n              \n\n               \n\n                Gene model used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.gene_db.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ensembl\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   GAF\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   RefSeq\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_id\n              \n\n              \n\n               Gene ID\n              \n\n              \n\n               \n\n                Gene ID provided in the chosen gene model, eg, ENSG00000157764\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalized_read_count\n              \n\n              \n\n               Normalized Read Count\n              \n\n              \n\n               \n\n                Normalized read count for the current gene\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_read_count\n              \n\n              \n\n               Raw Read Count\n              \n\n              \n\n               \n\n                Raw read count for the current gene\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               fold_change\n              \n\n              \n\n               Fold Change\n              \n\n              \n\n               \n\n                Gene expression fold change\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Sequencing-based Gene Expression (exp_seq) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Sequencing-based DNA Methylation (meth_seq) - Analysis Metadata File (m) \u203a", 
            "title": "Sequencing-based Gene Expression (exp_seq) - Primary File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/sequencing-based-mirna-expression-mirnaseq-analysis-metadata-file-m/", 
            "text": "Sequencing-based miRNA Expression (mirna_seq) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSequencing-based miRNA Expression (mirna_seq) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nmirna_seq_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^mirna_seq_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_platform\n              \n\n              \n\n               Sequencing Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               total_read_count\n              \n\n              \n\n               Total Read Count\n              \n\n              \n\n               \n\n                Total number of reads containing miRNA sequences, this is an indication of sequencing depth\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               reference_sample_type\n              \n\n              \n\n               Reference Sample Type\n              \n\n              \n\n               \n\n                Type of sample used as reference for calculating fold change\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.reference_sample_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   matched normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   unrelated normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   cell line derived from matched normal\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   pooled samples\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   other\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  BWA 0.6.2\n                  \n\n                   http://bio-bwa.sourceforge.net\n                  \n\n                  bwa aln -q20 HGref s1.fastq \n s1_bwa.sai\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalization_algorithm\n              \n\n              \n\n               Normalization Algorithm\n              \n\n              \n\n               \n\n                Name of normalization algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Cufflinks 2.1.0 http://cufflinks.cbcb.umd.edu\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms. Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Sequencing-based DNA Methylation (meth_seq) - Primary File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Sequencing-based miRNA Expression (mirna_seq) - Primary File (p)  \u203a", 
            "title": "Sequencing-based miRNA Expression (mirna_seq) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/sequencing-based-mirna-expression-mirnaseq-primary-file-p/", 
            "text": "Sequencing-based miRNA Expression (mirna_seq) - Primary File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSequencing-base miRNA Expression (mirna_seq) - Primary File (p)\n\n           \n\n           \n\n            File Key: \nmirna_seq_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^mirna_seq_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mirna_db\n              \n\n              \n\n               miRNA DB\n              \n\n              \n\n               \n\n                The name of the miRNA database used, chosen from the DCC\ns codelist\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.mirna_db.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRBase\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mirna_id\n              \n\n              \n\n               miRNA ID\n              \n\n              \n\n               \n\n                The miRNA accession ID in the chosen miRNA database. Use -777 when miRNA detected does not exist in the miRNA db, i.e., a possibly novel miRNA\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If the reported miRNA is in a public miRNA database (mirna_db is not null), a miRNA accession ID (mirna_id) must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalized_read_count\n              \n\n              \n\n               Normalized Read Count\n              \n\n              \n\n               \n\n                Normalized read count for the current miRNA\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_read_count\n              \n\n              \n\n               Raw Read Count\n              \n\n              \n\n               \n\n                Raw read count for the current gene\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               fold_change\n              \n\n              \n\n               Fold Change\n              \n\n              \n\n               \n\n                Gene expression fold change\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               is_isomir\n              \n\n              \n\n               Is Isomir\n              \n\n              \n\n               \n\n                A flag from a codelist that indicates if the current miRNA is an isomir, which is defined as having a variation with respect to the annotated annotated mature miRNA\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.is_isomir.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   unknown\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome\n              \n\n              \n\n               Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the miRNA. Do not fill when the detected miRNA is annotated in miRNA database\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If the detected miRNA is in a public miRNA Db (ie\n                  \n\n                 \n\n                 \n\n                  mirna_db is not null), the chromosome number should not be filled in (use \n-888\n)\n                  \n\n                 \n\n                 \n\n                  However if the reported miRNA is not in miRNA DB, chromosome must be filled in\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_start\n              \n\n              \n\n               Chromosome Start\n              \n\n              \n\n               \n\n                Chromosome start position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  243198475\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If the detected miRNA is not in a public miRNA Db (ie\n                  \n\n                 \n\n                 \n\n                  mirna_id and mirna_db are not provided), the chromosome start/end positions must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_end\n              \n\n              \n\n               Chromosome End\n              \n\n              \n\n               \n\n                Chromosome end position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  243198479\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If the detected miRNA is not in a public miRNA Db (ie\n                  \n\n                 \n\n                 \n\n                  mirna_id and mirna_db are not provided), the chromosome start/end positions must be specified\n                  \n\n                 \n\n                 \n\n                  Chromosome end position must be less than or equal to the length of the chromosome\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_strand\n              \n\n              \n\n               Chromosome Strand\n              \n\n              \n\n               \n\n                Chromosome strand of the feature being described.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.strand.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If the detected miRNA is not in a public miRNA Db (ie\n                  \n\n                 \n\n                 \n\n                  mirna_id and mirna_db are not provided), the chromosome strand needs to be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the detected miRNA has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the detected miRNA  is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If detected miRNA is verified, the verification platform must be specified (cannot be -777/-888)\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Sequencing-based miRNA Expression (mirna_seq) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Controlled Vocabulary (CV) Tables \u203a", 
            "title": "Sequencing-based miRNA Expression (mirna_seq) - Primary File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/simple-germline-variation-sgv-analysis-metadata-file-m/", 
            "text": "Simple Germline Variation (sgv) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSimple Germline Variation (sgv) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nsgv_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^sgv_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular normal sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characterse. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               base_calling_algorithm\n              \n\n              \n\n               Base Calling Algorithm\n              \n\n              \n\n               \n\n                Name of base calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  CASAVA http://support.illumina.com/sequencing/sequencing_software/casava.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  BWA 0.6.2\n                  \n\n                   http://bio-bwa.sourceforge.net\n                  \n\n                  bwa aln -q20 HGref s1.fastq \n s1_bwa.sai\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variation_calling_algorithm\n              \n\n              \n\n               Variation Calling Algorithm\n              \n\n              \n\n               \n\n                Name of variation calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Samtools http://samtools.sourceforge.net\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               seq_coverage\n              \n\n              \n\n               Seq Coverage\n              \n\n              \n\n               \n\n                Sequence coverage if analyzed by sequencing platforms\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Structural Somatic Mutations (stsm) - Secondary Analysis File (s)\n            \n\n            \n\n             up\n            \n\n            \n\n             Simple Germline Variation (sgv) - Primary Analysis File (p) \u203a", 
            "title": "Simple Germline Variation (sgv) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/simple-germline-variation-sgv-primary-analysis-file-p/", 
            "text": "Simple Germline Variation (sgv) - Primary Analysis File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSimple Germline Variation (sgv) - Primary Analysis File (p)\n\n           \n\n           \n\n            File Key: \nsgv_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^sgv_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variant_type\n              \n\n              \n\n               Variant Type\n              \n\n              \n\n               \n\n                A controlled vocabulary term describing the type of the observed variant\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  sgv_p.0.variant_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   single base substitution\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   insertion of \n= 200 bp\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   deletion of \n= 200 bp\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   multiple base substitution (\n= 2bp and \n= 200bp)\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome\n              \n\n              \n\n               Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the mutation/variation without the chr prefix\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_start\n              \n\n              \n\n               Chromosome Start\n              \n\n              \n\n               \n\n                Chromosome start position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343492\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome start position must be less than or equal to the chromosome end position\n                  \n\n                 \n\n                 \n\n                  If single-base substution or insertion, the chromosome start position must equal the chromosome end position\n                  \n\n                 \n\n                 \n\n                  If variant is a deletion or multiple-base substitution, then the difference between the chromosome end and start position must be less than or equal to 200\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_end\n              \n\n              \n\n               Chromosome End\n              \n\n              \n\n               \n\n                Chromosome end position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343499\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome end position must be less than or equal to the chromosome length\n                  \n\n                 \n\n                 \n\n                  If single-base substution or insertion, the chromosome start position must equal the chromosome end position\n                  \n\n                 \n\n                 \n\n                  If variant is a deletion or multiple-base substitution, then the difference between the chromosome end and start position must be less than or equal to 200\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_strand\n              \n\n              \n\n               Chromosome Strand\n              \n\n              \n\n               \n\n                Chromosome strand of mutation. Must always use forward strand (1)\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                ^(1)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               reference_genome_allele\n              \n\n              \n\n               Reference Genome Allele\n              \n\n              \n\n               \n\n                Allele in the reference genome. For insertions, use a dash sign for a missing base. For all other types of variations, use forward strand DNA sequence at the reference genome position as specified in chromosome, chromosome_start and chromosome_end\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+$){1,200}\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  GA\n                 \n\n                 \n\n                  -\n                 \n\n                 \n\n                  TCTT\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               genotype\n              \n\n              \n\n               Genotype\n              \n\n              \n\n               \n\n                Genotype of the control sample. Use a dash for each missing allele.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+/[ATGC\\-]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  GA/GA\n                 \n\n                 \n\n                  -/-\n                 \n\n                 \n\n                  TCTT/TCTT\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variant_allele\n              \n\n              \n\n               Variant Allele\n              \n\n              \n\n               \n\n                The allele in genotype that is different from reference_genome_allele\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+$){1,200}\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  -\n                 \n\n                 \n\n                  T\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The allele in this field must be one of the alleles defined in genotype field\n                  \n\n                 \n\n                 \n\n                  If variation is a deletion, the allele must be represented as a dash\n                  \n\n                 \n\n                 \n\n                  Otherwise, for all other variations, the allele must be represented as either A,C,T or G\n                  \n\n                 \n\n                 \n\n                  For a mismatch mutation, only one base must be provided\n                  \n\n                 \n\n                 \n\n                  For insertions and multiple base substitutions, the length of the variant_allele must be between 1-200\n                  \n\n                 \n\n                 \n\n                  If variatio is a multiple base substitution, the length of variant_allele and reference_genome_allele cannot both be 1\n                  \n\n                 \n\n                 \n\n                  The allele specified in variant_allele must not be the same as the allele specified in reference_genome_allele\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               quality_score\n              \n\n              \n\n               Quality Score\n              \n\n              \n\n               \n\n                Quality score of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               probability\n              \n\n              \n\n               Probability\n              \n\n              \n\n               \n\n                Probability of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               total_read_count\n              \n\n              \n\n               Total Read Count\n              \n\n              \n\n               \n\n                Total number of raw reads that cover the base(s) where the variation occurs\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variant_allele_read_count\n              \n\n              \n\n               Variant Allele Read Count\n              \n\n              \n\n               \n\n                Total number of raw reads that contain the variant allele\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The value for variant allele read count must be less than the value for total read count\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the mutation/variant is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified (cannot be -777/-888)\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Simple Germline Variation (sgv) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Splice Variation (jcn) - Analysis Metadata File (m) \u203a", 
            "title": "Simple Germline Variation (sgv) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/simple-somatic-mutations-ssm-analysis-metadata-file-m/", 
            "text": "Simple Somatic Mutations (ssm) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSimple Somatic Mutations (ssm) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nssm_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^ssm_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed non-normal sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular non-normal sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               matched_sample_id\n              \n\n              \n\n               Matched Sample ID\n              \n\n              \n\n               \n\n                Unique identifier for the matched normal sample used in the analysis; must exist in the sample file. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The sample identifiers used for matched_sample_id and analyzed_sample_id cannot be identical\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               base_calling_algorithm\n              \n\n              \n\n               Base Calling Algorithm\n              \n\n              \n\n               \n\n                Name of base calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  CASAVA http://support.illumina.com/sequencing/sequencing_software/casava.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Tophat 2.0.10\n                  \n\n                   http://tophat.cbcb.umd.edu\n                  \n\n                  tophat -p 3 -o s1_guided -G BH_WGS.gtf --no-novel-juncs sequence.txt\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variation_calling_algorithm\n              \n\n              \n\n               Variation Calling Algorithm\n              \n\n              \n\n               \n\n                Name of variation calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Samtools http://samtools.sourceforge.net\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               seq_coverage\n              \n\n              \n\n               Seq Coverage\n              \n\n              \n\n               \n\n                Sequence coverage if analyzed by sequencing platforms\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Analyzed Sample Data File (sample)\n            \n\n            \n\n             up\n            \n\n            \n\n             Simple Somatic Mutations (ssm) - Primary Analysis File (p) \u203a", 
            "title": "Simple Somatic Mutations (ssm) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/simple-somatic-mutations-ssm-primary-analysis-file-p/", 
            "text": "Simple Somatic Mutations (ssm) - Primary Analysis File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSimple Somatic Mutations (ssm) - Primary Analysis File (p)\n\n           \n\n           \n\n            File Key: \nssm_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^ssm_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutation_type\n              \n\n              \n\n               Mutation Type\n              \n\n              \n\n               \n\n                Type of mutation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  ssm_p.0.mutation_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   single base substitution\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   insertion of \n=200bp\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   deletion of \n=200bp\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   multiple base substitution (\n=2bp and \n=200bp)\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome\n              \n\n              \n\n               Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_start\n              \n\n              \n\n               Chromosome Start\n              \n\n              \n\n               \n\n                Chromosome start position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343492\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome start position must be less than or equal to the chromosome end position\n                  \n\n                 \n\n                 \n\n                  If single-base substution or insertion, the chromosome start position must equal the chromosome end position\n                  \n\n                 \n\n                 \n\n                  If mutation is a deletion or multiple-base substitution, then the difference between the chromosome end and start position must be less than or equal to 200\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_end\n              \n\n              \n\n               Chromosome End\n              \n\n              \n\n               \n\n                Chromosome end position of the feature being described\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343499\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome end position must be less than or equal to the chromosome length\n                  \n\n                 \n\n                 \n\n                  If single-base substution or insertion, the chromosome start position must equal the chromosome end position\n                  \n\n                 \n\n                 \n\n                  If mutation is a deletion or multiple-base substitution, then the difference between the chromosome end and start position must be less than or equal to 200\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chromosome_strand\n              \n\n              \n\n               Chromosome Strand\n              \n\n              \n\n               \n\n                Chromosome strand of mutation. Must always use forward strand (1)\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^(1)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               reference_genome_allele\n              \n\n              \n\n               Reference Genome Allele\n              \n\n              \n\n               \n\n                Allele in the reference genome. For insertions, use a dash. For all other types of mutations, use forward strand DNA sequence at the reference genome position as specified in chromosome, chromosome_start and chromosome_end\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+$){1,200}\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  GA\n                 \n\n                 \n\n                  -\n                 \n\n                 \n\n                  TCTT\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               control_genotype\n              \n\n              \n\n               Control Genotype\n              \n\n              \n\n               \n\n                Genotype of the control sample. Use a dash for a missing allele.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+/[ATGC\\-]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  GA/GA\n                 \n\n                 \n\n                  -/-\n                 \n\n                 \n\n                  TCTT/TCTT\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  One of the alleles in control_genotype must match the allele specified in mutat/ed_from_allele\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutated_from_allele\n              \n\n              \n\n               Mutated from Allele\n              \n\n              \n\n               \n\n                Allele that is believed to be the original allele in the ancestral cell that was mutated in the tumour cell. Use dash for insertions. Mutated allele must be one of the two alleles in the control_genotype\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+$){1,200}\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  GA\n                 \n\n                 \n\n                  -\n                 \n\n                 \n\n                  TCTT\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The allele in this field must be one of the alleles defined in control_genotype\n                  \n\n                 \n\n                 \n\n                  If mutation is an insertion, the allele must be represented as a dash (-)\n                  \n\n                 \n\n                 \n\n                  Otherwise, for all other mutations, the allele must be represented as either A,C,T or G\n                  \n\n                 \n\n                 \n\n                  For a mismatch mutation, only one base must be provided\n                  \n\n                 \n\n                 \n\n                  For deletions and multiple base substitutions, the length of the mutated_from_allele must be between 1-200\n                  \n\n                 \n\n                 \n\n                  If mutation is a multiple base substitution, the length of mutated_from_allele and mutated_to_allele cannot both be 1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutated_to_allele\n              \n\n              \n\n               Mutated to Allele\n              \n\n              \n\n               \n\n                The new allele identified in the tumour sample that is believed to be the resulting allele of a somatic mutation event during tumourgenesis. Use dash for deletions. Mutant allele must be one allele and must be one of the alleles defined in tumour_genotype\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+$){1,200}\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  -\n                 \n\n                 \n\n                  T\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The allele in this field must be one of the alleles defined in tumour_genotype\n                  \n\n                 \n\n                 \n\n                  If mutation is a deletion, the allele must be represented as a dash (-)\n                  \n\n                 \n\n                 \n\n                  Otherwise, for all other mutations, the allele must be represented as either A,C,T or G\n                  \n\n                 \n\n                 \n\n                  For a mismatch mutation, only one base must be provided\n                  \n\n                 \n\n                 \n\n                  For insertions and multiple base substitutions, the length of the mutated_to_allele must be between 1-200\n                  \n\n                 \n\n                 \n\n                  If mutation is a multiple base substitution, the length of mutated_from_allele and mutated_to_allele cannot both be 1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_genotype\n              \n\n              \n\n               Tumour Genotype\n              \n\n              \n\n               \n\n                Genotype of the tumour sample. Use a dash for each missing base\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+/[ATGC\\-]+(([/{1}][ATGC\\-]+){0,2})?+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  GA/-\n                 \n\n                 \n\n                  -/T\n                 \n\n                 \n\n                  TCTT/-\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Use a dash for a missing base\n                  \n\n                 \n\n                 \n\n                  Must be a string consisting of two or more aleles joined by a forward slash\n                  \n\n                 \n\n                 \n\n                  No whitespace allowed, and each allele must consist of either A, C, T, G or -\n                  \n\n                 \n\n                 \n\n                  One of the alleles must exist in mutated_to_allele\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               expressed_allele\n              \n\n              \n\n               Expressed Allele\n              \n\n              \n\n               \n\n                For heterozygous SNPs, the dominant allele as revealed by RNA-seq in the tumour sample. When multiple alleles are identified, up to four alleles can be specified, each separated by a comma (no whitespace allowed)\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n                (?iu)^([ATGC\\-]+(([,{1}][ATGC\\-]+){1,3})?+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  AC\n                 \n\n                 \n\n                  GT\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               quality_score\n              \n\n              \n\n               Quality Score\n              \n\n              \n\n               \n\n                Quality score of the mutation call\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               probability\n              \n\n              \n\n               Probability\n              \n\n              \n\n               \n\n                Probability of the mutation call\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               total_read_count\n              \n\n              \n\n               Total Read Count\n              \n\n              \n\n               \n\n                Total number of raw reads that cover the called mutation\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               mutant_allele_read_count\n              \n\n              \n\n               Mutant Allele Read Count\n              \n\n              \n\n               \n\n                Total number of raw reads that contain the mutant allele\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The value for mutant allele read count must be less than the value for total read count\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the mutation/variant is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified (cannot be -777/-888)\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_status\n              \n\n              \n\n               Biological Validation Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.biological_validation_status.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and not valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_platform\n              \n\n              \n\n               Biological Validation Platform\n              \n\n              \n\n               \n\n                Identifier of assay platform or technology used to validate the mutation/variant\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is biologically validated, the biological validation platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Simple Somatic Mutations (ssm) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Copy Number Somatic Mutations (cnsm) - Analysis Metadata File (m) \u203a", 
            "title": "Simple Somatic Mutations (ssm) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/specimen-data-file-specimen/", 
            "text": "Specimen Data File (specimen)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSpecimen Data File (specimen)\n\n           \n\n           \n\n            File Key: \nspecimen\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^specimen(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               donor_id\n              \n\n              \n\n               Donor ID\n              \n\n              \n\n               \n\n                Unique identifier for the donor; assigned by data provider. It must be coded, and correspond to a donor ID listed in the donor data file.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  90234\n                 \n\n                 \n\n                  BLD_donor_89\n                 \n\n                 \n\n                  AML-90\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_id\n              \n\n              \n\n               Specimen ID\n              \n\n              \n\n               \n\n                Unique identifier for a collected specimen assigned by data provider.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^([\\w+\\-\\_]+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  LAML_PO_00445\n                 \n\n                 \n\n                  THY_099-tumour\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_type\n              \n\n              \n\n               Specimen Type\n              \n\n              \n\n               \n\n                Controlled vocabulary description of specimen type.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.specimen_type.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   101\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - solid tissue\n                  \n\n                 \n\n                 \n\n                  \n\n                   102\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - blood derived\n                  \n\n                 \n\n                 \n\n                  \n\n                   103\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - bone marrow\n                  \n\n                 \n\n                 \n\n                  \n\n                   104\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - tissue adjacent to primary\n                  \n\n                 \n\n                 \n\n                  \n\n                   105\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - buccal cell\n                  \n\n                 \n\n                 \n\n                  \n\n                   106\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - EBV immortalized\n                  \n\n                 \n\n                 \n\n                  \n\n                   107\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - lymph node\n                  \n\n                 \n\n                 \n\n                  \n\n                   108\n                  \n\n                 \n\n                 \n\n                  \n\n                   Normal - other\n                  \n\n                 \n\n                 \n\n                  \n\n                   109\n                  \n\n                 \n\n                 \n\n                  \n\n                   Primary tumour - solid tissue\n                  \n\n                 \n\n                 \n\n                  \n\n                   110\n                  \n\n                 \n\n                 \n\n                  \n\n                   Primary tumour - blood derived (peripheral blood)\n                  \n\n                 \n\n                 \n\n                  \n\n                   111\n                  \n\n                 \n\n                 \n\n                  \n\n                   Primary tumour - blood derived (bone marrow)\n                  \n\n                 \n\n                 \n\n                  \n\n                   112\n                  \n\n                 \n\n                 \n\n                  \n\n                   Primary tumour - additional new primary\n                  \n\n                 \n\n                 \n\n                  \n\n                   113\n                  \n\n                 \n\n                 \n\n                  \n\n                   Primary tumour - other\n                  \n\n                 \n\n                 \n\n                  \n\n                   114\n                  \n\n                 \n\n                 \n\n                  \n\n                   Recurrent tumour - solid tissue\n                  \n\n                 \n\n                 \n\n                  \n\n                   115\n                  \n\n                 \n\n                 \n\n                  \n\n                   Recurrent tumour - blood derived (peripheral blood)\n                  \n\n                 \n\n                 \n\n                  \n\n                   116\n                  \n\n                 \n\n                 \n\n                  \n\n                   Recurrent tumour - blood derived (bone marrow)\n                  \n\n                 \n\n                 \n\n                  \n\n                   117\n                  \n\n                 \n\n                 \n\n                  \n\n                   Recurrent tumour - other\n                  \n\n                 \n\n                 \n\n                  \n\n                   118\n                  \n\n                 \n\n                 \n\n                  \n\n                   Metastatic tumour - NOS\n                  \n\n                 \n\n                 \n\n                  \n\n                   119\n                  \n\n                 \n\n                 \n\n                  \n\n                   Metastatic tumour - lymph node\n                  \n\n                 \n\n                 \n\n                  \n\n                   120\n                  \n\n                 \n\n                 \n\n                  \n\n                   Metastatic tumour - metastatsis local to lymph node\n                  \n\n                 \n\n                 \n\n                  \n\n                   121\n                  \n\n                 \n\n                 \n\n                  \n\n                   Metastatic tumour - metastatsis to distant location\n                  \n\n                 \n\n                 \n\n                  \n\n                   122\n                  \n\n                 \n\n                 \n\n                  \n\n                   Metastatic tumour - additional metastatic\n                  \n\n                 \n\n                 \n\n                  \n\n                   123\n                  \n\n                 \n\n                 \n\n                  \n\n                   Xenograft - derived from primary tumour\n                  \n\n                 \n\n                 \n\n                  \n\n                   124\n                  \n\n                 \n\n                 \n\n                  \n\n                   Xenograft - derived from tumour cell line\n                  \n\n                 \n\n                 \n\n                  \n\n                   125\n                  \n\n                 \n\n                 \n\n                  \n\n                   Cell line - derived from tumour\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_type_other\n              \n\n              \n\n               Specimen Type Other\n              \n\n              \n\n               \n\n                Free text description of site of specimen if 108 (\nNormal - other\n) or 113 (\nPrimary tumour - other\n) or 117 (\nRecurrent tumour - other\n) was specified in specimen_type field.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If specimen_type is specified as either Normal - other, Primary tumour - other or Recurrent tumour - other, specimen_type_other needs to be filled in\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_interval\n              \n\n              \n\n               Specimen Interval\n              \n\n              \n\n               \n\n                Interval between primary diagnosis and specimen acquisition, in days\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_donor_treatment_type\n              \n\n              \n\n               Specimen Donor Treatment Type\n              \n\n              \n\n               \n\n                Type of treatment the donor received prior to specimen acquisition.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.specimen_donor_treatment_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   no treatment\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   chemotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   radiation therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   combined chemo+radiation therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   immunotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   combined chemo+immunotherapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   surgery\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   other therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   other therapy\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   bone marrow transplant\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   stem cell transplant\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   monoclonal antibodies (for liquid tumours)\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_donor_treatment_type_other\n              \n\n              \n\n               Specimen Donor Treatment Type Other\n              \n\n              \n\n               \n\n                If \nother\n therapy indicated in previous column, describe it here. eg: molecular\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_processing\n              \n\n              \n\n               Specimen Processing\n              \n\n              \n\n               \n\n                Description of technique used to process specimen\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.specimen_processing.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   cryopreservation in liquid nitrogen (dead tissue)\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   cryopreservation in dry ice (dead tissue)\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   cryopreservation of live cells in liquid nitrogen\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   cryopreservation, other\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   formalin fixed, unbuffered\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   formalin fixed, buffered\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   formalin fixed \n paraffin embedded\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   fresh\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   other technique\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_processing_other\n              \n\n              \n\n               Specimen Processing Other\n              \n\n              \n\n               \n\n                If \nother\n specified for specimen_processing, may indicate technique here.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_storage\n              \n\n              \n\n               Specimen Storage\n              \n\n              \n\n               \n\n                Description of how specimen was stored. For specimens that were extracted freshly or immediately cultured, answer (1) \nNA\n.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.specimen_storage.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   frozen, liquid nitrogen\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   frozen, -70 freezer\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   frozen, vapor phase\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA later frozen\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   paraffin block\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   cut slide\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   other\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_storage_other\n              \n\n              \n\n               Specimen Storage Other\n              \n\n              \n\n               \n\n                If \nother\n specified for specimen_storage, may indicate technique here.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_confirmed\n              \n\n              \n\n               Tumour Confirmed\n              \n\n              \n\n               \n\n                Whether tumour was confirmed in the specimen by histological examination.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.yes_no.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_biobank\n              \n\n              \n\n               Specimen Biobank\n              \n\n              \n\n               \n\n                If the specimen was obtained from a biobank, provide the biobank name here\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_biobank_id\n              \n\n              \n\n               Specimen Biobank ID\n              \n\n              \n\n               \n\n                If the specimen was obtained from a biobank, provide the biobank accession number here.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_available\n              \n\n              \n\n               Specimen Available\n              \n\n              \n\n               \n\n                Whether additional tissue is available for followup studies.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.yes_no.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_histological_type\n              \n\n              \n\n               Tumour Histological Type\n              \n\n              \n\n               \n\n                \nWHO International Histological Classification of Tumours\n code. See\n                \n\n                 http://codes.iarc.fr/codegroup/2\n                \n\n                for details.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_grading_system\n              \n\n              \n\n               Tumour Grading System\n              \n\n              \n\n               \n\n                Name of tumour grading system\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_grade\n              \n\n              \n\n               Tumour Grade\n              \n\n              \n\n               \n\n                Tumour grade using indicated grading system\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_grade_supplemental\n              \n\n              \n\n               Tumour Grade Supplemental\n              \n\n              \n\n               \n\n                Optional additional grading provided as a comma-delimited list of \ngrading system:grade\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_stage_system\n              \n\n              \n\n               Tumour Stage System\n              \n\n              \n\n               \n\n                Name of tumour staging system used\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_stage\n              \n\n              \n\n               Tumour Stage\n              \n\n              \n\n               \n\n                Pathological tumour stage value using indicated staging system\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               tumour_stage_supplemental\n              \n\n              \n\n               Tumour Stage Supplemental\n              \n\n              \n\n               \n\n                Optional additional staging provided as a comma-delimited list of \nstaging system:stage\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               digital_image_of_stained_section\n              \n\n              \n\n               Digital Image of Stained Section\n              \n\n              \n\n               \n\n                Linkout(s) to digital image of a stained section, demonstrating a representative section of tumour\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               percentage_cellularity\n              \n\n              \n\n               Percentage Cellularity\n              \n\n              \n\n               \n\n                The ratio of tumour nuclei to total number of nuclei in a given specimen expressed as a percentage. Can populate information in either this field or level_of_cellularity\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               level_of_cellularity\n              \n\n              \n\n               Level of Cellularity\n              \n\n              \n\n               \n\n                The proportion of tumour nuclei to total number of nuclei in a given specimen. If exact percentage cellularity cannot be determined submitter has option to use this field to specify a level that defines a range of percentage.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  specimen.0.cellularity.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1-20%\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   21-40%\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   41-60%\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   61-80%\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   \n81%\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               specimen_notes\n              \n\n              \n\n               Specimen Notes\n              \n\n              \n\n               \n\n                Free text notes allowed\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Controlled\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Donor Biomarkers (biomarker)\n            \n\n            \n\n             up\n            \n\n            \n\n             Analyzed Sample Data File (sample) \u203a", 
            "title": "Specimen Data File (specimen)"
        }, 
        {
            "location": "/submission/dictionary/20/splice-variation-jcn-analysis-metadata-file-m/", 
            "text": "Splice Variation (jcn) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nSplice Variation (jcn) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \njcn_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^jcn_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_build_version\n              \n\n              \n\n               Gene Build Version\n              \n\n              \n\n               \n\n                Gene build version associated with the platform, tools or other methods used in the analysis; Supports the following syntax: \nDB:VERSION\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^(\\w+)\\:(\\w+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Ensembl:69\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               base_calling_algorithm\n              \n\n              \n\n               Base Calling Algorithm\n              \n\n              \n\n               \n\n                Name of base calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  CASAVA http://support.illumina.com/sequencing/sequencing_software/casava.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  BWA 0.6.2\n                  \n\n                   http://bio-bwa.sourceforge.net\n                  \n\n                  bwa aln -q20 HGref s1.fastq \n s1_bwa.sai\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               normalization_algorithm\n              \n\n              \n\n               Normalization Algorithm\n              \n\n              \n\n               \n\n                Name of normalization algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  RPKM http://www.ncbi.nlm.nih.gov/pubmed/18516045\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               seq_coverage\n              \n\n              \n\n               Seq Coverage\n              \n\n              \n\n               \n\n                Sequence coverage if analyzed by sequencing platforms\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Simple Germline Variation (sgv) - Primary Analysis File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Splice Variation (jcn) - Primary Analysis File (p) \u203a", 
            "title": "Splice Variation (jcn) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/splice-variation-jcn-primary-analysis-file-p/", 
            "text": "Splice Variation (jcn) - Primary Analysis File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Key: \njcn_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^jcn_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               junction_id\n              \n\n              \n\n               Junction ID\n              \n\n              \n\n               \n\n                For known exons, use exonID1_exonID2 where exonID1 and exonID2 are Ensembl IDs of the 5\n and 3\n exons, respectively.  For novel or putative exons, use assemblyBuild_exon1chr_exon1end_exon2chr_exon2start where assemblyBuild is hg19; exon1chr and exone2chr are the chromosomes of the 5\n and 3\n exons, respectively; exon1end is the end position of the 5\nexon; exon2start is the start position of the 3\nexon.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_stable_id\n              \n\n              \n\n               Gene Stable ID\n              \n\n              \n\n               \n\n                For providing Ensembl gene or transcript annotation use the DB Xref syntax: \nEnsembl:ENSGxxx\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_chromosome\n              \n\n              \n\n               Gene Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the above gene.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_strand\n              \n\n              \n\n               Gene Strand\n              \n\n              \n\n               \n\n                Strand of the chromosome\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.strand.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_start\n              \n\n              \n\n               Gene Start\n              \n\n              \n\n               \n\n                Start position of the entire gene on the chromosome as annotated in Ensembl\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343492\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome start position must be equal or greater than 1\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_end\n              \n\n              \n\n               Gene End\n              \n\n              \n\n               \n\n                End position of the entire gene on the chromosome as annotated in Ensembl\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343499\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Chromosome end position must be less than or equal to the length of the chromosome\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               second_gene_stable_id\n              \n\n              \n\n               Second Gene Stable ID\n              \n\n              \n\n               \n\n                In the case of a fusion gene, provide the Stable ID of the gene containing the 3\n exon at the junction.  For annotated genes, use Ensembl gene ID.  For putative and novel genes, use assemblyBuild_chr_start_end where assemblyBuild is hg19.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon1_chromosome\n              \n\n              \n\n               Exon1 Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the 5\n exon (#)\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon1_number_bases\n              \n\n              \n\n               Exon1 Number Bases\n              \n\n              \n\n               \n\n                Number of bases from 5\n exon\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon1_end\n              \n\n              \n\n               Exon1 End\n              \n\n              \n\n               \n\n                End position of the 5\n exon on the chromosome\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon1_strand\n              \n\n              \n\n               Exon1 Strand\n              \n\n              \n\n               \n\n                Chromsome strand of the 5\n exon\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.strand.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon2_chromosome\n              \n\n              \n\n               Exon2 Chromosome\n              \n\n              \n\n               \n\n                Name of the chromosome containing the 3\n exon (#)\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon2_number_bases\n              \n\n              \n\n               Exon2 Number Bases\n              \n\n              \n\n               \n\n                Number of bases from 3\n exon\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon2_start\n              \n\n              \n\n               Exon2 Start\n              \n\n              \n\n               \n\n                Start position of the 3\n exon on the chromosome\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^\\d+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  405343492\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               exon2_strand\n              \n\n              \n\n               Exon2 Strand\n              \n\n              \n\n               \n\n                Chromosome strand of the 3\n exon\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.strand.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               is_fusion_gene\n              \n\n              \n\n               Is Fusion Gene\n              \n\n              \n\n               \n\n                Indicate if the function is the result of a fusion gene\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.yes_no.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               is_novel_splice_form\n              \n\n              \n\n               Is Novel Splice Form\n              \n\n              \n\n               \n\n                Indicate if the splice form is novel\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.yes_no.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   yes\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   no\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               junction_seq\n              \n\n              \n\n               Junction Seq\n              \n\n              \n\n               \n\n                Provide junction sequence if either is_fusion_gene or is_novel_splice_form is true\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               junction_type\n              \n\n              \n\n               Junction Type\n              \n\n              \n\n               \n\n                Type of junction\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  jcn_p.0.junction_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   canonical\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-canonical\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   U12\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               junction_read_count\n              \n\n              \n\n               Junction Read Count\n              \n\n              \n\n               \n\n                Count of sequencing reads that span across exons\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               quality_score\n              \n\n              \n\n               Quality Score\n              \n\n              \n\n               \n\n                Quality score of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               probability\n              \n\n              \n\n               Probability\n              \n\n              \n\n               \n\n                Probability of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the mutation/variant is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_status\n              \n\n              \n\n               Biological Validation Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.biological_validation_status.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and not valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_platform\n              \n\n              \n\n               Biological Validation Platform\n              \n\n              \n\n               \n\n                Identifier of assay platform or technology used to validate the mutation/variant\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is biologically validated, the biological validation platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Splice Variation (jcn) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Array-based Gene Expression (exp_array) - Analysis Metadata File (m) \u203a", 
            "title": "Splice Variation (jcn) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/structural-somatic-mutations-stsm-analysis-metadata-file-m/", 
            "text": "Structural Somatic Mutations (stsm) - Analysis Metadata File (m)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nStructural Somatic Mutations (stsm) - Analysis Metadata File (m)\n\n           \n\n           \n\n            File Key: \nstsm_m\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^stsm_m(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed non-normal sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular non-normal sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               matched_sample_id\n              \n\n              \n\n               Matched Sample ID\n              \n\n              \n\n               \n\n                Unique identifier for the matched normal sample used in the analysis; must exist in the sample file\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  mut19\n                 \n\n                 \n\n                  LH12-fb\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  The sample identifiers used for matched_sample_id and analyzed_sample_id cannot be identical\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               assembly_version\n              \n\n              \n\n               Assembly Version\n              \n\n              \n\n               \n\n                Version of human reference genome assembly used in the analysis; specify the version used in alignments, or associated with the particular platform used\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.assembly_version.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   GRCh37\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               platform\n              \n\n              \n\n               Platform\n              \n\n              \n\n               \n\n                Identifier of platform or technology used for analysis or verification; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   81\n                  \n\n                 \n\n                 \n\n                  \n\n                   Complete Genomics\n                  \n\n                 \n\n                 \n\n                  \n\n                   82\n                  \n\n                 \n\n                 \n\n                  \n\n                   nanoString\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               experimental_protocol\n              \n\n              \n\n               Experimental Protocol\n              \n\n              \n\n               \n\n                Name of experimental protocol and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Paired End http://www.illumina.com/technology/paired_end_sequencing_assay.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               base_calling_algorithm\n              \n\n              \n\n               Base Calling Algorithm\n              \n\n              \n\n               \n\n                Name of base calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  CASAVA http://support.illumina.com/sequencing/sequencing_software/casava.ilmn\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               alignment_algorithm\n              \n\n              \n\n               Alignment Algorithm\n              \n\n              \n\n               \n\n                Name of alignment algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  BWA 0.6.2\n                  \n\n                   http://bio-bwa.sourceforge.net\n                  \n\n                  bwa aln -q20 HGref s1.fastq \n s1_bwa.sai\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variation_calling_algorithm\n              \n\n              \n\n               Variation Calling Algorithm\n              \n\n              \n\n               \n\n                Name of variation calling algorithm and option to include URL to written protocol and/or algorithm parameters. Syntax should be: \nName of Protocol\nsingle whitespace\nURL to protocol (optional)\nsingle whitespace\nalgorithm parameters (optional)\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                (^[\\w\\s_\\-\\.]+)((\\s)(http(s)?://|www[.])[-A-Za-z0-9+\n@#/%?=~_()|!:,.;]*)?((\\s)[-A-Za-z0-9_\\s|\n.]+)?\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Samtools http://samtools.sourceforge.net\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               other_analysis_algorithm\n              \n\n              \n\n               Other Analysis Algorithm\n              \n\n              \n\n               \n\n                Names of other analysis algorithms.  Separate multiple algorithms by commas.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sequencing_strategy\n              \n\n              \n\n               Sequencing Strategy\n              \n\n              \n\n               \n\n                Sequencing technique intended for the analyzed sample library.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.sequencing_strategy.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   WGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   WXS\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   RNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   miRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   ncRNA-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   WCS\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   POOLCLONE\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   AMPLICON\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   CLONEEND\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   FINISHING\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   MNase-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   DNase-Hypersensitivity\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Bisulfite-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   EST\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   FL-cDNA\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   CTS\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   MRE-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   MeDIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   MBD-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Tn-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   VALIDATION\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   FAIRE-seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   SELEX\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   RIP-Seq\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   ChIA-PET\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   OTHER\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   non-NGS\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               seq_coverage\n              \n\n              \n\n               Seq Coverage\n              \n\n              \n\n               \n\n                Sequence coverage if analyzed by sequencing platforms\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_repository\n              \n\n              \n\n               Raw Data Repository\n              \n\n              \n\n               \n\n                Public repository where raw data is submitted\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.raw_data_repository.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   EGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   dbSNP\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   TCGA\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   CGHub\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   GEO\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   TARGET\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               raw_data_accession\n              \n\n              \n\n               Raw Data Accession\n              \n\n              \n\n               \n\n                Accession for referencing the raw data at the public repository\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 If raw_data_repository is EGA, you can submit:\n                 \n\n                 1. A dataset (EGAD*) or study (EGAS*) ID\n                 \n\n                 OR\n                 \n\n                 2. A study (EGAS*) ID followed by\n                 \n\n                  \n\n                   a dataset (EGAD*) ID\n                  \n\n                  \n\n                   a sample (EGAN*) ID\n                  \n\n                  \n\n                   one or more experiment (EGAX*) ID\n                  \n\n                  \n\n                   one or more run (EGAR*) ID\n                  \n\n                 \n\n                 \n\n                  Examples:\n                 \n\n                 \n\n                  EGAS00001000354\n                 \n\n                 \n\n                  EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983:EGAN00001142752\n                 \n\n                 \n\n                  EGAS00001000354:EGAD00001000983\n                 \n\n                 \n\n                  EGAS00001000476:EGAD00001001089:EGAN00001627997:EGAX00001617535:EGAR00001337561:EGAR00009797935:EGAR00008994363\n                 \n\n                 \n\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Format of raw data accession must match the format required by the raw data repository\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Copy Number Somatic Mutations (cnsm) - Secondary Analysis File (s)\n            \n\n            \n\n             up\n            \n\n            \n\n             Structural Somatic Mutations (stsm) - Primary Analysis File (p) \u203a", 
            "title": "Structural Somatic Mutations (stsm) - Analysis Metadata File (m)"
        }, 
        {
            "location": "/submission/dictionary/20/structural-somatic-mutations-stsm-primary-analysis-file-p/", 
            "text": "Structural Somatic Mutations (stsm) - Primary Analysis File (p)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Key: \nstsm_p\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^stsm_p(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sv_id\n              \n\n              \n\n               Sv ID\n              \n\n              \n\n               \n\n                A unique identifier assigned to a particular structural variant observation (one ID per event).\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  sv12\n                 \n\n                 \n\n                  SA-AV123-98\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               placement\n              \n\n              \n\n               Placement\n              \n\n              \n\n               \n\n                Ordering of breakpoint pairs within a single structural change event\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               annotation\n              \n\n              \n\n               Annotation\n              \n\n              \n\n               \n\n                Annotation describing sequence mutation/variation based on breakpoint pairs\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               interpreted_annotation\n              \n\n              \n\n               Interpreted Annotation\n              \n\n              \n\n               \n\n                HGVS nomenclature for description of sequence mutation/variation. E.g. chr3:g.1234567-2345678inv.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               variant_type\n              \n\n              \n\n               Variant Type\n              \n\n              \n\n               \n\n                Type of mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  stsm_p.0.variant_type.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   deletion\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   tandem duplication\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   inversion\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   inverted duplication - head-to-head\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   inverted duplication - tail-to-tail\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   insertion\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   intrachromosomal rearrangement with inverted orientation\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   intrachromosomal rearrangement with non-inverted orientation\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   fold-back inversion\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   complex intrachromosomal rearrangement\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   reciprocal translocation\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   unbalanced translocation\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   interchromosomal insertion\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   interchromosomal rearrangement - unknown type\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   complex interchromosomal rearrangement\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   intrachromosomal amplicon-to-amplicon\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   intrachromosomal amplicon-to-nonamplified dna\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   interchromosomal amplicon-to-amplicon\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   interchromosomal amplicon-to-nonamplified dna\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   extrachromosomal\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_from\n              \n\n              \n\n               Chr From\n              \n\n              \n\n               \n\n                Name of the donor chromosome containing the mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_from_bkpt\n              \n\n              \n\n               Chr from Bkpt\n              \n\n              \n\n               \n\n                Breakpoint position of the mutation/variation on the donor chromosome\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_from_strand\n              \n\n              \n\n               Chr from Strand\n              \n\n              \n\n               \n\n                Donor chromome strand\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.strand.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_from_range\n              \n\n              \n\n               Chr from Range\n              \n\n              \n\n               \n\n                Number of bases around chr_from_bkpt that may contain the real breakpoint\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_from_flanking_seq\n              \n\n              \n\n               Chr from Flanking Seq\n              \n\n              \n\n               \n\n                Flanking sequences that are 200bp upstream and 200bp downstream to the chr_from_bkpt position.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_to\n              \n\n              \n\n               Chr To\n              \n\n              \n\n               \n\n                Name of the acceptor chromosome containing the mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.chromosome.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   Y\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   X\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   MT\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_to_bkpt\n              \n\n              \n\n               Chr to Bkpt\n              \n\n              \n\n               \n\n                Breakpoint position of the mutation/variation on the acceptor chromosome\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_to_strand\n              \n\n              \n\n               Chr to Strand\n              \n\n              \n\n               \n\n                Acceptor chromome strand\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.strand.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   -1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_to_range\n              \n\n              \n\n               Chr to Range\n              \n\n              \n\n               \n\n                Number of bases around chr_to_bkpt that may contain the real breakpoint\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               chr_to_flanking_seq\n              \n\n              \n\n               Chr to Flanking Seq\n              \n\n              \n\n               \n\n                Flanking sequences that are 200bp upstream and 200bp downstream to the chr_to_bkpt position.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               microhomology_sequence\n              \n\n              \n\n               Microhomology Sequence\n              \n\n              \n\n               \n\n                If a microhomology is inserted, provide sequence\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               non_templated_sequence\n              \n\n              \n\n               Non Templated Sequence\n              \n\n              \n\n               \n\n                If non-templated DNA is inserted, provide sequence\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               evidence\n              \n\n              \n\n               Evidence\n              \n\n              \n\n               \n\n                Evidence supporting a structural mutation/variation\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  stsm_p.0.evidence.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   Copy number change\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   FISH\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   Flow-sorted chromosome evidence\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   Paired sequence either side of breakpoint\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Partner breakpoint found\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR product across breakpoint\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Protein evidence\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Seen in multiple samples\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequence across breakpoint\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Partner breakpoint found, and paired sequence either side of breakpoint\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               quality_score\n              \n\n              \n\n               Quality Score\n              \n\n              \n\n               \n\n                Quality score of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               probability\n              \n\n              \n\n               Probability\n              \n\n              \n\n               \n\n                Probability of the observation\n               \n\n              \n\n              \n\n               DECIMAL\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               zygosity\n              \n\n              \n\n               Zygosity\n              \n\n              \n\n               \n\n                Zygosity\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  stsm_p.0.zygosity.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   homozygous\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   heterozygous\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   hemizygous\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   nullizygous\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_status\n              \n\n              \n\n               Verification Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been verified using an independent orthogonal genotype platform/technology\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.verification_status.v2\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and verified to be false\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               verification_platform\n              \n\n              \n\n               Verification Platform\n              \n\n              \n\n               \n\n                Identifier of orthogonal platform or technology used to confirm that the mutation/variant is true; identifier should be taken from controlled vocabulary list of platforms recognized by the DCC and should directly correspond to the particular technology (including version) used. If no appropriate term exists for a given platform, please contact the DCC to request an addition to the CV terms.\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is verified, the verification platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_status\n              \n\n              \n\n               Biological Validation Status\n              \n\n              \n\n               \n\n                Indicate if the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.biological_validation_status.v3\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   not tested\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and not valid\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   tested and inconclusive\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               biological_validation_platform\n              \n\n              \n\n               Biological Validation Platform\n              \n\n              \n\n               \n\n                Identifier of assay platform or technology used to validate the mutation/variant\n               \n\n              \n\n              \n\n               CV\n              \n\n              \n\n               \n\n                \n\n                 [\n                 \n\n                  GLOBAL.0.platform.v1\n                 \n\n                 ]\n                \n\n               \n\n               \n\n                \n\n                 \n\n                  \n\n                   1\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   2\n                  \n\n                 \n\n                 \n\n                  \n\n                   qPCR\n                  \n\n                 \n\n                 \n\n                  \n\n                   3\n                  \n\n                 \n\n                 \n\n                  \n\n                   capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   4\n                  \n\n                 \n\n                 \n\n                  \n\n                   SOLiD sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   5\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GA sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   6\n                  \n\n                 \n\n                 \n\n                  \n\n                   454 sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   7\n                  \n\n                 \n\n                 \n\n                  \n\n                   Helicos sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   8\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 6.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   9\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Genome-Wide Human SNP Array 5.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   10\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 100K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   11\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 500K Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   12\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Mapping 10K 2.0 Array Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   13\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix EMET Plus Premier Pack\n                  \n\n                 \n\n                 \n\n                  \n\n                   14\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Whole Human Genome Oligo Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   15\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 244A\n                  \n\n                 \n\n                 \n\n                  \n\n                   16\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 105A\n                  \n\n                 \n\n                 \n\n                  \n\n                   17\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV Association 2x105K\n                  \n\n                 \n\n                 \n\n                  \n\n                   18\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome 44K\n                  \n\n                 \n\n                 \n\n                  \n\n                   19\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 1x1M\n                  \n\n                 \n\n                 \n\n                  \n\n                   20\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   21\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 4x180K\n                  \n\n                 \n\n                 \n\n                  \n\n                   22\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CGH 8x60K\n                  \n\n                 \n\n                 \n\n                  \n\n                   23\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CNV 2x400K\n                  \n\n                 \n\n                 \n\n                  \n\n                   24\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human miRNA Microarray Kit (v2)\n                  \n\n                 \n\n                 \n\n                  \n\n                   25\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human CpG Island Microarray Kit\n                  \n\n                 \n\n                 \n\n                  \n\n                   26\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Promoter ChIP-on-chip Microarray Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   27\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human SpliceArray\n                  \n\n                 \n\n                 \n\n                  \n\n                   28\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human1m-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   29\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human660w-quad\n                  \n\n                 \n\n                 \n\n                  \n\n                   30\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humancytosnp-12\n                  \n\n                 \n\n                 \n\n                  \n\n                   31\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina human510s-duo\n                  \n\n                 \n\n                 \n\n                  \n\n                   32\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanmethylation27\n                  \n\n                 \n\n                 \n\n                  \n\n                   33\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina goldengate methylation\n                  \n\n                 \n\n                 \n\n                  \n\n                   34\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHT-12 v4.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   35\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanWG-6 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   36\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanRef-8 v3.0 beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   37\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina microRNA Expression Profiling Panel\n                  \n\n                 \n\n                 \n\n                  \n\n                   38\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-16\n                  \n\n                 \n\n                 \n\n                  \n\n                   39\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina humanht-17\n                  \n\n                 \n\n                 \n\n                  \n\n                   40\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 3x720 Whole-Genome v3.0 Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   41\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human CGH 2.1M Whole-Genome v2.0D Array\n                  \n\n                 \n\n                 \n\n                  \n\n                   42\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 385K\n                  \n\n                 \n\n                 \n\n                  \n\n                   43\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 4x72K\n                  \n\n                 \n\n                 \n\n                  \n\n                   44\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Gene Expression 12x135K\n                  \n\n                 \n\n                 \n\n                  \n\n                   45\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 2.1M Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   46\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen Human Methylation 385K Whole-Genome sets\n                  \n\n                 \n\n                 \n\n                  \n\n                   47\n                  \n\n                 \n\n                 \n\n                  \n\n                   Nimblegen CGS\n                  \n\n                 \n\n                 \n\n                  \n\n                   48\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human1M OmniQuad chip\n                  \n\n                 \n\n                 \n\n                  \n\n                   49\n                  \n\n                 \n\n                 \n\n                  \n\n                   PCR and capillary sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   50\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed gene expression array\n                  \n\n                 \n\n                 \n\n                  \n\n                   51\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix HT Human Genome U133A Array Plate Set\n                  \n\n                 \n\n                 \n\n                  \n\n                   52\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-1\n                  \n\n                 \n\n                 \n\n                  \n\n                   53\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-2\n                  \n\n                 \n\n                 \n\n                  \n\n                   54\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07-3\n                  \n\n                 \n\n                 \n\n                  \n\n                   55\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent Human Genome CGH Custom Microaary 2x415K\n                  \n\n                 \n\n                 \n\n                  \n\n                   56\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus PM\n                  \n\n                 \n\n                 \n\n                  \n\n                   57\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human U133 Plus 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   58\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Exon 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   59\n                  \n\n                 \n\n                 \n\n                  \n\n                   Almac Human CRC\n                  \n\n                 \n\n                 \n\n                  \n\n                   60\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HiSeq\n                  \n\n                 \n\n                 \n\n                  \n\n                   61\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human MIP 330K\n                  \n\n                 \n\n                 \n\n                  \n\n                   62\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Gene 1.0 ST\n                  \n\n                 \n\n                 \n\n                  \n\n                   63\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Human Omni1-Quad beadchip\n                  \n\n                 \n\n                 \n\n                  \n\n                   64\n                  \n\n                 \n\n                 \n\n                  \n\n                   Sequenom MassARRAY\n                  \n\n                 \n\n                 \n\n                  \n\n                   65\n                  \n\n                 \n\n                 \n\n                  \n\n                   Custom-designed cDNA array\n                  \n\n                 \n\n                 \n\n                  \n\n                   66\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanHap550\n                  \n\n                 \n\n                 \n\n                  \n\n                   67\n                  \n\n                 \n\n                 \n\n                  \n\n                   Ion Torrent PGM\n                  \n\n                 \n\n                 \n\n                  \n\n                   68\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina GoldenGate Methylation Cancer Panel I\n                  \n\n                 \n\n                 \n\n                  \n\n                   69\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina Infinium HumanMethylation450\n                  \n\n                 \n\n                 \n\n                  \n\n                   70\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 8 x 15K Human miRNA-specific microarray\n                  \n\n                 \n\n                 \n\n                  \n\n                   71\n                  \n\n                 \n\n                 \n\n                  \n\n                   M.D. Anderson Reverse Phase Protein Array Core\n                  \n\n                 \n\n                 \n\n                  \n\n                   72\n                  \n\n                 \n\n                 \n\n                  \n\n                   Microsatellite Instability Analysis\n                  \n\n                 \n\n                 \n\n                  \n\n                   73\n                  \n\n                 \n\n                 \n\n                  \n\n                   Agilent 244K Custom Gene Expression G4502A-07\n                  \n\n                 \n\n                 \n\n                  \n\n                   74\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanCNV370-Duo v1.0 BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   75\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina HumanOmniExpress BeadChip\n                  \n\n                 \n\n                 \n\n                  \n\n                   76\n                  \n\n                 \n\n                 \n\n                  \n\n                   PacBio RS sequencing\n                  \n\n                 \n\n                 \n\n                  \n\n                   77\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix OncoScan FFPE Express 2.0\n                  \n\n                 \n\n                 \n\n                  \n\n                   78\n                  \n\n                 \n\n                 \n\n                  \n\n                   Illumina MiSeq Personal Sequencer\n                  \n\n                 \n\n                 \n\n                  \n\n                   79\n                  \n\n                 \n\n                 \n\n                  \n\n                   Affymetrix Human Genome U219 Array Plate\n                  \n\n                 \n\n                 \n\n                  \n\n                   80\n                  \n\n                 \n\n                 \n\n                  \n\n                   HumanOmni2.5-8 BeadChip Kit\n                  \n\n                 \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  If mutation is biologically validated, the biological validation platform must be specified\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Structural Somatic Mutations (stsm) - Analysis Metadata File (m)\n            \n\n            \n\n             up\n            \n\n            \n\n             Structural Somatic Mutations (stsm) - Secondary Analysis File (s) \u203a", 
            "title": "Structural Somatic Mutations (stsm) - Primary Analysis File (p)"
        }, 
        {
            "location": "/submission/dictionary/20/structural-somatic-mutations-stsm-secondary-analysis-file-s/", 
            "text": "Structural Somatic Mutations (stsm) - Secondary Analysis File (s)\n\n\n\n\n\n \n\n  \n\n   \n\n    \n\n    \n\n    \n\n     \n\n      \n\n       \n\n        \n\n         \n\n          \n\n           \n\n            File Type: \nStructural Somatic Mutations (stsm) - Secondary Analysis File (s)\n\n           \n\n           \n\n            File Key: \nstsm_s\n\n           \n\n           \n\n            File Name\n            \n\n             Pattern\n            \n\n            : \n^stsm_s(\\.[a-zA-Z0-9]+)?\\.txt(?:\\.gz|\\.bz2)?$\n\n           \n\n           \n\n           \n\n           \n\n            \n\n             \n\n              \n\n               Data Element ID\n              \n\n              \n\n               Name\n              \n\n              \n\n               Description\n              \n\n              \n\n               Data Type\n              \n\n              \n\n               CV Codes\n              \n\n              \n\n               Required?\n              \n\n              \n\n               N/A Code Valid?\n              \n\n              \n\n               Controlled Access?\n              \n\n              \n\n               Regexp\n              \n\n              \n\n               Example\n              \n\n              \n\n               Additional Notes\n              \n\n             \n\n            \n\n            \n\n             \n\n              \n\n               analysis_id\n              \n\n              \n\n               Analysis ID\n              \n\n              \n\n               \n\n                Unique identifier assigned to a computational analysis run that was performed on a single analyzed sample and any associated matched samples using a particular set of methods, tools, etc.; analysis IDs must be unique and must not be reused by a project across subsequent analysis runs. Cannot contain whitespace, semi-colons or special characters. Can contain alphanumeric characters, dashes or underscores.\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  hnc_12\n                 \n\n                 \n\n                  CCG_34_94583\n                 \n\n                 \n\n                  BRCA47832-3239\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               analyzed_sample_id\n              \n\n              \n\n               Analyzed Sample ID\n              \n\n              \n\n               \n\n                A unique identifier representing the particular sample that was analyzed; analyzed sample identifiers must be used consistently to relate those described in the sample file and in the related analysis files\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  ov-45\n                 \n\n                 \n\n                  90343a\n                 \n\n                 \n\n                  BRCAZ-TG\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               sv_id\n              \n\n              \n\n               Sv ID\n              \n\n              \n\n               \n\n                A unique identifier assigned to a particular structural variant observation (one ID per event).\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^[\\w+\\-\\_]+$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  sv12\n                 \n\n                 \n\n                  SA-AV123-98\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               placement\n              \n\n              \n\n               Placement\n              \n\n              \n\n               \n\n                Ordering of breakpoint pairs within a single structural change event\n               \n\n              \n\n              \n\n               INTEGER\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Invalid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_affected_by_bkpt_from\n              \n\n              \n\n               Gene Affected by Bkpt From\n              \n\n              \n\n               \n\n                Transcript(s) affected by the breakpoints. Use Ensembl transcript id. Separate multiple transcripts from the same gene with commas, and separate transcripts from different genes with vertical bars. e.g.: transcriptA1,transcriptA2|transcriptB1|transcriptC1\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_affected_by_bkpt_to\n              \n\n              \n\n               Gene Affected by Bkpt To\n              \n\n              \n\n               \n\n                Gene(s) affected by the breakpoints. Use Ensembl gene id. Separate multiple genes with vertical bars in the form of geneA|geneB|geneC. If both breakpoints affect genes, then use \n|\n to separate them. If no gene is affected, use -888 (not applicable).\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               transcript_affected_by_bkpt_from\n              \n\n              \n\n               Transcript Affected by Bkpt From\n              \n\n              \n\n               \n\n                Transcript(s) affected by the breakpoints. Use Ensembl transcript id. Separate multiple transcripts from the same gene with commas, and separate transcripts from different genes with vertical bars. e.g.: transcriptA1,transcriptA2|transcriptB1|transcriptC1\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               transcript_affected_by_bkpt_to\n              \n\n              \n\n               Transcript Affected by Bkpt To\n              \n\n              \n\n               \n\n                Transcript(s) affected by the breakpoints. Use Ensembl transcript id. Separate multiple transcripts from the same gene with commas, and separate transcripts from different genes with vertical bars. e.g.: transcriptA1,transcriptA2|transcriptB1|transcriptC1\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               bkpt_from_context\n              \n\n              \n\n               Bkpt from Context\n              \n\n              \n\n               \n\n                Contextual description of the first break location (Exonic, Intronic, Intergenic)\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               bkpt_to_context\n              \n\n              \n\n               Bkpt to Context\n              \n\n              \n\n               \n\n                Contextual description of the second break location (Exonic, Intronic, Intergenic)\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Optional\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n             \n\n              \n\n               gene_build_version\n              \n\n              \n\n               Gene Build Version\n              \n\n              \n\n               \n\n                Gene build version associated with the platform, tools or other methods used in the analysis; Supports the following syntax: \nDB:VERSION\n\n               \n\n              \n\n              \n\n               TEXT\n              \n\n              \n\n               N/A\n              \n\n              \n\n               \n\n                Required\n               \n\n              \n\n              \n\n               \n\n                N/A Valid\n               \n\n              \n\n              \n\n               \n\n                Open Access\n               \n\n              \n\n              \n\n               \n\n                ^(\\w+)\\:(\\w+)$\n               \n\n              \n\n              \n\n               \n\n                \n\n                 \n\n                  Ensembl:69\n                 \n\n                \n\n                \n\n                \n\n               \n\n              \n\n              \n\n               \n\n                \n\n                \n\n                \n\n                \n\n               \n\n              \n\n             \n\n            \n\n           \n\n           \n\n           \n\n           \n\n          \n\n          \n\n          \n\n          \n\n          \n\n          \n\n           \n\n            \n\n             \u2039 Structural Somatic Mutations (stsm) - Primary Analysis File (p)\n            \n\n            \n\n             up\n            \n\n            \n\n             Simple Germline Variation (sgv) - Analysis Metadata File (m) \u203a", 
            "title": "Structural Somatic Mutations (stsm) - Secondary Analysis File (s)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-19/", 
            "text": "Dictionary v0.11c (April., 2015, Release 19)\n\n\nMay 15, 2015:\n\n\n\n\nAdded new term to donor.0.disease_status_last_followup.v1: \"no evidence of disease\".\n\n\n\n\nApril 20 2015:\nChange between 0.11b and 0.11c:\n\n\n\n\nChanged cancer_history_first_degree_relative to \"N/A Valid\" (for DCC-only data).\n\n\n\n\nApril 10 2015:\nChange between 0.11a and 0.11b:\n\n\n\n\nAdded new term \"Unknown\" to family.0.relationship_sex.v1 CV list.\n\n\nrelationship_disease_icd10: Removed script restriction to allow 'N/A'\n\n\nUpdated therapy.0.therapy_type.v1 CV list (used by first_therapy_type and second_therapy_type tables) to include three additional therapies.\n\n\n\n\nChanges to Specifications Since Version 0.10a (October., 2014)\nRevisions to Data Elements: Changes\nAll Files\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\ndonor_id, specimen_id, analyzed_sample_id\n\n\nAdded an MVEL script restriction to prevent ICGC-reserved prefixes from being used in identifier fields.\n\n\n\n\n\n\n\n\nDonor Clinical File\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nprior_malignancy\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\ncancer_type_prior_malignancy\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\ndonor_age_at_diagnosis, donor_age_at_enrollment, donor_age_at_last_followup\n\n\nUpdated MVEL script to prevent donor age from being expressed in days\n\n\n\n\n\n\ncancer_history_first_degree_relative\n\n\nUpdated MVEL script to prevent donor age from being expressed in days\n\n\n\n\n\n\n\n\nSpecimen Clinical File\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nspecimen_type_other\n\n\nMVEL script added to check for a required value if 'specimen_type' is indicated 'Normal - other', 'Primary tumour - other' or 'Recurrent tumour - other'\n\n\n\n\n\n\nspecimen_donor_treatment_type_other\n\n\nMVEL script added to check for required value if 'specimen_donor_treatment_type' is indicated 'other thearpy'\n\n\n\n\n\n\n\n\nDonor Family Clinical File\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\ndonor_has_relative_with_cancer_history\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nrelationship_type\n\n\nMVEL script added to check for a required value if 'cancer_history_first_degree_relative' is indicated as 'Yes'\n\n\n\n\n\n\nrelationship_type_other\n\n\nMVEL script added to check for a required value if 'relationship_type' is indicated as 'other'\n\n\n\n\n\n\nrelationship_sex\n\n\nMVEL script added to check for a required value if 'relationship_type' is specified\n\n\n\n\n\n\nrelationship_disease_icd10\n\n\nMVEL script added to check for a required value if 'relationship_type' is specified\n\n\n\n\n\n\nrelationship_disease\n\n\nMVEL script added to check for a required value if 'relationship_type' is specified\n\n\n\n\n\n\n\n\nDonor Exposure Clinical File\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\ntobacco_smoking_history_indicator\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\ntobacco_smoking_history_intensity\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nalcohol_history\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nalcohol_history_intensity\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\n\n\nDonor Postresection Therapy Clinical File\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nfirst_therapy_start_interval\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nfirst_therapy_duration\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nfirst_therapy_type\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nfirst_therapy_response\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nfirst_therapy_therapeutic_intent\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nsecond_therapy_start_interval\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nsecond_therapy_duration\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nsecond_therapy_type\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nsecond_therapy_response\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nsecond_therapy_therapeutic_intent\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nother_therapy\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\nother_therapy_response\n\n\nNew clinical field for PCAWG data\n\n\n\n\n\n\n\n\nDictionary viewer Tool highlights differences between different dictionary versions. Please try it out \nhere", 
            "title": "Dictionary - Release 19"
        }, 
        {
            "location": "/submission/dictionary/dictionary-19/#dictionary-v011c-april-2015-release-19", 
            "text": "May 15, 2015:   Added new term to donor.0.disease_status_last_followup.v1: \"no evidence of disease\".   April 20 2015:\nChange between 0.11b and 0.11c:   Changed cancer_history_first_degree_relative to \"N/A Valid\" (for DCC-only data).   April 10 2015:\nChange between 0.11a and 0.11b:   Added new term \"Unknown\" to family.0.relationship_sex.v1 CV list.  relationship_disease_icd10: Removed script restriction to allow 'N/A'  Updated therapy.0.therapy_type.v1 CV list (used by first_therapy_type and second_therapy_type tables) to include three additional therapies.   Changes to Specifications Since Version 0.10a (October., 2014)\nRevisions to Data Elements: Changes\nAll Files     Data Element ID  Comment      donor_id, specimen_id, analyzed_sample_id  Added an MVEL script restriction to prevent ICGC-reserved prefixes from being used in identifier fields.     Donor Clinical File     Data Element ID  Comment      prior_malignancy  New clinical field for PCAWG data    cancer_type_prior_malignancy  New clinical field for PCAWG data    donor_age_at_diagnosis, donor_age_at_enrollment, donor_age_at_last_followup  Updated MVEL script to prevent donor age from being expressed in days    cancer_history_first_degree_relative  Updated MVEL script to prevent donor age from being expressed in days     Specimen Clinical File     Data Element ID  Comment      specimen_type_other  MVEL script added to check for a required value if 'specimen_type' is indicated 'Normal - other', 'Primary tumour - other' or 'Recurrent tumour - other'    specimen_donor_treatment_type_other  MVEL script added to check for required value if 'specimen_donor_treatment_type' is indicated 'other thearpy'     Donor Family Clinical File     Data Element ID  Comment      donor_has_relative_with_cancer_history  New clinical field for PCAWG data    relationship_type  MVEL script added to check for a required value if 'cancer_history_first_degree_relative' is indicated as 'Yes'    relationship_type_other  MVEL script added to check for a required value if 'relationship_type' is indicated as 'other'    relationship_sex  MVEL script added to check for a required value if 'relationship_type' is specified    relationship_disease_icd10  MVEL script added to check for a required value if 'relationship_type' is specified    relationship_disease  MVEL script added to check for a required value if 'relationship_type' is specified     Donor Exposure Clinical File     Data Element ID  Comment      tobacco_smoking_history_indicator  New clinical field for PCAWG data    tobacco_smoking_history_intensity  New clinical field for PCAWG data    alcohol_history  New clinical field for PCAWG data    alcohol_history_intensity  New clinical field for PCAWG data     Donor Postresection Therapy Clinical File     Data Element ID  Comment      first_therapy_start_interval  New clinical field for PCAWG data    first_therapy_duration  New clinical field for PCAWG data    first_therapy_type  New clinical field for PCAWG data    first_therapy_response  New clinical field for PCAWG data    first_therapy_therapeutic_intent  New clinical field for PCAWG data    second_therapy_start_interval  New clinical field for PCAWG data    second_therapy_duration  New clinical field for PCAWG data    second_therapy_type  New clinical field for PCAWG data    second_therapy_response  New clinical field for PCAWG data    second_therapy_therapeutic_intent  New clinical field for PCAWG data    other_therapy  New clinical field for PCAWG data    other_therapy_response  New clinical field for PCAWG data     Dictionary viewer Tool highlights differences between different dictionary versions. Please try it out  here", 
            "title": "Dictionary v0.11c (April., 2015, Release 19)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-18/", 
            "text": "Dictionary v0.10a (October., 2014, Release 18)\n\n\nChanges to Specifications Since Version 0.9a (June., 2014)\n\n\nRevisions to Data Elements: Changes\n\n\nSimple Somatics Mutation - metadata (ssm_m), Copy Number Somatic Mutations - metadata (cnsm_m) and Structural Somatic Mutations (stsm_m) Files \n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nmatched_sample_id\n\n\nAdded an MVEL script restriction to prevent identical sample identifiers in both the matched_sample_id field and analyzed_sample_id fields.\n\n\n\n\n\n\n\n\nAll Metadata Files\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nraw_data_accession\n\n\nUpdated MVEL script to check format of accession ID when raw_data_repository is TARGET\n\n\n\n\n\n\n\n\nRevisions to CV Tables:\n\n\nGLOBAL.0.raw_data_repository.v2\n\n\n\n\nNew raw data repository TARGET added to codelist.\n\n\n\n\nDictionary viewer Tool highlights differences between different dictionary versions. Please try it out \nhere", 
            "title": "Dictionary - Release 18"
        }, 
        {
            "location": "/submission/dictionary/dictionary-18/#dictionary-v010a-october-2014-release-18", 
            "text": "", 
            "title": "Dictionary v0.10a (October., 2014, Release 18)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-18/#changes-to-specifications-since-version-09a-june-2014", 
            "text": "Revisions to Data Elements: Changes  Simple Somatics Mutation - metadata (ssm_m), Copy Number Somatic Mutations - metadata (cnsm_m) and Structural Somatic Mutations (stsm_m) Files      Data Element ID  Comment      matched_sample_id  Added an MVEL script restriction to prevent identical sample identifiers in both the matched_sample_id field and analyzed_sample_id fields.     All Metadata Files     Data Element ID  Comment      raw_data_accession  Updated MVEL script to check format of accession ID when raw_data_repository is TARGET     Revisions to CV Tables:  GLOBAL.0.raw_data_repository.v2   New raw data repository TARGET added to codelist.   Dictionary viewer Tool highlights differences between different dictionary versions. Please try it out  here", 
            "title": "Changes to Specifications Since Version 0.9a (June., 2014)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-17/", 
            "text": "Dictionary v0.9a (June., 2014. Release 17)\n\n\nMIGRATING VALIDATED RELEASE 16 DATA TO RELEASE 17\n\n\nSince changes to dictionary are minimal in this Release, DCC has made available migration scripts to help you convert your validated Release 16 submission files to Release 17. The scripts will perform the folllowing:\n\n\n\n\nRemoves columns no longer required\n\n\nPerforms the specimen_type mapping between old specimen_type terms and the new specimen_type terms. (Note: Perl script added for Perl users)\n\n\n\n\nDownload the script package from here or at GitHub . For more details, please review the README file in the package before executing.\n\n\nChanges to Specifications Since Version 0.8d (March., 2014)\n\n\nRevisions to Data Elements: Changes\n\n\nSpecimen Data File (specimen) \n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nspecimen_type\n\n\nMandatory. No longer accepts -777/-888\nNew specimen_type codelist\nPlease see the \n specimen mapping \n table describing how to map the \nold\n specimen_type terms to the \nnew\n specimen_type terms. For TCGA projects, this table also provides mapping between TCGA specimen types and the new specimen_type terms. \n\n\n\n\n\n\nspecimen_type_other\n\n\nNew MVEL script restriction. If specimen_type is either \"Normal - other\", \"Primary tumour - other\" or \"Recurrent tumour - other\", then specimen_type_other field must be filled in\n\n\n\n\n\n\n\n\nAnalyzed Sample Data File (sample) \n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nanalyzed_sample_type\n\n\nRemoved\n\n\n\n\n\n\nanalyzed_sample_type_other\n\n\nRemoved\n\n\n\n\n\n\n\n\nAll Data Type Files\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nnote\n\n\nRemoved\n\n\n\n\n\n\nraw_data_accession\n\n\nThe regular expression has been modified to allow submitters to submit:\nBoth EGA Study and Dataset IDs, delimited by a colon. Example: EGAS00001000354:EGAD00001000983\nsubmit EGA Sample ID, provided the EGA Study and Dataset accession IDs are submitted as well (delimited by a colon). Example: EGAS00001000354:EGAD00001000983:EGAN00001142752\nSubmitting just the EGA Study/Dataset accession IDs for raw_data_accession (as in previous Releases) is still valid.\n\n\n\n\n\n\n\n\nCopy Number - Metadata file (cnsm_m)\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nsequencing_strategy\n\n\nMandatory. No longer accepts -777/-888\n\n\n\n\n\n\n\n\nRevisions to CV Tables:\n\n\n**specimen.0.specimen_type.v3\n**\n\n\n\n\nNew more comprehensive specimen types.\n\n\nIn line with PanCancer tumour/normal designations", 
            "title": "Dictionary - Release 17"
        }, 
        {
            "location": "/submission/dictionary/dictionary-17/#dictionary-v09a-june-2014-release-17", 
            "text": "", 
            "title": "Dictionary v0.9a (June., 2014. Release 17)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-17/#migrating-validated-release-16-data-to-release-17", 
            "text": "Since changes to dictionary are minimal in this Release, DCC has made available migration scripts to help you convert your validated Release 16 submission files to Release 17. The scripts will perform the folllowing:   Removes columns no longer required  Performs the specimen_type mapping between old specimen_type terms and the new specimen_type terms. (Note: Perl script added for Perl users)   Download the script package from here or at GitHub . For more details, please review the README file in the package before executing.", 
            "title": "MIGRATING VALIDATED RELEASE 16 DATA TO RELEASE 17"
        }, 
        {
            "location": "/submission/dictionary/dictionary-17/#changes-to-specifications-since-version-08d-march-2014", 
            "text": "Revisions to Data Elements: Changes  Specimen Data File (specimen)      Data Element ID  Comment      specimen_type  Mandatory. No longer accepts -777/-888 New specimen_type codelist Please see the   specimen mapping   table describing how to map the  old  specimen_type terms to the  new  specimen_type terms. For TCGA projects, this table also provides mapping between TCGA specimen types and the new specimen_type terms.     specimen_type_other  New MVEL script restriction. If specimen_type is either \"Normal - other\", \"Primary tumour - other\" or \"Recurrent tumour - other\", then specimen_type_other field must be filled in     Analyzed Sample Data File (sample)      Data Element ID  Comment      analyzed_sample_type  Removed    analyzed_sample_type_other  Removed     All Data Type Files     Data Element ID  Comment      note  Removed    raw_data_accession  The regular expression has been modified to allow submitters to submit: Both EGA Study and Dataset IDs, delimited by a colon. Example: EGAS00001000354:EGAD00001000983 submit EGA Sample ID, provided the EGA Study and Dataset accession IDs are submitted as well (delimited by a colon). Example: EGAS00001000354:EGAD00001000983:EGAN00001142752 Submitting just the EGA Study/Dataset accession IDs for raw_data_accession (as in previous Releases) is still valid.     Copy Number - Metadata file (cnsm_m)     Data Element ID  Comment      sequencing_strategy  Mandatory. No longer accepts -777/-888     Revisions to CV Tables:  **specimen.0.specimen_type.v3 **   New more comprehensive specimen types.  In line with PanCancer tumour/normal designations", 
            "title": "Changes to Specifications Since Version 0.8d (March., 2014)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-16/", 
            "text": "Dictionary v0.8d (Mar., 2014. Release 16)\n\n\nNEW: Our new Dictionary Comparison Tool highlights differences between different dictionary versions. Please try it out \nhere\n\n\nMarch 31th 2014:\n\n\nChange between 0.8c and 0.8d:\n \n\n\n\n\nModified MVEL script restriction for \"mutated_to_allele\" in SSM Primary data file specification to handle homozygous -\n heterozygous mutations. \n\n\n\n\nMarch 19th 2014:\n\n\nChange between 0.8b and 0.8c:\n \n\n\n\n\nChanged \"total_read_count\" in \nexp_seq_m\n and \nmirna_seq_m\n to accept N/A reserve codes. Also added a link to WHO International Histological Classification of Tumours for the \"tumour_histological_type\" field in \nspecimen data specification\n \n\n\n\n\nMarch 11th 2014:\n\n\nChange between 0.8a and 0.8b:\n \n\n\n\n\nAdded a MVEL script restriction for \"mutated_to_allele\" field in Simple Somatic Mutations Primary File (ssm_p). See example \nhere\n \n\n\n\n\nChanges to Specifications Since Version 0.7e (Jan., 2014)\n\n\nImprovements:\n\n\n\n\nIncremental submission is now supported, please see \nhere\n for more information\n\n\nSelective validation is now supported, please see \nhere\n for more information\n\n\nArray-based submission formats have been heavily revised to improve compactness and reduce file sizes. These include:\n\n\nSequencing-based DNA Methylation (\nmeth_seq_m\n and \n meth_seq_p \n)\n\n\nArray-based DNA Methylation (\nmeth_array_m\n and \n meth_array_p \n)\n\n\nSequencing-based Gene Expression (\nexp_seq_m\n and \n exp_seq_p \n)\n\n\nArray-based Gene Expression (\nexp_array_m\n and \n exp_array_p \n)\n\n\nSequencing-based miRNA Expression (\nmirna_seq_m\n and \n mirna_seq_p \n)\n\n\n\n\n\n\n\n\nNOTE:\n For Array-based methylation data, probe IDs will be cross-referenced against array manifest files. Please click \n here \n for additional details. If your array manifest file is not included in the list, please contact DCC.\n\n\n\n\nPlease see our dictionary diff tool \nhere\n for more information\n\n\n\n\nRevisions to Data Elements: Additions\n\n\nAnalyzed Sample Data File (sample) \n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nstudy\n\n\nnew\nallows submitter to indicate if sample is part of study (ie. PanCancer)\n\n\n\n\n\n\n\n\nRevisions to Data Elements: Changes\n\n\nCopy Number Somatic Mutations (cnsm) - Primary Analysis File (p):\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nbiological_validation_status\n\n\nchanged to accept N/A reserve code -888\n\n\n\n\n\n\n\n\nSimple Somatic Mutations (ssm) - Primary Analysis File (p):\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nbiological_validation_status\n\n\nchanged to accept N/A reserve code -888", 
            "title": "Dictionary - Release 16"
        }, 
        {
            "location": "/submission/dictionary/dictionary-16/#dictionary-v08d-mar-2014-release-16", 
            "text": "NEW: Our new Dictionary Comparison Tool highlights differences between different dictionary versions. Please try it out  here  March 31th 2014:  Change between 0.8c and 0.8d:     Modified MVEL script restriction for \"mutated_to_allele\" in SSM Primary data file specification to handle homozygous -  heterozygous mutations.    March 19th 2014:  Change between 0.8b and 0.8c:     Changed \"total_read_count\" in  exp_seq_m  and  mirna_seq_m  to accept N/A reserve codes. Also added a link to WHO International Histological Classification of Tumours for the \"tumour_histological_type\" field in  specimen data specification     March 11th 2014:  Change between 0.8a and 0.8b:     Added a MVEL script restriction for \"mutated_to_allele\" field in Simple Somatic Mutations Primary File (ssm_p). See example  here", 
            "title": "Dictionary v0.8d (Mar., 2014. Release 16)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-16/#changes-to-specifications-since-version-07e-jan-2014", 
            "text": "Improvements:   Incremental submission is now supported, please see  here  for more information  Selective validation is now supported, please see  here  for more information  Array-based submission formats have been heavily revised to improve compactness and reduce file sizes. These include:  Sequencing-based DNA Methylation ( meth_seq_m  and   meth_seq_p  )  Array-based DNA Methylation ( meth_array_m  and   meth_array_p  )  Sequencing-based Gene Expression ( exp_seq_m  and   exp_seq_p  )  Array-based Gene Expression ( exp_array_m  and   exp_array_p  )  Sequencing-based miRNA Expression ( mirna_seq_m  and   mirna_seq_p  )     NOTE:  For Array-based methylation data, probe IDs will be cross-referenced against array manifest files. Please click   here   for additional details. If your array manifest file is not included in the list, please contact DCC.   Please see our dictionary diff tool  here  for more information   Revisions to Data Elements: Additions  Analyzed Sample Data File (sample)      Data Element ID  Comment      study  new allows submitter to indicate if sample is part of study (ie. PanCancer)     Revisions to Data Elements: Changes  Copy Number Somatic Mutations (cnsm) - Primary Analysis File (p):     Data Element ID  Comment      biological_validation_status  changed to accept N/A reserve code -888     Simple Somatic Mutations (ssm) - Primary Analysis File (p):     Data Element ID  Comment      biological_validation_status  changed to accept N/A reserve code -888", 
            "title": "Changes to Specifications Since Version 0.7e (Jan., 2014)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-15/", 
            "text": "Dictionary v0.7e (Jan., 2014. Release 15)\n\n\nJanuary 10th 2014:\n\n\nChange between 0.7d and 0.7e:\n \n\n\n\n\nRemoved MVEL script restriction for expressed_allele in Simple Somatic Mutations Primary (ssm_p) data file specification  \n\n\n\n\nJanuary 6th 2014:\n\n\nChange between 0.7c and 0.7d:\n \n\n\n\n\nMVEL script restriction changed in Simple Somatic Mutations (ssm_p) and Simple Germline Variation (sgv_p) Primary data file specification so mutant_allele_read_count and variant_allele_read_count can also be equal to total_read_count  \n\n\n\n\nDecember 12th 2013:\n\n\nChange between 0.7b and 0.7c:\n \n\n\n\n\nAllows submission of RNAseq data. \nPlease note, we are not accepting array-based data though for this Release\n  \n\n\n\n\nDecember 11th 2013:\n\n\nChange between 0.7a and 0.7b:\n \n\n\n\n\nA check was added to ensure the chromosome start position is less than or equal to the chromosome end position. This check was implemented in the MVEL script restriction for the \"chromosome_start\" and \"chromosome_end\" data elements.\n\n\n\n\nChanges to Specifications Since Version 0.6e (Sept 2013)\n\n\nImprovements:\n\n\n\n\nImproved Simple Somatic Mutation (SSM) submission file specification, added detailed explanation and examples.\n\n\nSimplified regular expressions in DCC Data Element specification\n\n\nExamples now provided for certain data elements to show valid values\n\n\nCross-field validation checks using MVEL scripts\n\n\nAdditional notes explaining validation criteria.\n\n\nImproved error reporting in submission system\n\n\n\n\nOther Changes:\n\n\n\n\nColumn order and case must match data file specification order/case\n\n\nExtra columns no longer allowed\n\n\nSimple Somatic Mutations restricted to forward strand\n\n\nStandardized file naming convention enforced\n\n\nOnly assembly version GRCh37 used\n\n\n\n\nRevisions to Data Elements:\n\n\nSimple Somatic Mutations - Primary File (ssm_p):\n\n\nChanges made to Simple Somatic Mutations (SSM) primary file to handle open/controlled access germline data:\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nchromosome_strand\n\n\nrestricted to forward strand (1) (required)\n\n\n\n\n\n\nrefsnp_allele\n\n\nRemoved\n\n\n\n\n\n\nrefsnp_strand\n\n\nRemoved\n\n\n\n\n\n\ncontrol_genotype\n\n\nchanged to controlled-access (required)\n\n\n\n\n\n\nmutated_from_allele\n\n\nnew field, controlled-access (required)\ndefined as the allele that is believed to be the original allele in the ancestral cell that was mutated in the tumour cell.\n\n\n\n\n\n\nmutated_to_allele\n\n\nnew field, open access (required)\ndefined as the new allele identified in the tumour sample that is believed to be the resulting allele of a somatic mutation event during tumourgenesis.\n\n\n\n\n\n\ntumour_genotype\n\n\nchanged to controlled-access (required)\n\n\n\n\n\n\nmutation_id\n\n\nRemoved\n\n\n\n\n\n\nexpressed_allele\n\n\nchanged to controlled-access (N/A valid)\n\n\n\n\n\n\ntotal_read_count\n\n\nrenamed from \"read_count\" (required)\n\n\n\n\n\n\nis_annotated\n\n\nRemoved\n\n\n\n\n\n\nmutant_allele_read_count\n\n\nnew field (required)\ndefined as the total number of raw reads containing the mutant allele\n\n\n\n\n\n\nxref_ensembl_id\n\n\nRemoved\n\n\n\n\n\n\nbiological_validation_status\n\n\nnew field (required)\ndefined as whether the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing\n\n\n\n\n\n\nbiological_validation_platform\n\n\nnew field (N/A valid)\ndefined as the identifier of assay platform or technology used to validate the mutation/variation\n\n\n\n\n\n\nuri\n\n\nRemoved\n\n\n\n\n\n\ndb_xref\n\n\nRemoved\n\n\n\n\n\n\n\n\nSimple Somatic Mutations - Secondary File (ssm_s)\n\n\n\n\nRemoved\n\n\n\n\nSimple Germline Variation - Primary File (sgv_p)\n\n\n\n\nRemoved\n\n\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nvariant_id\n\n\nRemoved\n\n\n\n\n\n\nchromosome_strand\n\n\nrestricted to forward strand (1) (required)\n\n\n\n\n\n\nrefsnp_allele\n\n\nRemoved\n\n\n\n\n\n\nrefsnp_strand\n\n\nRemoved\n\n\n\n\n\n\ngenotype\n\n\nrenamed from \"control_genotype\" (required)\n\n\n\n\n\n\nvariant_allele\n\n\nnew field (required)\ndefined as the allele in the genotype that is different from the reference genome allele\n\n\n\n\n\n\ntumour_genotype\n\n\nRemoved\n\n\n\n\n\n\nexpessed_allele\n\n\nRemoved\n\n\n\n\n\n\ntotal_read_count\n\n\nrenamed from \"read_count\" (required)\n\n\n\n\n\n\nvariant_allele_read_count\n\n\nnew field (required)\ndefined as number of raw reads containing variant allele\n\n\n\n\n\n\nis_annotated\n\n\nRemoved\n\n\n\n\n\n\nxref_ensembl_id\n\n\nRemoved\n\n\n\n\n\n\nuri\n\n\nRemoved\n\n\n\n\n\n\ndb_xref\n\n\nRemoved\n\n\n\n\n\n\nnote\n\n\nRemoved\n\n\n\n\n\n\n\n\nSimple Germline Variation - Metadata File (sgv_m):\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\nmatched_sample_id\n\n\nRemoved\n\n\n\n\n\n\nuri\n\n\nRemoved\n\n\n\n\n\n\ndb_xref\n\n\nRemoved\n\n\n\n\n\n\n\n\nSpecimen and Sample Files:\n\n\n\n\n\n\n\n\nData Element ID\n\n\nComment\n\n\n\n\n\n\n\n\n\n\npercentage_cellularity\n\n\nRemoved\n\n\n\n\n\n\nlevel_of_cellularity\n\n\nRemoved\n\n\n\n\n\n\n\n\nFor all other Data types (Copy Number Somatic Mutations (cnsm), Gene Expression (gene), miRNA Expression (mirna), Structural Somatic Mutations (stsm) and Splice Variation (jcn)) including Primary, Secondary and Metadata files:\n\n\n\n\nremoved \"\nuri\n\" and \"\ndb_xref\n\" from all submission files\n\n\nadded \n\"biological_validation_status\n\" and \"\nbiological_validation_platform\n\" to all primary files\n\n\n\n\nRevisions to CV Tables:\n\n\nGLOBAL.0.chromosome\n\n\n\n\nchanged Term IDs to actual chromosome values, ie X, Y, MT instead of 23, 24, 25\n\n\nremoved all other contigs in GRCh37\n\n\n\n\nGLOBAL.0.assembly\n:\n\n\n\n\nChanged to accept only GRCh37\n\n\n\n\nGLOBAL.0.sequencing_strategy\n:\n\n\n\n\nAdded new term: \"Non-NGS\"\n\n\n\n\nGLOBAL.0.verification_status\n:\n\n\n\n\nMade descriptions under \"Term\" more specific\n\n\n\n\nspecimen.0.cellularity.v1\n:\n\n\n\n\nnew table for \"level_of_cellularity\" data element in Specimen data file\n\n\n\n\nGLOBAL.0.biological_validation_status.v1\n:\n\n\n\n\nnew table for \"biological_validation_status\" data element in primary files", 
            "title": "Dictionary - Release 15"
        }, 
        {
            "location": "/submission/dictionary/dictionary-15/#dictionary-v07e-jan-2014-release-15", 
            "text": "January 10th 2014:  Change between 0.7d and 0.7e:     Removed MVEL script restriction for expressed_allele in Simple Somatic Mutations Primary (ssm_p) data file specification     January 6th 2014:  Change between 0.7c and 0.7d:     MVEL script restriction changed in Simple Somatic Mutations (ssm_p) and Simple Germline Variation (sgv_p) Primary data file specification so mutant_allele_read_count and variant_allele_read_count can also be equal to total_read_count     December 12th 2013:  Change between 0.7b and 0.7c:     Allows submission of RNAseq data.  Please note, we are not accepting array-based data though for this Release      December 11th 2013:  Change between 0.7a and 0.7b:     A check was added to ensure the chromosome start position is less than or equal to the chromosome end position. This check was implemented in the MVEL script restriction for the \"chromosome_start\" and \"chromosome_end\" data elements.", 
            "title": "Dictionary v0.7e (Jan., 2014. Release 15)"
        }, 
        {
            "location": "/submission/dictionary/dictionary-15/#changes-to-specifications-since-version-06e-sept-2013", 
            "text": "Improvements:   Improved Simple Somatic Mutation (SSM) submission file specification, added detailed explanation and examples.  Simplified regular expressions in DCC Data Element specification  Examples now provided for certain data elements to show valid values  Cross-field validation checks using MVEL scripts  Additional notes explaining validation criteria.  Improved error reporting in submission system   Other Changes:   Column order and case must match data file specification order/case  Extra columns no longer allowed  Simple Somatic Mutations restricted to forward strand  Standardized file naming convention enforced  Only assembly version GRCh37 used   Revisions to Data Elements:  Simple Somatic Mutations - Primary File (ssm_p):  Changes made to Simple Somatic Mutations (SSM) primary file to handle open/controlled access germline data:     Data Element ID  Comment      chromosome_strand  restricted to forward strand (1) (required)    refsnp_allele  Removed    refsnp_strand  Removed    control_genotype  changed to controlled-access (required)    mutated_from_allele  new field, controlled-access (required) defined as the allele that is believed to be the original allele in the ancestral cell that was mutated in the tumour cell.    mutated_to_allele  new field, open access (required) defined as the new allele identified in the tumour sample that is believed to be the resulting allele of a somatic mutation event during tumourgenesis.    tumour_genotype  changed to controlled-access (required)    mutation_id  Removed    expressed_allele  changed to controlled-access (N/A valid)    total_read_count  renamed from \"read_count\" (required)    is_annotated  Removed    mutant_allele_read_count  new field (required) defined as the total number of raw reads containing the mutant allele    xref_ensembl_id  Removed    biological_validation_status  new field (required) defined as whether the mutation/variation has been observed in a larger cohort/sample size, and is not an artifact or consequence of sample selection for sequencing    biological_validation_platform  new field (N/A valid) defined as the identifier of assay platform or technology used to validate the mutation/variation    uri  Removed    db_xref  Removed     Simple Somatic Mutations - Secondary File (ssm_s)   Removed   Simple Germline Variation - Primary File (sgv_p)   Removed      Data Element ID  Comment      variant_id  Removed    chromosome_strand  restricted to forward strand (1) (required)    refsnp_allele  Removed    refsnp_strand  Removed    genotype  renamed from \"control_genotype\" (required)    variant_allele  new field (required) defined as the allele in the genotype that is different from the reference genome allele    tumour_genotype  Removed    expessed_allele  Removed    total_read_count  renamed from \"read_count\" (required)    variant_allele_read_count  new field (required) defined as number of raw reads containing variant allele    is_annotated  Removed    xref_ensembl_id  Removed    uri  Removed    db_xref  Removed    note  Removed     Simple Germline Variation - Metadata File (sgv_m):     Data Element ID  Comment      matched_sample_id  Removed    uri  Removed    db_xref  Removed     Specimen and Sample Files:     Data Element ID  Comment      percentage_cellularity  Removed    level_of_cellularity  Removed     For all other Data types (Copy Number Somatic Mutations (cnsm), Gene Expression (gene), miRNA Expression (mirna), Structural Somatic Mutations (stsm) and Splice Variation (jcn)) including Primary, Secondary and Metadata files:   removed \" uri \" and \" db_xref \" from all submission files  added  \"biological_validation_status \" and \" biological_validation_platform \" to all primary files   Revisions to CV Tables:  GLOBAL.0.chromosome   changed Term IDs to actual chromosome values, ie X, Y, MT instead of 23, 24, 25  removed all other contigs in GRCh37   GLOBAL.0.assembly :   Changed to accept only GRCh37   GLOBAL.0.sequencing_strategy :   Added new term: \"Non-NGS\"   GLOBAL.0.verification_status :   Made descriptions under \"Term\" more specific   specimen.0.cellularity.v1 :   new table for \"level_of_cellularity\" data element in Specimen data file   GLOBAL.0.biological_validation_status.v1 :   new table for \"biological_validation_status\" data element in primary files", 
            "title": "Changes to Specifications Since Version 0.6e (Sept 2013)"
        }, 
        {
            "location": "/submission/faq/", 
            "text": "Data Submission FAQ\n\n\nHow do I upload my files to the submission system?\n\n\nBefore using the web-based submission system, you must upload your submission files to the SFTP server. Logging into the web submission system can be accomplished using your existing project SFTP account and password. For more details, visit the \nFile Submission\n page.  \n\n\nWhere can I find that latest DCC data file specification?\n\n\nYou can find the latest DCC data file specification and Release notes \nhere\n.\n\n\nHow do I put my submission files together?\n\n\nSubmission files must follow the rules in the DCC Data File specification. More details about submission file format can be found \nhere\n\n\nHow do I submit information about a simple somatic mutation?\n\n\nExamples of the format required for mutations can be found \nhere\n. Note, this is not a new format and has always been enforced by ICGC.\n\n\nWhere do I find the Release Notes showing changes between the last DCC data file\n\n\nspecification and the current DCC data file specification?\n\n\nThe latest dictionary Release Notes can be found \nhere\n\n\nWhat assembly version do you use?\n\n\nICGC DCC uses hg19 (GrCh37).\n\n\nHow do I get the JSON format of the DCC data file specification?\n\n\nYou can access the JSON format of the DCC data specification via REST webservice:\n\n\ncurl -v -XGET  -H \"Accept: application/json\"\n\n\nOptional: Format JSON to more readable format:\n\n\npython -mjson [name of JSON dictionary file downloaded in previous step] \n dictionary.mjson\n\n\nTo access the JSON format of the controlled vocabulary tables via REST webservice:\n\n\ncurl -v -XGET  -H \"Accept: application/json\"\n\n\nWhat do -777 and -888 mean? How do I use them?\n\n\n-777 and -888 are reserve codes accepted by ICGC for data elements where the data is verified to be unknown, or the information is not applicable. Details and examples can be found \nhere\n\n\nI got an error message during validation that I don't understand! How do I get more details?\n\n\nOnce validation is complete, you will be able to view a report generated by the submission system which gives details about errors. In addition, please refer to the \"Additional Notes\" section of the data file specification tables for each data type, which explain cross-field restrictions. If you encounter an error message you do not understand, please contact \ndcc-support@icgc.org\n.\n\n\nI can't log into the submission system. I think I forgot my username/password. How do I retrieve it?\n\n\nThe submission system will lock a user out if a password is entered incorrectly three times. Should you find yourself locked out, or if you have forgotten your password, please contact \ndcc-support@icgc.org\n and we will reset it.\n\n\nHow do I obtain the accession number required for the \"raw_data_accession\" field?\n\n\nWhen you submit your raw sequencing data to EGA's EBI repository, EGA will supply you with an accession number. You will need to use this accession number to populate the \nraw_data_accession\n field in the submission files.\n\n\nWhy do I have to submit my raw data to EBI's EGA repository before submitting data to ICGC DCC?\n\n\nICGC member projects are required by ICGC policies to submit their raw sequencing reads, and other primary data, to controlled access public repositories. The official ICGC DCC-supported repository for \nICGC sequencing reads\n is the European Bioinformatics Institute's (EBI) \nEuropean Genome-phenome Archive (EGA)\n.\n\n\nWhat does open and controlled access mean?\n\n\nOpen access refers to all data that is publicly available in the portal without restrictions. Controlled access refers to protected data, such as germline SNPs, that requires user certification for access. For more information on how to access controlled tier data in the ICGC Data Portal and data deposited to the EGA, please contact \nDACO\n.\n\n\nWhat language are the cross-field validation scripts written in?\n\n\nThe cross-field validation scripts are implemented in \nMVEL\n\n\nCan I submit just clinical data without experimental data to ICGC?\n\n\nPlease be advised that donors, specimen, and analyzed_samples with no associated experimental results will be ignored and not reported DCC Data Portal release.\n\n\nWhat are \"percentage_of_cellularity\" and \"level_of_cellularity\" fields in the Specimen and Analyzed Sample Data File data file specifications? Do I need to fill both in?\n\n\nCellularity is defined as the proportion of tumour nuclei to total number of nuclei in a given specimen or analyzed sample. The cellularity at the specimen level (ie. pathologist reported) could be different from the cellularity reported at the sample level (ie. using sequencing methods such as cell sorting). The two fields \"percentage_of_cellularity\" and \"level_of_cellularity\" record the same piece of information, but give the submitter the option to submit the information as either an integer value (percentage_of_cellularity) or a range of percentages (level_of_cellularity). An example would be in the case where a pathologist can only specify the cellularity of a specimen to be within a certain range (40-50% for example), then the \"level_of_cellularity\" data element could be populated with \"3\" (which defines 41-60% in the controlled vocabulary table), and \"percentage_of_cellularity\" could be populated with \"-888\" (not applicable).", 
            "title": "FAQ"
        }, 
        {
            "location": "/submission/faq/#data-submission-faq", 
            "text": "", 
            "title": "Data Submission FAQ"
        }, 
        {
            "location": "/submission/faq/#how-do-i-upload-my-files-to-the-submission-system", 
            "text": "Before using the web-based submission system, you must upload your submission files to the SFTP server. Logging into the web submission system can be accomplished using your existing project SFTP account and password. For more details, visit the  File Submission  page.", 
            "title": "How do I upload my files to the submission system?"
        }, 
        {
            "location": "/submission/faq/#where-can-i-find-that-latest-dcc-data-file-specification", 
            "text": "You can find the latest DCC data file specification and Release notes  here .", 
            "title": "Where can I find that latest DCC data file specification?"
        }, 
        {
            "location": "/submission/faq/#how-do-i-put-my-submission-files-together", 
            "text": "Submission files must follow the rules in the DCC Data File specification. More details about submission file format can be found  here", 
            "title": "How do I put my submission files together?"
        }, 
        {
            "location": "/submission/faq/#how-do-i-submit-information-about-a-simple-somatic-mutation", 
            "text": "Examples of the format required for mutations can be found  here . Note, this is not a new format and has always been enforced by ICGC.", 
            "title": "How do I submit information about a simple somatic mutation?"
        }, 
        {
            "location": "/submission/faq/#where-do-i-find-the-release-notes-showing-changes-between-the-last-dcc-data-file", 
            "text": "specification and the current DCC data file specification?  The latest dictionary Release Notes can be found  here", 
            "title": "Where do I find the Release Notes showing changes between the last DCC data file"
        }, 
        {
            "location": "/submission/faq/#what-assembly-version-do-you-use", 
            "text": "ICGC DCC uses hg19 (GrCh37).", 
            "title": "What assembly version do you use?"
        }, 
        {
            "location": "/submission/faq/#how-do-i-get-the-json-format-of-the-dcc-data-file-specification", 
            "text": "You can access the JSON format of the DCC data specification via REST webservice:  curl -v -XGET  -H \"Accept: application/json\"  Optional: Format JSON to more readable format:  python -mjson [name of JSON dictionary file downloaded in previous step]   dictionary.mjson  To access the JSON format of the controlled vocabulary tables via REST webservice:  curl -v -XGET  -H \"Accept: application/json\"", 
            "title": "How do I get the JSON format of the DCC data file specification?"
        }, 
        {
            "location": "/submission/faq/#what-do-777-and-888-mean-how-do-i-use-them", 
            "text": "-777 and -888 are reserve codes accepted by ICGC for data elements where the data is verified to be unknown, or the information is not applicable. Details and examples can be found  here", 
            "title": "What do -777 and -888 mean? How do I use them?"
        }, 
        {
            "location": "/submission/faq/#i-got-an-error-message-during-validation-that-i-dont-understand-how-do-i-get-more-details", 
            "text": "Once validation is complete, you will be able to view a report generated by the submission system which gives details about errors. In addition, please refer to the \"Additional Notes\" section of the data file specification tables for each data type, which explain cross-field restrictions. If you encounter an error message you do not understand, please contact  dcc-support@icgc.org .", 
            "title": "I got an error message during validation that I don't understand! How do I get more details?"
        }, 
        {
            "location": "/submission/faq/#i-cant-log-into-the-submission-system-i-think-i-forgot-my-usernamepassword-how-do-i-retrieve-it", 
            "text": "The submission system will lock a user out if a password is entered incorrectly three times. Should you find yourself locked out, or if you have forgotten your password, please contact  dcc-support@icgc.org  and we will reset it.", 
            "title": "I can't log into the submission system. I think I forgot my username/password. How do I retrieve it?"
        }, 
        {
            "location": "/submission/faq/#how-do-i-obtain-the-accession-number-required-for-the-raw_data_accession-field", 
            "text": "When you submit your raw sequencing data to EGA's EBI repository, EGA will supply you with an accession number. You will need to use this accession number to populate the  raw_data_accession  field in the submission files.", 
            "title": "How do I obtain the accession number required for the \"raw_data_accession\" field?"
        }, 
        {
            "location": "/submission/faq/#why-do-i-have-to-submit-my-raw-data-to-ebis-ega-repository-before-submitting-data-to-icgc-dcc", 
            "text": "ICGC member projects are required by ICGC policies to submit their raw sequencing reads, and other primary data, to controlled access public repositories. The official ICGC DCC-supported repository for  ICGC sequencing reads  is the European Bioinformatics Institute's (EBI)  European Genome-phenome Archive (EGA) .", 
            "title": "Why do I have to submit my raw data to EBI's EGA repository before submitting data to ICGC DCC?"
        }, 
        {
            "location": "/submission/faq/#what-does-open-and-controlled-access-mean", 
            "text": "Open access refers to all data that is publicly available in the portal without restrictions. Controlled access refers to protected data, such as germline SNPs, that requires user certification for access. For more information on how to access controlled tier data in the ICGC Data Portal and data deposited to the EGA, please contact  DACO .", 
            "title": "What does open and controlled access mean?"
        }, 
        {
            "location": "/submission/faq/#what-language-are-the-cross-field-validation-scripts-written-in", 
            "text": "The cross-field validation scripts are implemented in  MVEL", 
            "title": "What language are the cross-field validation scripts written in?"
        }, 
        {
            "location": "/submission/faq/#can-i-submit-just-clinical-data-without-experimental-data-to-icgc", 
            "text": "Please be advised that donors, specimen, and analyzed_samples with no associated experimental results will be ignored and not reported DCC Data Portal release.", 
            "title": "Can I submit just clinical data without experimental data to ICGC?"
        }, 
        {
            "location": "/submission/faq/#what-are-percentage_of_cellularity-and-level_of_cellularity-fields-in-the-specimen-and-analyzed-sample-data-file-data-file-specifications-do-i-need-to-fill-both-in", 
            "text": "Cellularity is defined as the proportion of tumour nuclei to total number of nuclei in a given specimen or analyzed sample. The cellularity at the specimen level (ie. pathologist reported) could be different from the cellularity reported at the sample level (ie. using sequencing methods such as cell sorting). The two fields \"percentage_of_cellularity\" and \"level_of_cellularity\" record the same piece of information, but give the submitter the option to submit the information as either an integer value (percentage_of_cellularity) or a range of percentages (level_of_cellularity). An example would be in the case where a pathologist can only specify the cellularity of a specimen to be within a certain range (40-50% for example), then the \"level_of_cellularity\" data element could be populated with \"3\" (which defines 41-60% in the controlled vocabulary table), and \"percentage_of_cellularity\" could be populated with \"-888\" (not applicable).", 
            "title": "What are \"percentage_of_cellularity\" and \"level_of_cellularity\" fields in the Specimen and Analyzed Sample Data File data file specifications? Do I need to fill both in?"
        }, 
        {
            "location": "/submission/guide/", 
            "text": "Guide\n\n\nOverview\n\n\nThere are five major steps in the data submission process:\n\n\n\n\nObtain login/password account from EGA's \nEBI\n repository/\n\n\nSubmit raw sequence data to the European Genome-phenome Archive\n\n\nPrepare the ICGC submission files according to DCC data format specifications\n\n\nSubmit files to the DCC Secure FTP server\n\n\nValidate submission files using web-based submission system\n\n\n\n\nFor Release 15, all submitted data must be based on \nHuman reference genome assembly\n \nGRCh37\n and \nEnsembl gene set\n \nversion 69\n.\n\n\nWhen submitting experimental data to the ICGC DCC, please make sure you've already deposited your raw data to the appropriate public data repositories (eg: sequencing reads to EBI EGA). You will need to populate the data elements \nraw_data_repository\n and \nraw_data_accession\n with the correct repository and accession number respectively.\n\n\nPlease contact the DCC (\n_dcc-support@icgc.org\n) if you have any questions or comments about the data submission process._\n\n\nNIGHT MODE", 
            "title": "Guide"
        }, 
        {
            "location": "/submission/guide/#guide", 
            "text": "", 
            "title": "Guide"
        }, 
        {
            "location": "/submission/guide/#overview", 
            "text": "There are five major steps in the data submission process:   Obtain login/password account from EGA's  EBI  repository/  Submit raw sequence data to the European Genome-phenome Archive  Prepare the ICGC submission files according to DCC data format specifications  Submit files to the DCC Secure FTP server  Validate submission files using web-based submission system   For Release 15, all submitted data must be based on  Human reference genome assembly   GRCh37  and  Ensembl gene set   version 69 .  When submitting experimental data to the ICGC DCC, please make sure you've already deposited your raw data to the appropriate public data repositories (eg: sequencing reads to EBI EGA). You will need to populate the data elements  raw_data_repository  and  raw_data_accession  with the correct repository and accession number respectively.  Please contact the DCC ( _dcc-support@icgc.org ) if you have any questions or comments about the data submission process._  NIGHT MODE", 
            "title": "Overview"
        }, 
        {
            "location": "/submission/software/", 
            "text": "Software\n\n\nOverview\n\n\nThis is the Software documentation page\n\n\nRelease Notes\n\n\nChanges in Submission System Software Release 3.6.1.1 - October 10, 2014\n\n\n\n\nAdded \"header-only file validation\" to inform the user of an unintended empty submission file\n\n\nAdded \"sample type validation\" to verify that samples referenced in meta file \nanalyzed_sample_id\n, \nmatched_sample_id\n and \nreference_sample_type\n fields are consistent with the \nspecimen_type\n field found in the associated specimen files.\n\n\n\n\nChanges in Submission System Software Release 2.6 - March 17, 2014\n\n\n\n\nIncremental data submission. Users can now manage their data submission directory and upload only new data. Please see \nhere\n for more information\n\n\nSupport multiple files. Data can be split in multiple files per data type\n\n\nSelective data validation. Users can now validate data by data type and not anymore the whole submission each time.\n\n\nNew user interface\n\n\nFaster validation engine\n\n\nMany bug fixes\n\n\n\n\nFor more information, please see the Submission System Guide available \n here \n. Please don't hesitate to contact us at \ndcc-support@icgc.org\n if you have any questions or to report any bugs.\n\n\nSincerely,\nThe DCC team.\n\n\nNIGHT MODE", 
            "title": "Software"
        }, 
        {
            "location": "/submission/software/#software", 
            "text": "", 
            "title": "Software"
        }, 
        {
            "location": "/submission/software/#overview", 
            "text": "This is the Software documentation page", 
            "title": "Overview"
        }, 
        {
            "location": "/submission/software/#release-notes", 
            "text": "", 
            "title": "Release Notes"
        }, 
        {
            "location": "/submission/software/#changes-in-submission-system-software-release-3611-october-10-2014", 
            "text": "Added \"header-only file validation\" to inform the user of an unintended empty submission file  Added \"sample type validation\" to verify that samples referenced in meta file  analyzed_sample_id ,  matched_sample_id  and  reference_sample_type  fields are consistent with the  specimen_type  field found in the associated specimen files.", 
            "title": "Changes in Submission System Software Release 3.6.1.1 - October 10, 2014"
        }, 
        {
            "location": "/submission/software/#changes-in-submission-system-software-release-26-march-17-2014", 
            "text": "Incremental data submission. Users can now manage their data submission directory and upload only new data. Please see  here  for more information  Support multiple files. Data can be split in multiple files per data type  Selective data validation. Users can now validate data by data type and not anymore the whole submission each time.  New user interface  Faster validation engine  Many bug fixes   For more information, please see the Submission System Guide available   here  . Please don't hesitate to contact us at  dcc-support@icgc.org  if you have any questions or to report any bugs.  Sincerely,\nThe DCC team.  NIGHT MODE", 
            "title": "Changes in Submission System Software Release 2.6 - March 17, 2014"
        }
    ]
}